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Abstract 
The intestine is exposed to a vast array of harmless dietary antigen as well as an 
enormous community of commensal bacteria. Alongside this harmless antigen, 
pathogens can enter the body via the intestinal mucosal surface. The intestinal 
immune system must discriminate between pathogens and innocuous antigens. 
Dendritic cells (DCs), present in the small intestine (SI) and colon, are 
fundamental in controlling intestinal immune responses; they migrate to the 
mesenteric lymph node (MLN) and prime effector or regulatory T cells. 
Furthermore, DCs direct the immune response in the gut-associated lymphoid 
tissues (GALT), the Peyer’s patches (PP) and isolated lymphoid follicles (ILFs).  
The aim of this work was to determine the anatomical origins of DCs in the MLN. 
First, the anatomical organisation of lymphatic vessels draining to the MLN from 
the SI and colon was investigated. Second, DC migration in mice lacking specific 
GALT was explored. Finally, the migration of DCs from PPs to the MLN was 
investigated. To achieve these aims, DC migration was studied using a variety of 
labelling methods, mice that lacked specific GALT were employed, and surgical 
procedures were used to collect DCs from the thoracic duct.   
Here, I demonstrate the anatomical segregation of DCs that migrate to the MLN 
from the SI and colon. This was reflected in differences in DC subset composition 
and antigen presentation in the SI and colon-draining nodes of the MLN. Separate 
analysis of MLN nodes will allow a more refined understanding of intestinal 
immune responses. All but one DC subset, CD103-CD11b- DCs, were still present 
in pseudo-afferent lymph from mice lacking both PPs and ILFs. This subset is 
therefore likely to originate from either PPs or ILFs. Surprisingly, CD103+CD8α+ 
DCs were present in these mice, showing that many CD8α+ DCs were resident in 
the lamina propria and are not limited to lymphoid tissue. Four DC subsets are 
able to migrate from the intestine in PP-null mice, suggesting that CD103-CD11b- 
DCs migrate specifically from ILFs. I then demonstrated that DCs migrate from 
PPs to the MLN. These migrating PP DCs expanded in response to a DC specific 
growth factor and their migration depended on CCR7 and S1P. These cells may 
play an important role in driving immune responses in the MLN and their 
manipulation could lead to advances in controlling intestinal immune responses. 
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Chapter 1:  Introduction 
1.1 Dendritic Cells- A Brief Introduction 
Dendritic cells (DCs) are specialised antigen presenting cells (APCs), which are 
essential for the induction and direction of an adaptive immune response. The 
term dendritic cell was coined in 1973 by Steinman and Cohn, who described a 
unique group of cells in the murine lymph nodes (LNs) and Peyer’s patches (PP) 
(Steinman and Cohn, 1973). Since this first account, the role of DCs in the 
immune system has been much investigated. It has become clear that DCs form a 
link between the innate and adaptive immune responses and represent an 
immunological communication system between peripheral tissues and organised 
secondary lymphoid tissues. 
DCs are present in the majority of tissues and organs throughout the body. They 
act as sentinels, continuously sampling their environment. They process antigen, 
undergo maturation and migrate from the periphery into organised lymphoid 
tissues by the lymphatic system. This is an essential step in the life cycle of a 
DC. Once in the draining LN they can interact with cells of the adaptive immune 
system required to initiate the immune response. This occurs in both the steady-
state and during inflammation, and can result in immunological tolerance or the 
initiation of an immune response. 
The extensive research into DCs has revealed that this term describes a 
heterogeneous population of cells, covering distinct subsets of DCs 
distinguishable by their expression of different surface markers, tissue 
distribution and functions. There are three major types of DCs: conventional DCs 
(cDCs), plasmacytoid DCs (pDCs) and follicular DCs (fDCs). fDCs are wholly 
different from cDCs and pDCs, they are not haematopoietic cells and present 
antigen in an MHC independent manner (Cyster et al., 2000; El Shikh et al., 
2009; Tew et al., 2001). Their main function is to maintain immunological 
memory in B cell follicles of secondary lymphoid organs (Aguzzi and Krautler, 
2010). As fDCs are distinct from cDCs and pDCs, and have not been the subject 
of my experiments, they will not be discussed further.  
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cDCs and pDCs are both present in peripheral tissue and both can prime naïve T 
cells (Kadowaki et al., 2001). cDCs are highly phagocytic while pDCs have poor 
phagocytic capacity. cDCs are able to migrate from the peripheral tissues to the 
LNs where they present antigen to naïve T cells. The migration of pDCs in 
afferent lymphatics is disputed. However, it is has been shown that pDCs are 
able to migrate to peripheral LNs via the blood (Ochando et al., 2006; Pascale et 
al., 2008; Yrlid et al., 2006b). Given the unique role that cDCs play in initiating 
and propagating the immune response and their ability to migrate from the 
periphery to the draining LNs, cDCs are being investigated further in this 
project. 
1.2 Dendritic Cell Development 
DCs in the periphery have a limited lifespan and must be continually replaced by 
circulating precursors. The precise origins of DCs and their differentiation 
programmes are complex and are only beginning to be fully understood. Models 
suggest that cDCs derive from committed cDC progenitors that develop in the 
bone marrow (BM) and travel via the blood to lymphoid organs and nonlymphoid 
organs, where they differentiate into mature cDCs (Fogg et al., 2006; Geissmann 
et al., 2010). Two distinct cell lineages can be recognised in the BM, myeloid 
and lymphoid. DCs represent a unique cell as they can be derived from both 
myeloid and lymphoid lineages (Manz et al., 2001). However, the majority of 
DCs in all compartments, except for the thymus, are derived from myeloid 
precursors (Liu and Nussenzweig, 2010; Naik, 2008). 
The development of DCs in BM involves the differentiation of haematopoietic 
stem cells (HSC) through a number of morphologically distinct intermediate 
stages. At each stage there is a progressive lineage commitment and cells lose 
the potential to give rise to other cell types. The HSC is able to give rise to 
common myeloid progenitors (CMP) and the granulocyte macrophage progenitor 
(GMP). The CMP gives rise to the DC and monocyte precursor (MDP). The MDP no 
longer has granulopoietic potential and is characterised by the expression of c-
kit, fms-like tyrosine kinase 3 (Flt3) and CX3CR1. This precursor is the first that 
is dedicated to the myeloid lineage (Fogg et al., 2006). Following the MDP there 
is likely to be a common DC progenitor (CDP), which can give rise to pDCs and 
DCs although its position remains controversial (Auffray et al., 2009; Naik et al., 
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2007; Onai et al., 2007). Previous work suggested that monocytes were able to 
differentiate into DCs following transendothelial migration, while monocytes 
that remained in the subendothelial matrix differentiated into macrophages 
(Randolph et al., 1998). However, it has become clear that there is actually a 
DC-committed precursor that is independent of monocytes. The CDP has been 
shown to give rise to pDCs directly, and to the pre-cDC that can differentiate 
into cDCs but not pDCs (Diao et al., 2006; Fogg et al., 2006; Naik et al., 2006). 
This process is depicted in Figure 1.1. 
 
 
Figure 1-1 Dendritic Cell Development. 
DCs in BM differentiate from haematopoietic stem cells (HSC). The HSC gives rise to the common 
myeloid progenitors (CMP) or the granulocyte macrophage progenitor (GMP). The CMP gives rise 
to the DC and monocyte precursor (MDP). Following the MDP there is likely to be a common DC 
progenitor which can give rise to pDCs and DCs. The MDP has been shown to give rise to pDCs 
directly, and to the pre-cDC that can differentiate into cDCs but not pDCs. 
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1.2.1  Cytokines Involved In Dendritic Cell Development 
FLt3 and its ligand Flt3L are essential for the development of DCs in mice and 
humans (Naik et al., 2007). Various cell types constitutively secrete Flt3L 
including endothelial cells and activated T cells. However, the expression of the 
Flt3 receptor is restricted to the DC lineage. In vitro the addition of Flt3L to BM 
is sufficient to drive the differentiation of DCs, which closely resemble 
physiologically relevant populations of DCs in the steady-state (Naik et al., 
2005). The loss of Flt3 expression in haematopoietic cells results in the loss of 
the ability of these cells to differentiate into DCs (Karsunky et al., 2003), a 
feature that can be rescued by increased expression of Flt3 in progenitors (Onai 
et al., 2006). The injection or induced expression of Flt3L in mice leads to a 
massive expansion of DCs in lymphoid and non-lymphoid organs, including the 
intestine (Schulz et al., 2009). Consistently, mice that are deficient in Flt3 or 
Flt3L have greatly reduced numbers of pDCs and cDCs in lymphoid organs 
(McKenna et al., 2000).  
Another growth factor that has been implicated in the generation of DCs is 
granulocyte macrophage-colony stimulating factor (GM-CSF, CSF-2). It is widely 
used for the in vitro generation of DCs from BM (Inaba et al., 1992). However, 
the DCs produced following culture with CSF-2 are functionally and 
morphologically different to cDCs isolated ex vivo (Inaba et al., 1992). Unlike 
Flt3L, CSF-2 has been implicated in controlling the development of inflammatory 
DCs (Inaba et al., 1992). However, it does not appear to be necessary in the 
development of steady-state DCs in lymphoid organs. Instead, it may be required 
as an additional growth factor in some non-lymphoid tissues, but only for some 
subsets of DCs (Bogunovic et al., 2009). Further work will be required to fully 
determine the role of CSF-2 as a growth factor for DCs in non-lymphoid tissues.  
Monocyte-colony stimulating factor (M-CSF, CSF-1) is an essential cytokine for 
the development of macrophages, however its role in the development of DCs 
remains uncertain. Although it was initially suggested that it was dispensable for 
the development of DCs, recent work has suggested that it may play a role. Data 
from CSF-1R green fluorescent protein (GFP) reporter mice indicated that the 
CSF-1R was expressed in most DCs present in lymphoid organs. However the 
exact correlation of the level of GFP expression with CSF-1R remains unclear 
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(MacDonald et al., 2005). Mice lacking CSF-1 had reduced numbers of DCs, 
however CSF-1 null mice also had reduced spleen size, which may perhaps 
explain the lower numbers of DCs (Naik, 2008). 
Taken together the data from these studies show that Flt3 is essential for the 
development of cDCs and pDCs under steady-state conditions, whereas CSF-2 
and CSF-1 play a more minor role. 
1.3 Conventional Dendritic Cell Subsets 
DCs can be divided into several groups and subsets. Here I will introduce some of 
these DC subsets. A more detailed account of migratory DC subsets in the 
context of the intestine will be presented in subsequent sections. 
Phenotypically, DCs have a forward and side scatter profile similar to monocytes 
and express the haematopoeitc marker CD45, the integrin CD11c and major 
histocompatibility complex class II (MHCII). DCs were first described in the 
mouse spleen and further subsets of DCs were also initially described here 
(Vremec et al., 1992). These subsets are considerably different, both in the 
expression of many genes, and functionally they appear to be specalised for 
different aspects of antigen presentation. Mouse splenic DCs were originally 
divided into two subsets based upon their expression of CD8α (Vremec et al., 
1992). CD8α+ DCs were also CD205+, CD11b- and CD172a-. In comparison CD8α- 
DCs are CD205-, CD11b+ and CD172a+. This CD8α- subset could further be divided 
into subsets based upon the expression of CD4. CD8α+ DCs do not express CD4 
(Vremec et al., 2000). These subsets have also been described within the 
resident DC compartment in LNs, although LNs also contain migratory 
populations from non-lymphoid organs such as the intestine, lung or skin 
(Annacker et al., 2005).  
As well as these DC subsets being phenotypically distinct, they are found in 
different areas of lymphoid organs and are functionally different. While CD8+ 
DCs are found in T cell zones, CD8- DCs are present in marginal zones (Steinman 
et al., 1997). Upon stimulation these CD8- DCs are able to migrate into T cell 
regions (Reis e Sousa et al., 1997). Functionally CD8α+ DCs play a fundamental 
role in antiviral responses, in the response to intracellular pathogens, and are 
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the most efficient DC subset for the uptake of apoptotic cells (Iyoda et al., 
2002). The CD8α+ DC subset is specialised for the presentation of exogenously-
derived antigen on MHC class I by a process known as cross presentation during 
which antigen is presented to CD8+ T cells (den Haan et al., 2000) (Schnorrer et 
al., 2006). Upon activation CD8α+ DCs produce IL-12, making them capable of 
driving the development of Th1 T cells and cytotoxic T cell responses from CD8+ 
T cells (Yamazaki et al., 2008). As well as this, CD8α+ DCs can produce 
transforming growth factor β (TGF-β) and have been shown to be more efficient 
in the induction of forkhead box P3 (Foxp3+) regulatory T cells (Yamazaki et al., 
2008). Therefore, these cells are ideally specialised to play a role in the 
induction of peripheral self-tolerance by capturing self-antigens and presenting 
them to naïve CD4+ and CD8+ T cells using the cross presentation pathway (Belz 
et al., 2002).  
In comparison to CD8α+ DCs, CD8α- DCs are less well characterised. They have 
been shown to have an overall better capacity for phagocytosis (Leenen et al., 
1998), and in vivo they appear to preferentially present antigen via MHCII 
(Yamazaki et al., 2008). CD8α-CD4- DCs are able to prime CD4+ T cells resulting 
in a tolerogenic response by their production of IL-10 via a TGF-β dependent 
mechanism (Zhang et al., 2005). This DC subset is not able to stimulate CD8+ T 
cells as well as CD8α+ DCs. In addition when a TLR agonist was used to stimulate 
CD8α-CD4- DCs they induced the development of CD4+ Th1/Th17 T cells (Zhang 
et al., 2010). Key differences between CD8α+ DCs and CD11b+ DCs are 
summerised in Figure 1.2. 
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Figure 1-2 Functions of Dendritic Cell Subsets 
Phenotypically distinct subsets of DCs have been described, CD8α+CD11b-CD4- DCs, CD8α-
CD11b+CD4- DCs and CD8α-CD11b+CD4+ DCs. CD8α+ DCs are found mainly in T cell zones within a 
lymph node, while CD11b+ DCs have been described residing within the marginal zone of a LN 
and migrating into T cell zones upon antigen uptake. CD8α+ DCs are able to cross-present antigen 
via MHC I, while CD11b+ DCs preferentially present antigen on MHC II. Additionally CD8α+ DCs are 
the most efficient subset for the uptake of apoptotic cells, while CD11b+ DCs have an enhanced 
capacity for phagocytosis. 
1.4 Plasmacytoid Dendritic Cells 
Plasmacytoid DCs (pDCs) are developmentally, phenotypically and functionally 
distinct from cDCs. They display MHCII, CD4, B220 and low levels of CD11c. They 
are specalised for mounting rapid type 1 IFN responses to nucleic acids that can 
be derived from viruses, bacteria or dead cells (Tang et al., 2010). In vivo 
depletion of pDCs results in abrogated production of IFN-α in response to 
cytomegalovirus infection (Dalod et al., 2002). Therefore pDCs play an essential 
role in anti-viral innate immune responses. Furthermore, pDCs promote the 
antiviral activity of other cells, including cDCs, NK cells, T cells and B cells. For 
example during infection with HIV, pDCs induce the maturation of cDCs via the 
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production of type 1 IFNs and TNF-α (Fonteneau et al., 2004). There is also 
evidence that pDCs play a role in autoimmunity; chronically activated pDCs and 
the high levels of IFN-α they produce have been implicated in the pathogenesis 
of systemic lupus erythematosus and psoriasis (Tang et al., 2010). 
1.5 Pattern Recognition By Dendritic Cells 
In the periphery DCs act as sentries, continually sampling the environment.  As 
well as transporting endocytosed material to secondary lymphoid organs, DCs are 
able to monitor this matter by their expression of pattern recognition receptors 
(PRRs). These are activated by molecular motifs associated with foreign antigens 
not normally found in the mammalian host known as pathogen associated 
molecular patters (PAMPs).  The best-characterised family of PRRs are the Toll-
like receptors (TLRs), which are capable of recognising motifs on a wide range of 
bacterial, viral, fungal and parasitic pathogens (Takeda and Akira, 2005). In the 
presence of a pathogen there is an increase in the capacity of DCs to activate 
the adaptive immune system due to their activation of by TLRs and other PRRs.  
 
To date there have been 13 different members of the TLR family identified. 
They can be divided into two separate groups based upon their location within 
the cell and the type of agonist they are able to respond to. TLRs 1, 2, 4, 5, 6, 
10 and 11 are present on cell surfaces and recognise extracellular agonists. In 
comparison, TLRs 3, 7, 8 and 9 are found on intracellular membranes and mostly 
recognise nucleic acids. Although TLRs 12 and 13 have been cloned from the 
murine genome, their function is still under investigation. All TLRs, except for 
TLR3, rely on the adaptor protein MyD88, while TLR3 signals through the adaptor 
protein TRAF-interacting protein (TRIP) (Tabeta et al., 2004).  
 
TLR expression varies between DC subsets; pDCs express high levels of TLR7 and 
TLR9 (Edwards et al., 2003). CD8α+ DCs have been shown to express TLR3, and 
are able to respond to apoptotic cells with the addition of poly I:C (Schulz et al., 
2005). This mechanism presumably allows CD8α+ DCs to survey apoptotic cells 
for the presence of a viral infection. CD8α+ DCs do not express detectable TLR7 
(Edwards et al., 2003), thus the activation of these DCs by RNA which is normally 
present in host apoptotic cells is prevented. 
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1.6 Dendritic Cell Migration 
DCs are present in non-lymphoid tissues including the intestine, lung and skin. 
These are vulnerable sites where pathogens can enter, and DCs play an essential 
role in mediating the immune response to pathogens. This is fundamental to the 
initiation and propagation of the immune response, and indeed is the rate-
limiting factor in the process (Teoh et al., 2009). DCs reside in an immature 
state in the periphery. They sample antigen, and migrate out of the tissue into 
draining LNs via the afferent lymphatics. This allows DCs to migrate into LNs 
where they are able to interact with naïve T cells, steps that are imperative for 
DCs to complete their maturation process. 
 
The lymphatic system has a dual purpose, not only is it required for fluid uptake 
and drainage but it is also essential for leukocyte migration. It is a hierarchical 
system comprising small blind-ended capillaries in the peripheral tissues that 
join larger collector ducts, which in turn drain into lymph nodes. Efferent 
lymph, leaving lymph nodes in the abdominal viscera drains into the cisterna 
chyli and thoracic duct, eventually emptying into the venous system in the neck. 
Lymph flows exclusively from the periphery towards the draining LNs. As DCs are 
found in only afferent lymphatics and not efferent lymphatics, it appears that 
once DCs have arrived in the LN they do not travel any further but die there. 
This is unlike lymphocytes that are able to migrate from LNs in efferent 
lymphatics and return to the circulation. 
 
Capillaries of the lymphatic system have an unusual structure, the endothelial 
junctions of these cells overlap with oak leaf morphology. These areas of overlap 
function as primary valves. Recent work has further revealed a structure in 
which the scalloped edges of the leaflets form junctions in a button-like 
arrangement (Baluk et al., 2007). These button junctions constitute pores, and 
allow the easy passage of fluids as well as being the site of leukocyte entry 
(Lynch et al., 2007). Adherens and tight junction proteins such as claudins, 
vascular endothelial (VE)-cadherin, zona-occludens, junctional adhesion 
molecule A (JAM-A) and the endothelial selective adhesion molecules (ESAM) are 
expressed at the borders of the lymphatic vessel, while CD31 and the lymphatic 
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hyaluronan (HA) receptor lymphatic vessel endothelial hyaluronan receptor-1 
(LYVE-1) are expressed at the tips.  
 
The exact mechanism by which DCs gain access to lymphatics is unclear, 
however it has been suggested that areas of high CCL21 concentrations forms 
complexes with type IV collagen at the basement membrane of initial 
lymphatics. Migrating DCs then contact these CCL21 puncta before actually 
transmigrating into the lymph vessel lumen from these points (Tal et al., 2011). 
DCs from CCR7-/- mice, which are unable to migrate from peripheral tissues, 
have been seen to migrate randomly around initial lymphatics but fail to dock 
with and transmigrate into these vessels (Ohl et al., 2004; Tal et al., 2011). 
Once inside, DCs crawl along the inner surface of the lymphatic endothelium, 
and by sensing lymph flow, they receive guidance cues that allow for directed 
downstream migration. Finally, once DCs reach the larger collecting vessels they 
drift freely in lymph (Alvarez et al., 2008).  
 
The overall mechanism of DC migration into lymphatic vessels involves a number 
of chemokines. The interaction between CCR7 expressed upon DCs and its 
ligands CCL21 and CCL19 is the most widely studied and crucial interaction (Ohl 
et al., 2004; Randolph, 2001). The deletion of CCR7 results in a complete 
absence of migratory DCs in draining LNs, while deletion of both CCL19 and 
CCL21 leads to defects in lymphatic trafficking (Gunn et al., 1999; Mori et al., 
2001). As well as CCR7 and its ligands there is evidence that adhesion to the 
lymphatic vessel endothelium and transmigration involves other receptors, such 
as intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 
(VCAM-1) or E-selectin (Johnson et al., 2006; Johnson and Jackson, 2008). These 
are reviewed in (Jackson, 2009). However, it is clear that the interaction of 
CCR7 with its ligands is the primary interaction for mediating DC migration into 
the lymphatics (Braun et al., 2011).  
 
CCR7 is also involved in guiding migrating DCs within the LN, although this 
process is not completely understood. For example, although several integrins 
are highly expressed upon DCs, peripheral DCs do not appear to require these for 
traveling into and within the LN cortex. CCR7 is believed to be involved in 
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guiding DCs deeper into the cortex where CCL19 and CCL21 are most strongly 
expressed around HEVs (Braun et al., 2011). 
 
The mobilisation and migration of DCs from some tissues is also likely to involve 
Sphingosine-1 Phosphate (S1P) (Czeloth et al., 2005; Idzko et al., 2006). S1P is a 
small soluble bioactive lipid metabolite that has been detected throughout 
eukaryotes (Spiegel and Milstien, 2003). There are five distinct S1P receptors 
(S1PR1-5), which are expressed throughout the immune system (Rosen et al., 
2009). The discovery of the immunosuppressive drug FTY720 that acts upon four 
of the five S1PRs (not S1PR2) has allowed the functions of these S1PRs to be 
examined in further detail (Brinkmann et al., 2002; Mandala et al., 2002). S1PRs 
are coupled to various heterotrimeric G-proteins allowing them to mediate 
diverse functions, which are reviewed by (Rosen et al., 2007; Rosen et al., 2013; 
Sanchez and Hla, 2004). S1PR1 facilitates T cell trafficking at multiple stages of 
T cell development, including thymocyte egress into periphery, egress of mature 
T cells out of lymph nodes during systemic trafficking as well as after immune 
activation and retention of T cells in non-lymphoid tissues. The interaction 
between S1P and S1PR1 has been shown to be essential for the exit of 
lymphocytes into lymphatic vessels (Cyster, 2005; Cyster and Schwab, 2012). T 
cells expressing S1PR1 are able migrate towards an S1P gradient. T cells from 
S1PR1 deficient mice fail to egress from the thymus and peripheral lymphoid 
organs. The interaction between S1P and S1PR1 appears to act by overcoming 
CCR7 and CXCR5 signals, which mediate cell retention (Pham et al., 2008; Sinha 
et al., 2009). Using S1PR1 deficient T cells, or mice in which the lymphatic 
endothelium is S1PR1 deficient, it was shown that treatment of the T cells to 
inhibit CCR7 and CXCR5 retention signals have restored lymphocyte egress 
through the cortical sinuses, even in the absence of the S1P and S1PR1 signalling 
axis (Pham et al., 2010; Pham et al., 2008). Effector T cells eventually re-
express S1PR1 and thereby egress from the lymph node to the lymph and into 
the peripheral tissues 
 
DCs are able to express all five S1PRs (Czeloth et al., 2007), which can mediate 
a range of functions from endocytosis to affecting DC polarisation of T cells 
when exposed to bacterial products (Idzko et al., 2002; Maeda et al., 2007). 
Importantly, S1PRs are likely to play a key role in DC trafficking. The position of 
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33D1+ DCs within the spleen has been shown to depend upon S1PR1, although 
these DCs display S1PR1 at much lower levels compared to T cells (Czeloth et 
al., 2007). Additionally, upon their maturation some subsets of intestinal DCs 
have been shown to upregulate S1PR1 and S1PR3, which resulted in an increased 
capacity for these DCs to migrate towards S1P (Czeloth et al., 2005; 
Rathinasamy et al., 2010). Therefore, it is likely that S1P and S1PR signalling will 
play an important role in DC trafficking from the periphery to the draining LN. 
 
The migration of DCs from the periphery to the draining LNs happens in both the 
steady state and can be enhanced by the presence of proinflammatory stimuli. 
The intravenous (i.v) administration of LPS, or the oral administration of the 
TLR7/8 agonist Resiquimod (R848), induced a major increase in DC migration, 
leaving peripheral tissues virtually devoid of DCs (Yrlid et al., 2006c). These 
effects are dependent upon the systemic production of TNF-α. DC migration 
from the skin can be enhanced following contact sensitisation and is dependent 
upon CD40-CD40L interaction (Moodycliffe et al., 2000). During inflammation 
endothelial cells may upregulate the expression of some adhesion molecules, 
such as CX3CL1. CX3CL1 has been shown to be upregulated by dermal lymphatic 
endothelial cells following treatment with TNF-α or FITC skin painting leading to 
increased dermal DC migration from the skin (Johnson and Jackson, 2013). 
Additionally, CCL21 is rapidly secreted by lymphatic endothelial cells in response 
to treatment with TNF-α, providing a mechanism by which there is increased DC 
migration to draining LNs following inflammation (Johnson and Jackson, 2010). 
This demonstrates how the immune response can respond quickly in the 
presence of a pathogen. 
 
1.7 Antigen Uptake and Presentation 
DCs are able to take up a diverse array of antigens, which they can present to 
naïve T cells on either MHC class I or MHC class II. Immature, but not mature 
DCs, are specialised for antigen uptake. This occurs via endocytosis, with most 
immature DCs exhibiting three types of endocytosis; macropinocytosis, 
phagocytosis and clathrin-mediated endocytosis (Mellman and Steinman, 2001). 
Macropinocytosis and phagocytosis are related process that both depend upon 
actin assembly. Phagocytosis is triggered by the attachment of extracellular 
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particles to surface receptors that then initiate particle uptake. This is a 
particularly efficient mechanism for the generation of antigenic peptides, and is 
probably the most physiologically relevant form of antigen uptake (Inaba et al., 
1998).  
 
Following antigen uptake, antigens are degraded and loaded onto MHC 
molecules. The intracellular pathways for peptide loading and presentation by 
DCs have been analysed in detail and are reviewed by Guermonprez et al. and 
Blum et al. (Guermonprez et al., 2002), (Blum et al., 2013). Here, I will give a 
brief account of antigen presentation by DCs.  
 
Initially, DCs were described to present antigen to CD4+ T cells via MHCII. 
Peptide loading on MHCII molecules begins with the synthesis of MHCII dimers in 
the endoplasmic reticulum (Cresswell, 1996). These then pass through the Golgi 
body and are then transported to the endocytic pathway, which contain antigen 
taken up by DCs (Villadangos et al., 1999). MHCII dimers become able to bind 
antigen under the control of H2-M and H2-O (Kropshofer et al., 1999). Once 
stabilized by loading with peptide derived from antigen, the MHCII/antigen 
complex is then transported to the plasma membrane. 
 
Most peptides presented via MHCI are generated from ubiquitinated proteins. 
However, some subsets of DCs, namely CD8α+ DCs, are able to carry out cross 
presentation. This is a process that involves presentation of peptide derived 
from exogenous antigen presented on MHCI to CD8+ T cells. Cross presentation is 
essential for the generation of cytotoxic T cell responses against tumours and 
intracellular pathogens. There have been two main pathways described for the 
cross presentation; TAP independent and TAP dependent (Yewdell et al., 1999). 
Like presentation via MHCII, TAP independent cross presentation requires MHCI 
molecules to access in the endocytic pathway. The TAP dependent pathway 
requires a membrane pathway linking the lumen of endocytic compartments in 
the cytosol (Rodriguez et al., 1999). 
 
Taken together, these specalised mechanisms for antigen uptake and 
presentation can begin to account for the unique role played by DCs in the 
generation of an adaptive immune response.  
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1.8 Dendritic Cell Interactions with the Adaptive Immune 
Response 
After infection with a pathogen, an important function of DCs is to communicate 
the type of immune response necessary to successfully clear the infecting 
organism. They perform this by their interactions with cells of the adaptive 
immune response such as T and B cells. It is therefore essential to understand 
the biology of DC:T cell and DC:B cell interactions. 
 
1.8.1  CD4+ T Cells 
CD4+ T cells play a central role in many types of immune responses. They are 
able to orchestrate immune responses to a variety of pathogens in a number of 
ways. For example, by providing help to B cells to make antibodies, by 
supporting CD8+ T cell responses, or by regulating macrophage function. 
Additionally, they are able to regulate and suppress immune responses to control 
autoimmunity and to adjust the magnitude and persistence of responses. These 
various functions can be achieved through the differentiation of naïve CD4+ T 
cells by presentation of their cognate antigen by DCs, with the context by which 
the DC presents antigen being crucial (Zhu and Paul, 2008). 
 
The differentiation of CD4+ T cells is highly regulated, and there are at least 
three different signals required for their differentiation into effector cells. The 
first signal is provided by DCs presenting exogenously derived antigen cells via 
MHC class II. This complex is recognised by a particular T cell clone and interacts 
with T cell receptor (TCR) αβ and CD4 molecules on the T cells.  This interaction 
results in the activation of the naïve CD4+ T cell, but it does not commit this to a 
specific lineage (Zhu and Paul, 2008). The second signal is also provided by DCs. 
This involves the binding of costimulatory molecules such as CD86 and CD80 on 
DCs to the activatory CD28, or the inhibitory cytotoxic T lymphocyte antigen 4 
(CTLA-4) on CD4+ T cells, controlling T cell activation (Lenschow et al., 1996).  
Further signals, are required for full T cell activation. These come from the 
interaction between CD40 on DCs and CD40L on naïve T cells (Behrens et al., 
2004; Mosmann and Coffman, 1989).  Together signals one and two lead to IL-2 
production by the T cell needed for the clonal expansion of the T cells. If T cells 
do not receive both signals they enter a state of anergy rather than becoming 
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fully activated. This provides a mechanism by which peripheral self-tolerance 
can be maintained, essential because not all self reactive T cells are deleted in 
the thymus during T cell development. 
 
Signal three is provided by cytokines secreted by DCs, directing the 
differentiation of CD4+ T cells into different lineages. Originally CD4+ T cells 
were viewed as having two major fates, T helper 1 (Th1) cells or Th2 cells. Th1 
cells express T-bet and produce IFN-γ, and require IL-12 derived from either DCs 
or innate cells. Th2 cells express Gata3 and produce IL-4; they require IL-4 for 
their development, which may be derived from basophils, eosinophils, mast cells 
or γδ T cells (Voehringer et al., 2004; Woerly et al., 2002; Zuany-Amorim et al., 
1998). The Th1 response is important for the activation macrophages, the 
clearance of intracellular pathogens and the activation of naïve CD8+ T cells. 
Th2 cells produce IL-2, IL-5, IL-10 and IL-13 and are involved in allergic 
responses. These cytokines have important roles in the production of IgE, the 
recruitment of basophils and eosinophils. Therefore, the Th2 response is mainly 
involved in the clearance of extracellular pathogens. 
 
However, the Th1/Th2 paradigm does not explain some aspects of immunity and 
autoimmunity. The discovery of regulatory T cells (Tregs) was key to 
understanding mechanisms of autoimmunity (Josefowicz and Rudensky, 2009). 
There are two distinct types of Tregs, natural Tregs (nTregs) and inducible Tregs 
(iTregs). nTregs are generated from the thymus and are distinct from iTregs, 
which are generated from naïve CD4+ T cells in the periphery (Geiger and Tauro, 
2012). The differentiation of iTregs from naïve T cells requires TGF-β, which 
induces the expression of Foxp3. Foxp3 is specifically induced only on iTregs and 
is required for their maintenance in the peripheral immune compartment. 
Although there are differences in the development of nTregs and iTregs, both 
produce IL-10 and TGF-β. These inhibitory cytokines are important in 
maintaining tolerance and controlling inflammatory responses. 
 
More recently Th17 cells have become a focus of attention due to the role they 
play in the pathogenesis of various autoimmune diseases, including rheumatoid 
arthritis, multiple sclerosis, and inflammatory bowel disease (Wilke et al., 
2011). RORγt is the master regulator for Th17 cells, which produce IL-17 and 
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express IL-23R on their surface. Their differentiation requires TGF-β and IL-6 
that can be produced by DCs, which induces RORγt expression on CD4+ T cells 
(Mangan et al., 2006). They have been proposed to play a role in the protection 
against extracellular bacteria, protozoa and fungi. In the steady-state the 
largest population of Th17 cells is found in the intestinal mucosa, and the 
development of this population is largely dependent upon the colonisation of 
commensal microbiota (Ivanov et al., 2008). 
 
Follicular helper T cells (Tfh) are the most recently described lineage of T cells. 
They are found in the germinal centers of lymphoid tissues and are found close 
to B cells. They are defined by the expression of Bcl6 and IL-21, and provide B 
cell help by promoting class switching (Crotty, 2011; Fazilleau et al., 2009). The 
development of Th subsets is outlined in Figure 1.2. 
 
 
Figure 1-3 Development of T helper Subsets 
Dendritic cells present antigen on MHCII to the T cell receptor on naïve T cells. This is 
accompanied by co-stimulation by the interaction by CD80/86 to CD28 or CTLA-4 and CD40 and 
CD40L on naïve T cells. Cytokines secreted by DCs, direct the differentiation of CD4+ T cells into 
different lineages. Th1 cells express T-bet and produce IFN-γ, and require IL-12 for their 
development. Th2 cells express Gata3 and produce IL-4; they require IL-4 for their development, 
they produce IL-2, IL-5, IL-10 and IL-13. The differentiation of Tregs requires TGF-β; Tregs 
express Foxp3 and produce IL-10 and TGF-β. Th17 cells require TGF-β and IL-6 for their 
development and their master regulator is RORγt. They produce IL-17, IL-23R and IL-6. Tfh cells 
express Bcl6 and produce CXCR5 and IL-21. 
 
There is increasing evidence of flexibility between T helper subsets (Murphy and 
Stockinger, 2010; O'Shea and Paul, 2010). For example not all cytokines are 
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selectively produced by different subsets of Th cells some are more widely 
expressed. As such, IL-10 was originally considered to be a Th2 cytokine. But 
more recent work has shown that Th1, Tregs and various innate immune cells 
can also produce IL-10 (Saraiva and O'Garra, 2010). It is also now becoming clear 
that some populations of T helper cells can change their phenotype during and 
after development. For instance, during differentiation of Tregs, the presence of 
IL-6 switches the development of Tregs to Th17 cells. Thus under inflammatory 
conditions in the presence of IL-6 inflammatory Th17 cells are produced, but 
under non-inflammatory conditions, Tregs are induced (Dons et al., 2012). 
Furthermore the differentiation of Th17 can be inhibited, and the production of 
Tregs increased, in the presence of retinoic acid (RA). RA is produced by 
intestinal DCs and acts directly on T cells enhancing TGF-β signaling while 
inhibiting IL-6 signalling (Jaensson et al., 2008). The Treg phenotype can, 
however, be plastic and fully differentiated Tregs can lose the expression of 
Foxp3 and produce proinflamatory cytokines such as IFN-γ (Oldenhove et al., 
2009). Another example of plasticity is provided by Th2 cells that can express T-
bet and IFN-γ during a viral infection (Hegazy et al., 2010). However, the most 
flexible subset appears to be Tfh, which have been shown to convert to Th1, Th2 
or Th17 in vitro, and in vivo Tregs can become Tfh cells (Lu et al., 2011; Tsuji et 
al., 2009). 
 
Taken together these data show the flexibility of CD4+ T cells, which is likely to 
be advantageous in terms of host defense. However further information is 
required and as there is no simple way to determine stability versus plasticity 
this may be challenging. 
 
1.8.2  CD8+ T cells 
DCs also play an important role in priming CD8+ T cells. Unlike CD4+ T cells, the 
range of phenotypes of effector cells is limited. Upon activation, all CD8+ T cells 
become cytotoxic T lymphocytes (CTLs). Classically CD8+ T cells recognise 
antigen presented via MHC class I molecules.  MHC class I molecules are present 
on the surface of all nucleated cells in the body and present peptides from 
endogenously derived antigens.  This provides a mechanism by which the 
immune response can specifically recognise cells infected with intracellular 
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pathogens or tumour cells.  The CD8+ T cell can then destroy the aberrant cell to 
circumvent the spread of the infection or cancer, whilst avoiding killing healthy 
bystander cells (Kurts et al., 2010). This restriction is potentially problematic in 
one situation; naïve CD8+ T cells must be primed by APCs, usually DCs, before 
they can exert their cytotoxic actions.  Therefore, if DCs were not able to 
present peptides derived from exogenous antigens of MHC class I, they would not 
be able to activate the naïve CD8+ T cell, unless the DCs themselves were 
infected.  This ability of DCs to present exogenous antigen via MHC class I to 
CD8+ T cells is termed cross presentation (Heath and Carbone, 2001).  This 
allows the priming of naïve CD8+ T cells by DCs, which is essential in the 
response to viral infections and some bacterial infections (Kurts et al., 2010). 
 
There are two ways by which DCs are able to activate CTL responses. Under 
inflammatory conditions DCs are activated by TLR binding resulting in their 
maturation. Mature DCs then interact with naïve CD8+ T cells resulting in their 
production of IL-2, which stimulates their expansion. This type of CD8 T cell DC 
interaction is rare and only occurs under specific circumstances. More often DCs 
are provided with help from CD4+ effector T cells (Wu and Liu, 1994). Upon CD4+ 
T cell recognition of cognate antigen on the surface of DCs, there is upregulation 
of costimulatory molecules such as CD80 and CD86 on the surface of the DC 
(Schoenberger et al., 1998). These DCs are then more potent stimulators of CD8+ 
T cell differentiation. 
 
1.8.3  B Cells 
DCs are able to indirectly and directly provide proliferation and survival signals 
to B cells. DCs are able to induce the development of T helper cells that then 
influence B cell maturation (Qi et al., 2006). Alternatively, a population of DCs 
can present intact antigen to B cells directly (Colino et al., 2002; Wykes et al., 
1998). Following intravital multiphoton microscopy DCs in the LN paracortex 
were shown to interact with migrating B cells in vivo (Qi et al., 2006). DC-B cell 
interactions have been shown to lead to B cell activation via increased cell-to-
cell contact times (Qi et al., 2006). This may provide a mechanism by which B 
cells can rapidly mount antibody responses. 
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1.9 Lymphoid Tissue Development 
Lymphoid organs can be divided into three major categories, primary, secondary 
and tertiary based upon specific functional criteria. Primary lymphoid organs, 
the thymus and bone marrow, are responsible for the formation of the primary 
repertoire of lymphocyte effector cells. Secondary lymphoid organs are involved 
in the coordination of the immune response. They concentrate foreign antigen in 
specific areas and facilitate the interaction between APCs and antigen specific 
lymphocytes. LNs are located throughout the body and support a quick and 
effective immune response. Tertiary lymphoid tissues are comparable to 
secondary lymphoid organs, but they emerge under inflammatory conditions. 
The development of secondary lymphoid organs is predetermined during 
embryogenesis, while tertiary lymphoid organs can arise under environmental 
influences and are not restricted to specific developmental areas or anatomic 
locations. Here I will discuss the development of secondary and tertiary 
lymphoid organs, mainly within the context of the intestine.  
1.9.1  Lymph Node Development 
The anatomically distinct tissues designed to facilitate an adaptive immune 
response are secondary lymphoid organs. Secondary lymphoid organs include the 
network of LNs throughout the body, the spleen, and PPs. The development of 
secondary lymphoid organs is a highly controlled and ordered process initiated 
during embryogenesis. The development of lymphoid organs does not happen 
simultaneously, but sequentially (Figure 1.3). This was demonstrated using 
timed injections of lymphotoxin-β receptor immunoglobulin fusion proteins 
(LTβR-Ig) that can inhibit the formation of lymphoid organs. For example, 
injections at day 12.5 of embryonic development (E12.5) prevented the 
development of all LNs and PP, while injections at E15.5 allowed the formation 
of brachial and axillary LNs (Rennert et al., 1996). The mechanism by which 
LTβR-Ig acts is outlined below in Figure 1.3. 
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Figure 1-4 Timeline of the Sequential Development of Secondary Lymphoid Organs. 
Mesenteric lymph nodes (MLN) develop between E10.5 and E15.5, cervical lymph nodes (CLN) 
between E11.5 and E14, brachial lymph nodes (BLN) between E12 and E15, axillary lymph nodes 
(ALN) between E12 and E15, inguinal (ILN) between E16 and E16.5, PPs between E16 and birth 
and popliteal lymph nodes (PLN) between E17 and E17.5. In comparison, nasal-associated 
lymphoid tissue (NALT) and tear duct-associated lymphoid tissue (TALT) develop post birth. 
Cryptopatches (CPs) develop from two weeks post birth, and these can then develop into 
isolated lymphoid follicles (ILFs) under environmental influences. Colonic solitary intestinal 
lymphoid tissue (SILT) develops around two weeks after birth (Adapted from (Mebius, 2003)). 
The earliest event during LN development is the formation of lymph sacs, and 
these were considered to be a necessary requirement for the development of 
LNs (Kelly and Scollay, 1992; Mebius et al., 1997; Mebius et al., 1996). During 
the first phase of LN development Prox1 expressing endothelial cells form lymph 
sacs at precise positions in the developing embryo (Wigle and Oliver, 1999). 
However, more recently, using Prox1 deficient and Prox1 conditional knock out 
animals, it was demonstrated that the formation of lymph sacs was not the 
triggering factor in the development of LNs (Vondenhoff et al., 2009b). Instead 
it was suggested that LN morphogenesis was initiated by the expression of 
CXCL13 by RA producing neurons (van de Pavert et al., 2009), which attract 
lymphoid tissue inducer (LTi) cells. Despite this recent work, the signals that 
trigger LN morphogenesis are still poorly understood. Therefore further work is 
required to fully determine the identity of signals that control the initiation of 
LN development. 
The first cells that colonise developing secondary lymphoid organs and the 
principal cells involved in their development are LTi cells (Mebius et al., 1997). 
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LTi cells are a subset of innate lymphoid cells (ILCs). ILCs lack specific antigen 
receptors, but produce effector cytokines and play important roles in not only 
the formation of lymphoid tissue but also in tissue homeostasis and in immunity 
to infectious microorganisms. The study of the development and functions of 
ILCs is a rapidly expanding field and is discussed in detail elsewhere (Spits et al., 
2013; Spits and Cupedo, 2012). Here I will focus on the development and 
functions of LTi cells in the context of secondary lymphoid organ development. 
LTi cells are believed to develop from a foetal liver progenitor defined as CD3-, 
CD4-, cKit+, IL-7Rα+ and α4β7+. Between E9.5 and E16.5 they colonise the 
developing embryo (Rennert et al., 1996; Veiga-Fernandes et al., 2007). In 
RORγt deficient mice or in mice lacking the helix-loop-helix inhibitor Id2, LTi 
cells are not generated and these mice lack all LNs, PPs and isolated lymphoid 
follicles (ILFs) (Eberl and Littman, 2004; Yokota et al., 1999). RORγt is a ligand-
dependent nuclear hormone receptor that is expressed only on LTi cells during 
embryogenesis, as well as on cells that develop post-natally such as Th17 cells 
and RORγt+ ILCs that are distinct from LTi cells (Cella et al., 2009; Satoh-
Takayama et al., 2008). LTi cells are defined as CD4+CD3-IL7α+cKit+, they can be 
identified by their expression of RORγt, lymphotoxin-α1β2 (LTα1β2), IL-7Rα and 
the absence of lineage markers (Mebius et al., 1997). The transfer of LTi cells 
can rescue the development of PPs in CXCR5-/- mice that have abrogated PP 
development (Finke et al., 2002), demonstrating the requirement of these cells 
in the development of secondary lymphoid organs (Fukuyama and Kiyono, 2007). 
The interaction of LTi cells with lymphoid tissue organiser (LTo) cells is crucial in 
the development of secondary lymphoid organs. LTo cells are mesenchymal cells 
that give rise to the stromal cell subsets that are present in mature lymph nodes 
(Cupedo et al., 2004). During lymphoid tissue organogenesis LTo cells express 
the lymphotoxin-β receptor (LTβR) which interacts with LTα1β2 expressed by LTi 
cells (Honda et al., 2001; Yoshida et al., 2002a). Injections of LTβR-Ig inhibit 
this interaction. The interaction between LTi cells and LTo cells triggers the 
maturation of LTo cells and begins a positive feedback loop involving LTαβ/LTβR 
signalling that promotes and sustains lymphoid organ formation. Briefly, LTo 
signalling via LTβR induces the expression of TNF-related activation induced 
cytokine (TRANCE, also known as TNFSF11 and RANKL) and IL-7, which results in 
increased LTα1β2 expression by newly arriving LTi cells and therefore increased 
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signalling via LTβR (Honda et al., 2001; Mebius, 2003; Yoshida et al., 2002a). 
The maturation of LTo cells results in the increased expression CCL19, CCL21, 
CXCL13, IL-7, VCAM-1 and ICAM-1 which support the attraction and retention of 
more haematopoietic cells, leading to LN growth (Cuff et al., 1999; Mebius, 
2003). This process is depicted in Figure 1.4. Cytokines and chemokines are 
essential in the development of LNs, demonstrated by the combined ablation of 
CXCL13, CCL21 and CCL19 or CCR7 and CXCR5 resulting in the lack of LN and PP 
development (Luther et al., 2003; Ohl et al., 2003). The induction of the 
lymphangiogenic factor VEGF-C by LTo cells promotes the link between 
developing LNs and the lymphatic vasculature (Vondenhoff et al., 2009a). 
Subsequently, these structures can become colonised by lymphocytes resulting 
in the development of a highly organised lymphoid organ. 
 
Figure 1-5 Lymph Node Development. 
Retinoic acid is released resulting in the gathering of lymphoid tissue organiser (LTo) cells, which 
in turn release CXCL13. This results in lymphoid tissue inducer (LTi) cells leaving the blood 
vessels and the interaction between LTβR on LTo cells and LTα1β2 on LTi cells. This starts a 
positive feedback loop via the induction of TRANCE. It also leads to the maturation of LTo cells 
that produce CCL19, CCL21, CXCR13, ICAM-1, VCAM-1 and IL-7. The interaction between TRANCE 
and TRANCER results in the increased expression of LTα1β2 on newly arriving LTi cells, resulting 
the attraction of further haematopoietic cells leading to the growth of the lymph node. 
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1.10 Splenic Development 
The development of the spleen is distinct from other secondary lymphoid 
tissues, as LTi cells are not necessary for their initial splenic development, 
demonstrated by the presence of a spleen in RORγt-/- and Id2-/- animals (Eberl, 
2005; Yokota et al., 1999). Instead the initial event in splenic development is 
the formation of the splanchnic mesodermal plate (SMP) that forms at E12 
(Mebius and Kraal, 2005). The spleen is then colonised at E12 by LTi cells 
following an upregulation of VCAM-1 on LTo cells (Withers et al., 2007) (Mebius 
et al., 1997). Lymphotoxin dependent signals from LTi cells then regulate T cell 
organisation; thereafter the development of splenic white pulp is more similar 
to the development of other secondary lymphoid organs (Withers et al., 2007). 
However additional lymphotoxin independent signals are also necessary for the 
organisation of T cell zones in the spleen, which may account for the fact that 
RORγt-/- and Id2-/- mice have aberrant segregated B and T cell areas (Eberl, 
2005; Yokota et al., 1999). 
 
1.11 Mesenteric Lymph Node Development  
The development of the mesenteric lymph node (MLN) is likely to require 
additional chemokines compared to the development of other peripheral LNs. 
For example, mice lacking CXCL13 or CXCR5 do not develop peripheral LNs, yet 
MLNs, facial and cervical LNs develop normally. The combined elimination of 
CXCL13, CCL19 and CCL21, or their receptors CXCR5 and CCR7 prevents the 
development of all LNs except the MLNs (Ansel et al., 2000; Luther et al., 2003; 
Ohl et al., 2003). Furthermore MLNs, but not PPs or other peripheral LNs develop 
in LTβ-deficient mice, which are deficient for the LTα1β2 ligand of LTβR. The 
mechanism by which MLNs form in these animals was proposed to be due to the 
expression of LIGHT which can act as a substitute for LTβ in the formation of 
MLNs (Alimzhanov et al., 1997; Scheu et al., 2002).  
 
1.12 Peyer’s Patch Development 
Although there is much overlap between LN development and PP development, 
there are some key differences. Unlike LNs that develop at defined positions in 
the body, PPs develop at inconsistent locations and in varying numbers along the 
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anti-mesenteric axis of the SI. Similar to LN development the initial step in PP 
organogenesis involves the colonisation of LTi cells. This occurs at E12.5 and is 
initially restricted to the duodenum and caecum, but by E15.5 these LTi cells are 
distributed evenly throughout the intestinal wall. Aggregates of these cells form 
1 day later, leading to the formation of PP primordia (Hashi et al., 2001; Veiga-
Fernandes et al., 2007). Therefore PP primordia appear to have a stochastic 
distribution, distinct from LNs that develop at precise locations. 
As outlined above, signalling between LTi and LTo cells results in the 
upregulation of LTα1β2 via the interaction between TRANCE and its receptor 
TRANCER. This results in the survival and differentiation of LTi cells, and in line 
with this TRANCE deficient embryos have reduced numbers of LTi cells (Kim et 
al., 2000). However TRANCE signalling is not required for PP development 
(Dougall et al., 1999), and LTo cells from PPs do not express TRANCE. Although 
they were able to generate PPs, TRANCE deficient animals showed decreased 
numbers of B cells within PPs. Another pair of molecules that play different roles 
in the development of LNs and PPs are IL-7 and IL-7R; IL-7Rα-/- mice lack PPs, 
but brachial, axillary LNs and MLNs all develop normally until the neonatal stage 
(Adachi et al., 1998; Mebius, 2003). Furthermore, the tyrosine kinase receptor 
RET is also involved to differential degrees in LNs and PP formation. RET is 
expressed by a subset of cells that are similar to LTi cells, but they express 
CD11c. These cells are essential for haematopoietic cell clusters, and in RET-/- 
mice LTi clusters are missing (Veiga-Fernandes et al., 2007). It has been 
proposed that the activation of RET on these CD11c+ cells leads to the induction 
of LTα1β2 expression, which interacts with LTβR on LTo cells leading to the 
attraction and retention of LTi cells in the PP. Although CD11c+ cells are 
commonly found in developing PPs, few can be found in developing LNs (Adachi 
et al., 1998). Therefore, further work is required to determine the role these 
CD11c+ haematopoietic cells play in the development of LNs outwith the 
intestine. There are also differences between the levels of expression of 
transcription factors and cytokine expression on LTo cells from PPs and LNs, 
although the functional consequences of this are not yet clear (Okuda et al., 
2007). Taken together these data support the concept that LN and PP 
development are controlled differently, however further work is required to 
fully determine the different pathways of PP and LN development. 
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1.13 Development of Mucosal Associated Lymphoid Tissues 
Secondary lymphoid tissues also include several mucosal associated lymphoid 
tissues, such as the nasopharynx-associated lymphoid tissue (NALT), tear duct-
associated lymphoid tissue (TALT), cryptopatches (CP) and ILFs. In contrast to 
PPs and LNs, the development of these lymphoid tissues occurs after birth. A 
population of LTi cells is likely to play a role in their development and is present 
in adult mice. These adult LTi cells express OX40 ligand and CD30 ligand, unlike 
LTi cells found in developing embryos (Eberl and Littman, 2004; Kim et al., 
2005). Their ontogeny is also different; foetal RORγt+ LTi cells mature in the 
foetal liver but in the adult RORγt+ cells are BM derived and matured outwith the 
BM and in a notch2-dependent manner (Possot et al., 2011). 
 
The cellular and molecular interactions required for the development of these 
mucosal associated lymphoid tissues are beginning to be elucidated. The 
formation of TALTs and NALTs occurs independently of LTβR-mediated 
signalling, however the development of NALTs requires Id2 suggesting there may 
be a role for LTi cells (Fukuyama et al., 2002; Nagatake et al., 2009). 
 
The largest populations of adult LTi cells are found in the intestinal lamina 
propria (LP) within CPs (Lane et al., 2009; Pabst et al., 2006). CPs are small 
aggregates of cells, which contain immature lymphocytes and DCs (Kanamori et 
al., 1996). CPs form within the LP around two weeks after birth (Kanamori et 
al., 1996). Current evidence suggests that CPs do not continually develop 
throughout adulthood (Velaga et al., 2009), but these small clusters are able to 
develop into ILFs (Pabst et al., 2006; Pabst et al., 2005; Taylor et al., 2007). ILFs 
are organised lymphoid structures that possess distinct B and T cell areas, an 
epithelium containing M cells and are able to take up bacteria (Lorenz and 
Newberry, 2004). Collectively CPs and ILFs are commonly referred to as solitary 
intestinal lymphoid tissues (SILT). The process of the expansion of CPs into ILFs 
involves an increase in the size of the CP and an influx in B cells. There is a 
requirement for the microbiota in this process, as it is reduced in germ-free (GF) 
animals (Pabst et al., 2006) and signaling from dietary ligands via the aryl 
hydrocarbon receptor (AhR) is likely to play a role. Signalling between LTβR and 
LTα1β2 is also required, as timed injections of LTβR-Ig during the first two 
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weeks of birth can prevent the formation of CPs and therefore ILFs (Bouskra et 
al., 2008). DCs have also been proposed to play a role in the formation of ILFs 
via the production of CXCL13. In CXCL13 deficient animals there was no 
transformation of CPs into ILFs and the source of this CXCL13 was attributed to 
DCs (McDonald et al., 2010). RORγt expression is also required for the 
development of SILT, as mice lacking RORγt do not develop CPs or ILFs (Eberl 
and Littman, 2004). In order for a CP to expand into an ILF, the expression of 
CCR6 by B cells is essential. Therefore it is likely that its ligand CCL20 plays a 
role in attracting B cells to CPs (McDonald et al., 2007). CCL20 can be expressed 
by epithelial cells that overlay follicles, perhaps in response to LTα1β2 signalling 
(Randall et al., 2008). Additionally, commensal bacteria in the intestine can 
induce CCL20 production by crypts resulting in the formation of ILFs by CPs 
sensing the microbiota via nucleotide-binding oligomerisation domain protein 1 
(NOD1) (Bouskra et al., 2008). Therefore ILF formation can be viewed as 
inducible; furthermore upon treatment with antibiotics to reduce commensal 
bacteria the generation of ILFs was reduced. Therefore, the continuing 
expansion and reduction of ILFs to CPs and vice versa is likely to represent 
equilibrium between the intestinal immune system and commensal bacteria 
(Eberl, 2005) (Figure 1.5).  
 
 
 43 
 
Figure 1-6 The Development of Cryptopatches and their Expansion into Isolated Lymphoid 
Follicles. 
Dietary ligands signal via the aryl hydrocarbon receptor (AHR) on lymphoid tissue inducer (LTi) 
cells, resulting in the formation of a cryptopatch (CP). CPs develop into immature isolated 
lymphoid follicles (ILFs) upon further AHR signaling and NOD1 signalling from microbiota, they 
recruit T and B cells via LTβR and LTα1β2, CXCL13 and CCR6. Mature ILFs promote the formation 
of IgA plasmablasts. Once challenges from the microbiota are reduced, mature ILFs become 
immature ILFs. Adapted from (Knoop et al., 2011). 
Here I have described the development of lymphoid tissue in the SI, however the 
situation in the colon is different.  Similar to the SI the colon contains two 
developmentally distinct lymphoid tissues, which have only recently been 
described (Baptista et al., 2013). Colonic patches are similar to PPs in that they 
develop during embryogenesis, a process that was likely to be dependent upon 
LTi cells that were detected in the developing colonic patch. Further similarities 
were evidenced by the requirement of CXCL13 and LTα for the development of 
colonic patches and PPs. Colonic patches also contained distinct B and T cell 
areas, but unlike PPs these distinct areas did not segregate into organised areas 
until after birth (Baptista et al., 2013; Hashi et al., 2001). Therefore, there are 
likely to be some differences in the way the development of colonic patches and 
PPs develop.  Recent work also identified colonic SILT that developed post-
natally, however these structures are distinct from SI ILFs, demonstrated by the 
development of colonic SILT in CXCL13-/- mice that do not contain SI ILFs 
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(McDonald et al., 2010). They also do not depend upon TRANCE for their 
development (Knoop et al., 2011). Instead the development of colonic SILT 
appears to be dependent upon CCR6 and CCL20 signalling. Furthermore colonic 
SILT development is not dependent upon the microbiota, while the development 
of SI ILFs is dependent on commensal bacteria (Baptista et al., 2013; Kweon et 
al., 2005). While it has been suggested that the development of colonic SILT is 
dependent upon the presence of LTi cells, RORγt-/- mice contain lymphoid tissue 
specifically in their colon (Baptista et al., 2013; Lochner et al., 2011). Whether 
RORγt independent lymphoid structures represent these colonic SILT or a tertiary 
lymphoid structure, which develops in the colon when there are no other 
lymphoid tissues, remains unclear. Further research into these colonic structures 
is required to determine their developmental cues and the molecular 
mechanisms that govern this development. 
 
1.14 Formation of Tertiary Lymphoid Organs 
Tertiary lymphoid organs resemble ILFs, with organised B and T cell 
compartments and can produce effector B and T cells (Lee et al., 2006; Moyron-
Quiroz et al., 2006; Nasr et al., 2007). However, tertiary lymphoid organs only 
develop under conditions of inflammation (Lochner et al., 2011). When these are 
formed at the site of a pathogenic infection, such as during influenza infection 
of the lungs, they can contribute to the generation of a protective response 
(Moyron-Quiroz et al., 2004). However tertiary lymphoid organs have also been 
reported at sites where there is presentation of autoantigens, such as in the 
pancreas of non-obese diabetic (NOD) mice, and in this case they may lead to 
the propagation of tissue damage (Anderson and Bluestone, 2005). The 
generation of tertiary lymphoid organs was reported to be similar to that of 
secondary lymphoid organs, with CXCL13 playing a role by attracting B cells 
(Dejardin et al., 2002). But in contrast to the formation of LNs, tertiary 
lymphoid organs can develop in RORγt-/- animals, via an LTi independent 
pathway in response to environmental factors (Lochner et al., 2011) (Lee et al., 
2006). 
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1.15 The Intestinal Immune System 
The intestine has a surface area over 200 times that of the skin. It primarily 
functions to process foodstuffs and to allow the absorption of nutrients and 
water. The intestine is constantly exposed to a vast array of harmless antigen 
from dietary agents and an enormous community of commensal bacteria, which 
outnumber human cells in the body by ten times (Macpherson et al., 2009). 
Alongside this harmless antigen most pathogens enter the body via a mucosal 
surface such as the intestine (Mowat, 2003). Therefore, the intestinal immune 
system has to discriminate between pathogenic material and harmless antigen, 
and then mount an appropriate immune response. In order to fulfil this essential 
task, the intestinal immune system has evolved to become the largest and most 
complex part of the immune system. A breakdown in the discrimination between 
harmful and harmless antigen by the intestinal immune system can result in the 
development of pathogenesis in the form of inflammatory bowel disease (IBD) or 
coeliac disease (CD). Due to their unique ability to stimulate primary immune 
responses DCs play an essential role in the intestinal immune system. They are 
also able to determine the outcome of the immune response; therefore they also 
play a vital role in maintaining the delicate balance between immunity and 
tolerance in the intestine. 
1.15.1  Antigen Uptake in the Intestine 
The mucosal surfaces of the digestive system are covered by an epithelial 
barrier, consisting of only a single layer of epithelial cells that separate the 
external gut lumen from the underlying LP. This epithelial layer has a high 
cellular turnover and contains proliferating cells, which replace those that are 
lost and shed into the lumen. Intestinal epithelial cells are derived from stem 
cells, which, in the SI, are located in crypts near the base of the villi. These 
intestinal stem cells give rise to distinct cell lineages; enterocytes, goblet cells, 
enteroendocrine cells, and Paneth cells (Bjerknes and Cheng, 1999; Hermiston 
and Gordon, 1995). These cells migrate towards the tip of the villus, except 
Paneth cells that remain in the crypt and produce defensins, lysozyme and 
phospholipase A2 (Ayabe et al., 2000; Wilson et al., 1999). Although the colon 
lacks villi there is a similar replacement of epithelial cells from the crypt, 
however Paneth cells are only produced in the proximal colon (Chang and 
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Leblond, 1971). A physiochemical barrier is maintained by the intestinal 
epithelium, via the production of mucus from goblet cells and antimicrobial 
peptides from Paneth cells. Thus, contact between the contents of the gut 
lumen and the epithelium is limited. When intact, the intestinal epithelium 
largely prevents the passive entry of large particulate antigen and bacteria. 
Small soluble molecules may pass the epithelium by non-mediated inactive 
passive diffusion (Travis and Menzies, 1992). However, effective immune 
surveillance of the mucosal surface requires the transport of intact 
macromolecules and microorganisms across the epithelial barrier to cells such as 
DCs. Several mechanisms for antigen uptake in the intestine have been 
described and will be outlined below. 
 
1.15.2  M Cell Mediated Antigen Uptake 
Microfold (M) cells are atypical epithelial cells that are specialised for the 
transport of large particulate antigens and microorganisms across the epithelial 
barrier. M cells are located on the follicle-associated epithelium (FAE) of the PPs 
and ILFs (Borghesi et al., 1999; Neutra et al., 1996). Although some previous 
reports have suggested that M cells are present within the villous epithelium 
(Jang et al., 2004; Vallon-Eberhard et al., 2006), more recent work has 
suggested that these represent a functionally immature M cell which is unlikely 
to play a role in antigen sampling in the villi (Kobayashi et al., 2012). The FAE 
has fewer mucus-producing goblet cells and lysozyme producing Paneth cells, 
making it easily accessible from the gut lumen. M cells internalise particulate 
antigen via endocytosis in clathrin-coated vesicles, actin-dependent 
phagocytosis, or macropinocytosis (Neutra et al., 2001; Owen, 1999). Unlike DCs 
or macrophages, M cells transcytose the internalised antigen rather than 
targeting it for degradation. This delivers antigen to DCs, macrophages or B cells 
in the M cell basolateral pocket, which may involve intercellular communication 
channels (Hase et al., 2009b). Therefore, this mechanism appears to be 
specialised for the uptake of intestinal bacteria and large particulate antigens. 
 
 In order to mediate the uptake of specific microorganisms M cells express a 
range of molecules. For instance, murine M cells express glycoconjugates that 
can bind Ulex europaeus agglutinin (UEA)-1 (Chionh et al., 2009). Another 
example is glycoprotein-2 (GP-2) that is expressed on the surface of M cells and 
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binds to FimH, which is expressed by many commensal and pathogenic 
enterobacteria (Hase et al., 2009a). M cells also express the C5a receptor that 
binds proteins that are similar to outer membrane protein H expressed by 
Yersinia enterocolitica (Kim et al., 2011). Some studies have also suggested that 
M cells express an IgA specific receptor that binds to the constant regions of 
secretory IgA (sIgA), although the receptor has not yet been identified (Mantis et 
al., 2002; Mantis et al., 2011; Rey et al., 2004). As ILFs and PPs produce large 
amounts of IgA, this may be a mechanism to regulate and allow the coexistence 
of commensal bacteria and preventing the development of aberrant immune 
responses. M cells continually sample antigen in the steady-state and this can be 
increased upon exposure to microbial products. For example injections of 
peptidoglycan from Staphylococcus aureus or Streptococcus pneumoniae into the 
intestinal lumen have been shown to increase the transport of microparticles 
across the FAE (Chabot et al., 2006; Meynell et al., 1999).  
 
As M cells represent a point of entry into the host, some pathogens exploit M 
cells to cause infection. For example, Yersinia species are able to produce 
invasin that specifically binds to integrin-β1 on M cells, facilitating its entry into 
M cells (Clark et al., 1998). Listeria monocytogenes produces internalin B and 
Salmonella enterica utilises a secretion system to specifically target M cells, 
although the specific receptors for their uptake have not yet been identified 
(Chiba et al., 2011; Jones et al., 1994). It has also been suggested that prions 
selectively gain access to M cells, although the mechanism by which this is 
achieved is yet to be determined (Donaldson et al., 2012) and other studies 
suggested prions were able to access the intestine independently of M cells 
(Jeffrey et al., 2006; Mishra et al., 2004). There is great interest in 
understanding M cell receptors and their signalling mechanisms in order to 
improve oral vaccine delivery systems. However, further work will be required in 
order to fully elucidate the mechanisms involved in antigen acquisition and 
transport by M cells.  
 
1.15.3  Dendritic Cell Uptake of Luminal Antigen  
In addition to M-cell mediated antigen uptake, it was proposed that CD11c-
expressing cells associated with the gut epithelium in the LP were a population 
of DCs capable of capturing luminal bacteria directly (Rescigno et al., 2001).  
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The presence of trans-epithelial dendrites on this subset of mononuclear cells 
was confirmed using transgenic mice expressing the GFP in place of CX3CR1, 
with heterozygous mice functioning as reporter mice (Jung et al., 2000).  
Fluorescence imaging hinted trans-epithelial dendrites mediated the uptake of 
S. enterica, as the number of trans-epithelial dendrites in the terminal ileum 
increased after Salmonella challenge and this response was markedly reduced in 
CX3CR1 deficient mice (Niess et al., 2005). The formation of trans-epithelial 
dendrites is dependent upon the expression of CX3CR1 (Niess et al., 2005). 
Furthermore, following administration of fluorescently labelled Escherichia coli 
in CX3CR1 deficient animals there were fewer bacteria recovered from the MLN. 
The number of trans-epithelial dendrites was increased after the introduction of 
TLR ligands and was reduced in mice given broad-spectrum antibiotics or mice 
lacking the TLR adaptor molecule MyD88 (Chieppa et al., 2006; Niess et al., 
2005; Vallon-Eberhard et al., 2006). Together these observations were the basis 
of the suggestion that in vivo CX3CR1+ cells in the LP extended trans-epithelial 
dendrites to sample bacteria from the gut lumen.   
 
However, association of bacteria with a cell does not necessarily mean that 
these cells have actively sampled the bacteria. Further evidence began to call 
into question the physiological role played by these antigen sampling CX3CR1+ 
cells. Upon inoculation with Aspergillus fumigatus, for instance, pathogen 
uptake was not affected in the absence of CD11c+ cells, or in CX3CR1 deficient 
mice that also lack trans-epithelial dendrites (Vallon-Eberhard et al., 2006).  
Additionally, the presence of trans-epithelial dendrites appears to be mouse 
strain dependent. Trans-epithelial dendrites have also been observed in CD11c-
GFP and MHCII-GFP reporter mice although their position remains controversial 
due to substantial differences in the distribution of dendrites in comparison to 
CX3CR1 reporter mice (Chieppa et al., 2006; Niess et al., 2005).  
 
Although there was some variation in reports regarding the importance of trans-
epithelial dendrites in the adaptive immune response, it was generally assumed 
that epithelial-associated CX3CR1+ mononuclear LP DCs were able to acquire 
luminal antigen via trans-epithelial dendrites and transport it to the MLN via 
lymphatics. However, more recent evidence has definitively shown that the 
majority of CX3CR1+ CD11c+ cells do not represent DCs; instead these are more 
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likely to represent a population of sedentary macrophages (Schulz et al., 2009). 
CX3CR1+ LP cells and cDCs arise from different progenitors and serve different 
functions. Subsets of DCs which express CD103 appear to confer typical 
properties of the intestinal immune response such as the ability to migrate to 
the draining LN and are able to present antigen to naïve T cells, although 
genuine CD103- DCs expressing intermediate levels of CX3CR1 are also present 
and behave in a similar manner to CD103+ DCs (Bain et al., 2013; Cerovic et al., 
2012; Schulz et al., 2009). Upon further characterisation, the CX3CR1hi CD11c+ 
cells also appeared to express F4/80, CD14 and CD64; markers commonly used to 
identify macrophages (Bain et al., 2013; Schulz et al., 2009; Tamoutounour et 
al., 2012).  Additionally, in comparison to CD103+ DCs, CX3CR1hiCD11c+ cells 
were inefficient at inducing the proliferation of naïve T cells as assessed by a 
thymidine incorporation assay (Schulz et al., 2009). Finally, the CX3CR1hi 
intestinal cells are monocyte-derived and CSF-1 dependent, while the CD103+ 
DCs arise from preDCs and are dependent on the growth factor FLt3L (Bain et 
al., 2013; Bogunovic et al., 2009; Tamoutounour et al., 2012; Varol et al., 2009). 
Therefore, it is likely that CX3CR1hi CD11c+ cells are a gut resident population of 
macrophages, not of a population of migratory DCs. LP-resident cells expressing 
intermediate levels of CX3CR1 are heterogeneous and contain a mix of sedentary 
macrophages and a population of Flt3-dependent DCs capable of migrating in 
intestinal lymph (Bain et al., 2013; Cerovic et al., 2012). This CX3CR1 expression 
by DCs was notably lower than that expressed by CX3CR1hi macrophages (Cerovic 
et al., 2012). Recently, Diehl et al. reported that a CX3CR1hi population of cells 
were also able to migrate to the MLN, in a CCR7 dependent manner, in the 
steady-state and following Salmonella infection (Diehl et al., 2013). However, in 
our hands, we find only the CX3CR1int population of bona-fide DCs (which lack 
the expression of macrophage markers F4/80, CD14 and CD64 and share an 
ontogeny with CD103+ DCs) migrate in the steady-state following thoracic duct 
cannulation (TDC) and mesenteric lymphadenectomy (MLNx) (Cerovic et al., 
2012) (V.Cerovic, personal communication). It is possible that Diehl et al. have 
misclassified CX3CR1int cells as CX3CR1hi cells, thus leading to the conclusion 
that macrophages migrate to the MLN. However we, and others, have shown this 
does not occur in the steady-state (Cerovic et al., 2012; Schulz et al., 2009). 
The ability of CX3CR1hi/+ cells to migrate under conditions of inflammation has 
also been reported during DSS induced colitis, although the origin of these cells 
 50 
is unclear (Zigmond et al., 2012). Such migration of CX3CR1 expressing cells 
under conditions of inflammation may represent an interesting pathway by 
which antigen can gain access to the MLN, and therefore deserves much further 
investigation. 
 
Recently, Farache et al. crossed CX3CR1GFP/+ mice with CD11c-YPF mice in order 
to determine whether bona-fide DCs were able to extend trans-epithelial 
dendrites. These studies used 2-photon microscopy to identify 
CD11cYFP+CX3CR1GFP- cells that they correlate with CD103+ DCs (Farache et al., 
2013). Interestingly these cells were responsive to CSF-2, a marker more 
commonly associated with the expansion of macrophages, although is likely to 
act as an accessory for the expansion of some subsets of CD103+ DCs (Bogunovic 
et al., 2009) (Greter et al., 2012). The authors showed that CD11cYFP+CX3CR1GFP- 
cells were able to internalise non-invasive Salmonella and that these cells were 
less efficient than CX3CR1GFP+ at the uptake of soluble OVA. However, they do 
not directly show CD103+ DCs extending dendrites. Interestingly, recent work by 
McDole et al. did not identify the formation of trans-epithelial dendrites, 
although they used the same mouse model as Farache et al. (McDole et al., 
2012). Instead the authors identified CD11cYFP+CX3CR1GFP- cells forming goblet 
cell associated antigen passages, which were visible after the intraluminal 
injection of rhodamine dextran. In contrast to previous reports, the authors do 
not suggest that DCs are acquiring antigen from the gut lumen, but from the LP. 
However, it is contradictory to previous reports, which used flow cytometry to 
show that after intraluminal injection of fluorescently labelled ovalbumin the 
majority of fluorescent antigen was taken present in CX3CR1+ cells in the LP, not 
CD103+ DCs (Schulz et al., 2009). Furthermore following FITC dextran 
administration a larger population of SSClo cells, distinct from CD103+ DCs, 
appeared to be positive for FITC dextran (McDole et al., 2012). Therefore the 
relevance of antigen uptake via goblet cell associated antigen passages requires 
further investigation. 
Recently Lelouard et al. described a population of CD11c+CX3CR1+ DCs which 
express lysosome M and are able to extend dendrites that capture fluorescent 
micropartices or S. typhimurium (Lelouard et al., 2012; Lelouard et al., 2010). 
Unlike previous mechanisms described for DC subsets in the villus epithelium 
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that describe dendrites extending paracellularly between epithelial cells, these 
“LysoDC” extend dendrites in a transcellular manner and sample via M cell 
pores. Briefly, there is a cytoskeleton rearrangement in both the M cell and the 
LysoDC which allows the LysoDC to extend through a transcellular pore created 
by the M cell, without breaking the integrity of the epithelial barrier. Although 
the authors have designated these CD11c+CX3CR1+Lysozyme M+ cells as DCs, it is 
unclear if these are genuine DCs or a population of macrophages. Although the 
authors showed that CD11c+CX3CR1+Lysozyme M+ cells had the highest expression 
of CD11c, MHCII and costimulatory molecules the ability of these cells to 
migrate, present antigen and stimulate the proliferation of naïve T cells has not 
yet been addressed. 
The observations outlined above describe a number of studies using 2-photon 
microscopy for the direct observation of DCs in situ. However it is important to 
remember that during experimental imaging there is likely to be tissue 
disruption in order to immobilise the intestine for the imaging.  Furthermore 
disruption to the mucus layer caused by the injection of large volumes of fluid, 
or resulting from imaging experiments, may force contact between the 
epithelium and luminal contents. Therefore further work must be completed in 
order to determine the functional relevance of these antigen uptake 
mechanisms. 
1.15.4  Antigen Uptake Via the Neonatal Fc Receptor 
Under specific circumstances, enterocytes have also been shown to mediate 
antigen sampling in the SI. Enterocytes are mainly involved with food 
absorption, but they are also able to express the neonatal Fc receptor (FcRn) 
until adulthood (Dickinson et al., 1999). Human FcRn has been shown to mediate 
the transport of IgG across the epithelium and can transfer IgG together with its 
cognate antigen as an immune complex across the intestinal epithelial barrier. 
Antigen is then passed to DCs and presented to T cells in the MLN (Yoshida et 
al., 2004; Yoshida et al., 2006). More recent work has demonstrated the 
importance of this pathway for some pathogens. For instance, there was 
enhanced epithelial invasion of Helicobacter heilmannii following infection in 
FcRn deficient mice (Ben Suleiman et al., 2012). Therefore this pathway may 
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represent a process by which antigen that has previously raised an IgG response 
may swiftly be captured and processed.  
 
1.16 Dendritic Cell Subsets in the Intestine  
1.16.1  Dendritic Cell Subsets in the Lamina Propria 
DCs in the LP have been principally defined by their co-expression of CD11c and 
MHC class II. However, the use of only these markers to define distinct intestinal 
DC subsets is complex as CD11c is also expressed on functionally distinct 
macrophages, along with CX3CR1, F4/80 and CD64 (Bain et al., 2013; Cerovic et 
al., 2012; Tamoutounour et al., 2012). Subsequently, in addition to CD11c and 
MHCII, CD103 has been used as a de facto marker of DCs in both the siLP and cLP 
(Johansson-Lindbom et al., 2005; Rivollier et al., 2012; Schulz et al., 2009). 
However we have shown that following TDC there are four functionally and 
phenotypically distinct subsets of DC identified by their expression of CD103 and 
CD11b, including two CD103- subsets (Cerovic et al., 2012). Corresponding DC 
subsets were also identified in the siLP, and CD103 and CD11b have also been 
used to identify DC subsets in the cLP (Rivollier et al., 2012).  
 
The majority of CD103+ DCs in the siLP express CD11b, but some CD103+ siLP DCs 
express CD8α instead of CD11b (Fujimoto et al., 2011; Jakubzick et al., 2008). In 
comparison in the cLP the ratio between these two DC subsets is reversed, with 
CD103+CD11b- DCs being the largest population and CD103+CD11b+ comprising a 
smaller population (Denning et al., 2007). As CD8α+ has previously been used to 
identify DCs as lymphoid-tissue resident cells, this was a surprising finding 
(Jakubzick et al., 2008). Determining whether CD103+CD8α+ DCs are a 
contamination from intestinal lymphoid tissue or are a population genuinely 
present in the LP is essential for elucidating the function of this DC subset. In 
addition to the two subsets of CD103+ DCs, there are also CD103-CD11b+ DCs and 
CD103-CD11b- DCs present in the intestinal lymph and siLP (Cerovic et al., 2012). 
Both of these CD103- DC subsets express CCR7, expand in response to FLt3L, 
present antigen to naïve T cells and express the DC restricted transcription 
factor Zbtb46 (Cerovic et al., 2012; Satpathy et al., 2012). Interestingly CD103-
CD11b+ DCs also express intermediate levels of CX3CR1, but do not express other 
macrophage-associated markers such as F4/80 or CD64. 
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Although these distinct DC subsets originate from the same pre-cDC precursor 
(C.L Scott, personal communication), the development of different subsets 
requires specific factors. For example, CD103+CD11b+ DCs require CSF-2 for their 
development, demonstrated by their selective impairment in CSF-2R-deficient 
mice (Greter et al., 2012). CD103+CD11b+ DCs are also dependent upon Notch-2 
and IRF4 for their development, but CD103+CD11b- DCs development is 
unaffected by the absence of these factors (Lewis et al., 2011; Persson et al., 
2013). In contrast, CD103+CD11b-CD8α+ DCs require Batf3 and IRF-8 for their 
development, but CD103+CD11b+ DCs are unaffected in the absence of these 
transcription factors (Edelson et al., 2010). The ontogeny of CD103- DC subsets is 
less clear, although it has been shown that these cells develop from the common 
pre-cDC precursor (Schraml et al., 2013) and they are unaffected by conditional 
IRF4 depletion (Persson et al., 2013). 
 
1.16.2  Functions of Dendritic Cell Subsets in the Lamina Propria 
In order for DCs to perform their major function of initiating an adaptive 
immune response, their migration to the draining LN is crucial. In the steady-
state DCs from the intestine constitutively migrate through the lymphatics to the 
MLN where they present peripherally derived antigen to T cells (Pugh et al., 
1983; Wilson et al., 2008).  This is essential for the induction of oral tolerance, 
and following pathogen stimulation DCs can also initiate an adaptive immune 
response (Milling et al., 2007; Worbs et al., 2006).  Additionally it has been 
demonstrated in rats that microbial stimuli can influence the migration and 
maturation of DCs.  Upon oral administration of the TLR7/8 agonist R848 there is 
a dramatic increase in DCs migrating from the LP to T cell areas of the MLN in a 
TNF-α dependent manner.  This demonstrates that the presence of pathogenic 
microbial products can increase the rate of DC migration to the MLN, presumably 
resulting in a more rapidly induced adaptive immune response (Yrlid et al., 
2006c). 
 
The migration of DCs from the LP to the draining MLN is a CCR7 dependent 
process.  In CCR7-/- mice the numbers of CD103+ DCs are reduced in the MLN but 
not in the LP (Jang et al., 2006; Johansson-Lindbom et al., 2005; Ohl et al., 
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2004).  CD103+ DCs accumulate with delayed kinetics in the MLN compared to 
the LP in BrdU pulse chase experiments, indicating that CD103+ LP DCs represent 
a migratory DC population in the LP (Jaensson et al., 2008).  Furthermore, using 
confocal microscopy to study lymphatic vessel in vivo and flow cytometry to 
assess DC subsets in draining MLN-afferent lymph, it was directly shown that LP 
derived CD103+ DCs make up the major population of DCs in murine draining 
lymph (Schulz et al., 2009).  Additionally CX3CR1hi expressing cells cannot be 
detected in the draining lymph either in the steady-state or following 
administration of R848, providing further evidence to support the hypothesis 
that these cells are not DCs (Schulz et al., 2009).   
 
Additionally, the migration of DCs from the LP to the MLN may be influenced by 
pDCs. Following the oral administration of the TLR 7/8 ligand R848 there is a 
rapid mobilisation of DCs from the LP into intestinal lymph (Yrlid et al., 2006c).  
However, some DC subsets obtained from intestinal lymph are unable to respond 
directly to R848, as they do not express TLR7 or TLR8 (Yrlid et al., 2006a). 
Instead it has been shown that after oral application of R848 intestinal pDCs are 
required for the mobilisation of DCs from the LP. This effect is likely to be 
mediated by TNF-α (Wendland et al., 2007; Yrlid et al., 2006a).  
 
1.16.3  Peyer’s Patch Dendritic Cells 
In the PPs there are three major populations of CD11c+ DCs; CD11b+ in the 
subepithelial dome, CD8α+ in the inter-follicular regions and CD11b-CD8α- DCs 
which are found throughout the PPs except in the germinal centres (Iwasaki and 
Kelsall, 2000; Iwasaki and Kelsall, 2001). More recently within the CD11b-CD8α- 
subset, a subset of CX3CR1+ DCs which also express lysozyme was described 
(LysoDCs) (Lelouard et al., 2010). These were located only in the subepithelial 
dome. More recent work has used CD103 as a marker to define DC subsets within 
the SI and colon, and indeed some CD103+ DCs have been identified in the PPs 
however the majority of DCs in the PPs are CD103- (Bogunovic et al., 2009; 
Jaensson et al., 2008). 
 
The anatomical location of PPs DCs is dependent upon the expression of various 
chemokines and their receptors.  As revealed by in situ hybridisation all three 
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subsets of PP DCs express CCR7 (Iwasaki and Kelsall, 2000).  In the steady state 
CD11b+ DCs express CCR6 and CCR1, in addition to CCR7, and so migrate towards 
CCL20 and CCL19.  CCL20 is constitutively expressed by epithelial cells in the 
follicle associated epithelium leading to the hypothesis that CD11b+ DCs are 
constantly recruited to the subepithelial dome (Cook et al., 2000; Zhao et al., 
2003).  In accordance with this it was reported that CD11b+ DCs were severely 
reduced or completely absent in the subepithelial domes of CCR6 deficient mice 
or following in vivo antibody neutralisation of CCL9 (Cook et al., 2000; Varona et 
al., 2001). In comparison, CD8α+ DCs constitutively express CCR7, but not CCR6, 
and so are able to migrate towards CCL19 and CCL21, but not CCL20 (Iwasaki 
and Kelsall, 2000).  CCL19 and CCL21 are constitutively expressed in the inter-
follicular region suggesting that CD8α+ DCs are resident in the inter-follicular 
region.  The chemokines responsible for the migration and localisation of CD11b-
CD8α- DCs have not yet been identified.  
 
Upon in vivo activation with the soluble tachyzoite antigen from Toxoplasma 
gondii (STAg) CD11b+ and possibly some CD11b-CD8α- DCs migrated from the 
subepithelial dome into the inter-follicular regions, where T cell priming can 
occur.  This correlated with an upregulation of CCR7 and a downregulation of 
CCR6 upon overnight culture (Iwasaki and Kelsall, 2000). These support the 
hypothesis that activation of DCs in the subepithelial dome, as would occur 
following exposure to microorganisms entering via M cells, results in the 
upregulation of CCR7 and migration to the inter-follicular regions by the 
upregulation of CCR7 where T cell priming can occur. 
 
In the steady-state DCs are present in the follicle-associated epithelium in 
smaller numbers than in the subepithelial dome. Oral administration of cholera 
toxin, cholera toxin B-toxin, Escherichia coli heat labile toxin or Salmonella 
typhimurium infection can induce an influx of DCs from the subepithelial dome 
into the follicle-associated epithelium (Anosova et al., 2008).  It was also shown 
that PP DCs in the subepithelial dome that express CCR6 appear to migrate into 
the follicle-associated epithelium, where they form clusters with antigen 
specific CD4+ T cells.  Furthermore the activation and expansion of specific T 
cells was dependent upon CCR6 (Salazar-Gonzalez et al., 2006). These CCR6-
expressing DCs were not recruited to the intestinal LP, suggesting that these DCs 
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may have specific functions in organised lymphoid tissues, where the CCR6 
ligand is constitutively expressed. 
 
1.16.4  Functions of Peyer’s Patch Dendritic Cell Subsets 
It has been shown that PP CD11b+ DCs produced relatively low levels of IL-12 and 
IFN-γ upon stimulation with Staphylococcus aureus (Iwasaki and Kelsall, 2001).  
Compared to CD8α+ or CD8α-CD11b- DCs, however, CD11b+ DCs from PPs 
produced high levels of IL-10, and induced naïve T cells to differentiate into IL-
10 producing T cells.  In comparison, CD8α+ and CD11b-CD8α- DCs produced IL-12 
and little or no IL-10 under the same conditions (Iwasaki and Kelsall, 2001).  
These studies support the hypothesis that in the steady state PP CD11b+ DCs 
produce IL-10 and possibly TGF-β upon interaction with naïve T cells causing 
their differentiation into Th2 cells producing IL-4, IL-10 and TGF-β. 
 
Several characteristics have been attributed to CD8α+ and CD11b-CD8α- DCs.  
Following reovirus infection dome region CD11b-CD8α- DCs take up viral antigens 
from dying infected epithelial cells.  As CD11b-CD8α- DCs have been shown in 
vitro to produce high levels of IL-12 it is likely these cells go on to drive a Th1 
type response (Fleeton et al., 2004).  CD8α+ DCs also present viral antigen to T 
cells, although it is still unclear if this is the result of direct viral antigen uptake 
or the cross presentation of antigen transported into the T cell zone by other DC 
subsets (Fleeton et al., 2004). 
 
All subsets of PPs DCs, but not splenic or DCs from other tissues, are able to 
induce the expression of the mucosal homing receptor α4β7 and CCR9 on T cells 
in vitro (Mora et al., 2003).  Upon adoptive transfer of PPs DCs, primed CD8+ T 
cells preferentially migrate to mucosal lymphoid tissues (Mora et al., 2005).  
This demonstrates that DCs from peripheral tissues are able to imprint T cells 
with tissue-specific homing receptors.  The ability to imprint gut homing T cells 
is dependent upon the generation of the vitamin A metabolite retinoic acid (RA) 
by DCs (Iwata et al., 2004). 
 
The PP is also the primary site for the production of IgA, which prevents invading 
pathogens and commensal bacteria from binding to the intestinal epithelium and 
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neutralises their toxins to maintain homeostasis at the mucosal surface (Cerutti, 
2008; Tezuka and Ohteki, 2010).  Accumulating evidence indicates that DCs are 
critical to the synthesis of IgA.  For instance, PP DCs produce TGF-β and IL-6, 
facilitating the switching of TLR-activated B cells from IgM to IgA expression; 
this also causes the generation of IgA plasmablasts.  Following the retention or 
upregulation of CCR9 and α4β7, and the downregulation of CXCR5 expression, 
IgA+ plasmablasts migrate from the PP to the gut LP where they further 
differentiate into IgA plasma cells (Cerutti and Rescigno, 2008).  Vitamin A levels 
have also been shown to be associated with IgA responses in the intestine, with 
vitamin A deficiency leading to reduced levels of IgA (Stephensen, 2001).  
Furthermore, it has been demonstrated that the ability of DCs from the PP to 
promote T-cell-independent class switching to IgA can be attributed to the 
combined effects of RA and IL-5 or IL-6 (Mora et al., 2006). 
 
1.16.5  Dendritic Cell Subsets in Isolated Lymphoid Follicles 
Previously, the phenotype of ILF DCs has been investigated by manually 
separating ILFs from all other intestinal tissues, followed by flow cytometry 
(McDonald et al., 2010). This study showed that the majority of CD11c+ cells 
within the ILF were CD11b-, although the authors did not report on the 
expression of CD103 in the ILF-derived DCs (McDonald et al., 2010). The 
phenotype of DCs in the ILF has also been investigated using 
immunohistochemistry (Jaensson et al., 2008; McDonald et al., 2010). Jaensson 
et al. showed that the majority of DCs within ILFs are CD103-, although some 
were CD103+. This suggests that there are likely different subsets present within 
the ILF, although due to their small size determining these subsets using flow 
cytometry or immunohistochemistry will be challenging.  
 
1.16.6  Functions of Dendritic Cells Within Isolated Lymphoid 
Follicles 
ILFs are distinct anatomical structures in the intestine, which contribute to the 
intestinal mucosal immune system by acting as inducible sites for the generation 
of adaptive immunity. DCs that originate here are likely to have been exposed to 
a different immune and antigenic environment than LP- or PP-derived DCs. This 
specialised environment could generate the features that distinguish the ILF-DCs 
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from the other migrating intestinal DC populations. Due to their small size little 
has been done to elucidate the specific functions of ILF DCs. However, like PP 
DCs, they are likely to be specialised for inducing B cell class switching as ILFs 
have been shown to play a compensatory role in producing antigen specific IgA in 
PP-null mice (Glaysher and Mabbott, 2007; Lorenz and Newberry, 2004). The ILF 
generation of IgA has been shown to be independent of T cell help, therefore 
the DCs present in the ILF can present antigen to B cells directly (Tsuji et al., 
2008). However this did not rule out the ability of DCs to present antigen to T 
cells, which are present in ILFs. 
 
1.17 Functions of Dendritic Cells in the Mesenteric Lymph 
Nodes 
Both in the steady state and under conditions of inflammation the MLN is home 
to several populations of CD11c+ DCs.  It contains the four migratory DC subsets 
arriving from the LP, and perhaps DCs from the PPs and ILFs, as well as DCs that 
have developed from blood borne precursors.  The expression of CD103 on DCs is 
likely to mark many of the DCs arriving from the LP. However not all migratory 
DCs are CD103+ some are CD103- (Cerovic et al., 2012). DCs in the MLN have the 
ability to generate gut-homing T cells, therefore naïve T cells primed here will 
preferentially localise their effects in the intestine. 
 
1.17.1  Oral Tolerance 
Oral tolerance is the state of local and systemic immune unresponsiveness that 
is induced by the oral administration of innocuous antigen, such as food protein. 
This state of hyporesponsiveness to fed antigen prevents unnecessary 
inflammation and hypersensitivity to harmless antigen. Oral tolerance can be 
transferred from one animal to another via the transfer of Tregs, or can be 
abolished by the depletion of Foxp3+ T cells (Hadis et al., 2011; Zhang et al., 
2001). The MLN, specifically the migration of DCs to the MLN, is essential for the 
generation of oral tolerance. CCR7 deficient mice demonstrate this; where 
intestinal DCs cannot migrate to the MLN, are unable to mount a T cell response 
in the MLN, cannot generate Foxp3+ Tregs, and thus are defective in their ability 
to generate oral tolerance (Johansson-Lindbom et al., 2005; Worbs et al., 2006).  
Of the migratory DCs in the MLN it is likely to be CD103+ rather than CD103- DCs 
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that play a major role in the induction of tolerance.  This was demonstrated 
after the oral administration of ovalbumin (OVA), where purified CD103+ but not 
CD103- MLN DCs to induced OVA-specific T cell response in vitro (Coombes et al., 
2007; Jaensson et al., 2008). In vivo the depletion of either CD103+CD11b+ or 
CD103+CD11b- DCs does not result in a decrease in the number of responding T 
cells in the LP (Edelson et al., 2010; Persson et al., 2013; Welty et al., 2013). A 
reduction in intestinal regulatory T cells was only observed when animals lacked 
all CD103+ intestinal DCs. Therefore there is likely to be some degree of 
functional overlap between CD103+CD11b+ and CD103+CD11b- DCs in the 
induction of tolerance (Welty et al., 2013).  
 
It has been suggested that CD103+ DCs are conditioned by epithelial cell derived 
factors to promote a tolerogenic response.  The interaction between E-cadherin 
expressed by epithelial cells and CD103 on DCs, along with factors such as TGF-
β, IL-10, RA, TSLP, PGE2 and VIP can condition DCs (Annacker et al., 2005; 
Coombes and Powrie, 2008; Coombes et al., 2007; McDonald et al., 2012; 
Rimoldi and Rescigno, 2005).  This appears to facilitate DCs to drive a regulatory 
type response in the intestine, by fostering the conversion of naïve T cells 
recognising innocuous antigen into Foxp3+ Tregs (Coombes et al., 2007). 
 
It has also been proposed that pDCs play a role in the generation of oral 
tolerance (Goubier et al., 2008). Depletion of pDCs using the pDC specific Gr1 
mAb resulted in abrogated induction of oral tolerance to a hapten as well as 
reducing systemic tolerance to OVA (Goubier et al., 2008). However as intestinal 
pDCs are unable to migrate to the draining MLN, it is unlikely these are acting in 
a similar manner to cDCs from the SI (Yrlid et al., 2006b). The liver can also 
function of a site of soluble oral antigen presentation due to the way in which it 
receives soluble antigen in the bloodstream from the portal vein (Yang et al., 
1994). The authors noticed that the transfer of pDCs from the liver of animals 
fed with specific antigen to naïve mice resulted in the suppression of delayed 
type hypersensitivity responses (Goubier et al., 2008). As the pDC depletion used 
by the authors was systemic, it may be that pDCs may induce anergy or deletion 
of antigen specific T cells, possibly CD8+ T cells in the liver or perhaps the GALT 
(Goubier et al., 2008; Dubois et al., 2009).  
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1.17.2  Functions of Retinoic Acid in Dendritic Cells  
The MLN is a site of enhanced Treg differentiation and T cells primed at this site 
are induced to express the gut homing receptors CCR9 and α4β7 (Coombes et 
al., 2007; Johansson-Lindbom et al., 2003).  These properties have been shown 
to be dependent upon the ability of intestinal DCs to generate the vitamin A 
metabolite RA (Coombes et al., 2007; Iwata et al., 2004). In the intestine 
vitamin A is obtained from the diet, which is oxidised to retinal by alcohol 
dehydrogenase (ADH) and then further to RA by aldehyde dehydrogenase (ALDH) 
(Mora et al., 2008). DCs express Aldh1a2, which encodes retinaldehyde 
dehydrogenase 2 (RALDH2), an enzyme that converts retinal to RA (Coombes et 
al., 2007). CD103+CD11b+, CD103+CD8α+ and CD103- DC subsets have all been 
shown to possess ALDH activity, and thus the ability to metabolise vitamin A 
(Cerovic et al., 2012). Therefore they have the potential to generate gut tropic 
T cells, and perhaps Foxp3+ Tregs cells. 
 
1.17.3  The Generation of Foxp3+ Regulatory T Cells in the 
Mesenteric Lymph Node   
DCs are able to promote the development of Foxp3+ Tregs.  In this process TGF-β 
facilitates the generation and maintenance of Foxp3+ Tregs, and RA is an 
essential cofactor.  In the absence of exogenously added TGF-β, OVA-loaded 
CD103+ DCs from the MLN, but not CD103- DCs, were able to induce the 
generation of Foxp3+ Tregs from naïve T cells (Coombes et al., 2007; Jaensson et 
al., 2008). One of the possible reasons for the functional difference between 
CD103+ and CD103- MLN-derived DCs may be the ability of CD103+ DCs to produce 
higher levels of TGF-β than CD103- DCs although the CD103+ DCs would be likely 
to be derived from the LP with CD103- DCs being a combination of blood derived 
DCs and some immunogenic migratory CD103- from the LP. Specifically CD103+ 
DCs express higher levels of tissue plasminogen factor latent TGF-β binding 
protein 3 and ALDH, which play roles in the efficient secretion and activation of 
TGF-β (Coombes et al., 2007).  When cultures of CD103+ MLN-derived DCs were 
incubated with naïve T cells in the presence of TGF-β and synthetic RA 
inhibitors, the induction of Foxp3+ Tregs were completely abrogated, indicating 
that RA is an essential cofactor to increase the rate of Treg induction mediated 
by TGF-β.  RA alone has little effect upon Foxp3 expression, therefore it has 
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been suggested that there is cooperation between the TGF-β and RA pathways 
(Balmer and Blomhoff, 2002). It was also shown that CD103+ and CD103- MLN-
derived DCs were equally potent in generating Foxp3+ Tregs from naïve CD4+ T 
cells in the presence of exogenous TGF-β and RA (Coombes et al., 2007).  
 
1.17.4  The Induction of Gut Homing Receptors on T Cells by 
Dendritic Cells  
Another key step in the development of oral tolerance is the generation of gut 
homing T cells. Tissue-selective trafficking of T lymphocytes is guided by a 
combination of adhesion molecules and chemokines.  Upon activation in the MLN 
by DCs, T cells can upregulate CCR9 and α4β7 integrin endowing these cells with 
the capacity to home to the SI (Jaensson et al., 2008; Johansson-Lindbom et al., 
2005). Consequently CCR9 deficient CD8+ T cells have severely impaired access 
to SI epithelium. The key role played by the of the expression of gut homing 
molecules on T cells is demonstrated by a decreased ability to generate oral 
tolerance in CCR9 or β7 deficient mice (Cassani et al., 2011; Wagner et al., 
1996), although other groups have found that CCR9 deficient animals may 
generate normal oral tolerance (A. Mowat, personal communication). 
 
The ability to cause the retention or upregulation of CCR9 and α4β7 is mediated 
by MLN-derived CD103+ DCs.  Conversely CD103- DCs from MLN failed to induce 
CCR9 expression on T cells (Johansson-Lindbom et al., 2005). However we have 
shown that CD103- DCs from intestinal lymph can result in CCR9 expression in 
responding T cells, although to a lower extent (Cerovic et al., 2012).  This 
property appears to be due to the increased capacity of SI CD103+ DCs to 
generate RA, which itself is sufficient to induce CCR9 and α4β7 expression on 
activated T cells (Coombes et al., 2007).  Additionally the ability of DCs to 
induce α4β7 and CCR9 was partially inhibited with the retinal dehydrogenase 
inhibitor citral (Iwata et al., 2004).  RA acts on the heterodimeric retinoic acid 
receptor (RAR) expressed in T cells, causing the induction of CCR9 and α4β7 
expression.  This interaction, along with antigen dose, has been shown to 
influence the expression of CCR9 in T cells (Svensson et al., 2008).  The ability 
to generate gut-tropic α4β7 T cells, however, appears to be less dependent on 
high levels of RA. Both CD103+ and CD103- DCs are able to generate similar 
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numbers of CD8+ T cells expressing α4β7, although CD103+ DCs were still more 
efficient that their CD103- counterparts (Jaensson et al., 2008; Johansson-
Lindbom et al., 2005).   
 
Recent work by Haddis et al. has shown that, in order to generate effective oral 
tolerance MLN derived Tregs undergo a secondary expansion upon their arrival to 
the siLP (Hadis et al., 2011). However, in the presence of cholera toxin (CT) this 
expansion was abrogated suggesting that intestinal inflammation prevents the 
generation of a tolerogenic response. The authors showed that in the steady-
state the expansion of Tregs in the siLP required CX3CR1, specifically the 
production of IL-10 from CX3CR1 macrophages in the intestine (Hadis et al., 
2011). Similarly, the production of IL-10 in the colon is required to maintain 
Tregs in the colon (Murai et al., 2009). 
 
1.17.5  Initiation of an Adaptive Immune Response By Dendritic 
Cells 
Despite their ability to induce a tolerogenic response, intestinal DCs retain 
functional plasticity and can induce the differentiation of effector T cells. There 
is some evidence showing that TLR stimulation is likely to be responsible for the 
ability of DCs to switch between generating Tregs and initiating an active 
immune response, although much further work is required to fully elucidate how 
this occurs. Upon TLR5 stimulation CD103+CD11b+ DCs are able to produce IL-23 
and stimulate IFN-γ and IL-17 production from responding T cells (Kinnebrew et 
al., 2012). Similarly, CD103+ DCs from lymph respond to TLR2 stimulation by 
producing IL-12p40 and IL-6 resulting in IFN-γ producing effector T cells (Cerovic 
et al., 2012). Intriguingly, CD103- DCs from the MLN and lymph appear to have a 
more immunogenic phenotype and prime IFN-γ and IL-17 producing effector T 
cells in the absence of overt stimulation (Cerovic et al., 2012). Therefore in the 
absence of TLR stimulation there is a small subset of DCs that retain an 
immunogenic phenotype. 
 
Recently work has begun to determine the effect of individual DC subsets on the 
immune response. Depletion of CD103+CD11b+ DCs results in a reduction of Th17 
cells in the siLP, which was dependent upon the ability of CD103+CD11b+ DCs to 
produce IL-6 (Lewis et al., 2011; Persson et al., 2013). Furthermore, following 
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stimulation with the TLR5 ligand flagellin CD103+CD11b+ DCs can induce the 
differentiation of IgA-producing B cells, independent of GALT. Furthermore, 
CD103+CD11b+ DCs supported the development of antigen specific Th17 cells and 
Th1 cells following TLR5 stimulation (Uematsu et al., 2006) (Cerovic et al., 
2012).  
 
Like other CD8α expressing DCs, CD103+CD11b- DCs are able to cross-present 
antigen and prime effector CD8+ T cells. The ability to cross-present antigen and 
generate CTL responses against tumours and intracellular pathogens is limited to 
these CD8α+ DCs. Analogous populations to CD103+CD11b- DCs in the rat have 
been shown to take up apoptotic cells in the LP and transport them to the MLN 
(Huang et al., 2000). It is likely that CD103+CD11b- DCs in the mouse also act to 
take up apoptotic cells and present this to CD8+ T cells. Previously, we have 
shown that CD103+CD11b- DCs have ALDH activity and are able to induce CCR9 
expression in responding T cells. Therefore these CD103+CD11b- DCs may 
contribute to peripheral tolerance by sampling dying cells and generating 
regulatory T cells in response to self-antigen. Alternatively, CD103+CD11b- DCs 
may take up virally infected cells and communicate this with the MLN. As such, 
CD103+CD11b- DCs express TLR3, TLR7 and TLR9 therefore they are able to 
respond to microbial challenge. Upon TLR stimulation CD103+CD11b- DCs were 
able to produce IL-12p40, and produce antigen-specific IFN-γ producing CTLs 
that lead to the development of SI inflammation (Fujimoto et al., 2011) (V. 
Cerovic, personal communication). 
CD103-CD11b+ DCs are the only subset able to prime the development of IFN-γ 
and IL-17 producing T cells, even without stimulation. In comparison, CD103-
CD11b- DCs induce only IL-17 production from CD4+ T cells (Cerovic et al., 2012).  
However, much further research is required to determine the function of these 
newly described subsets of intestinal DCs. 
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1.18 Hypothesis and Aims  
Understanding the functions of DCs in the MLN is a vital area of research if DCs 
are to be targeted by orally-delivered adjuvants, the details of how they 
influence immune responses must be determined. Recent findings regarding 
CD103+ and CD103- DCs have revealed much about their phenotype and function.  
However, there are still fundamental gaps in the understanding of the roles 
played by intestinal DC subsets in vivo.  
 
I sought to determine the anatomical origins of the DCs that migrate to the MLN, 
including all the recently described migratory DC subsets in the intestine. I 
hypothesised there would be differences in the endpoint of migration of DCs 
between the SI and colon, and that DC might migrate to the MLN from both the 
siLP and GALT. Using an array of surgical and labelling techniques, and mouse 
models, I was able to test these hypotheses and provide an up to date analysis of 
the origins of each of the DC subsets in the intestine.  
 
In the first results chapter, Chapter 3, I sought to compare the migration of DCs 
from the SI and colon to the MLN. Most current research examines the entire 
MLN, as a reflection of both the SI and colon. However, as these organs are 
physically and functionally different, and contain distinct cell populations, I 
hypothesised that there would be significant differences in the lymphatic 
drainage of DCs to different areas of the MLN. In Chapter 4 I aimed to describe 
the contribution of DCs from SI-associated lymphoid tissue to total DC migration. 
Two mouse models were employed and compared. One lacked both PPs and ILFs 
and the other lacked only PPs, I suggest there would be differences in the 
composition of DC subsets between the two mouse models. In Chapter 5 I 
intended to determine if DCs can migrate from PPs to the MLN, using two 
labelling techniques. The question of whether DCs migrate from PPs and ILFs to 
the MLN has been a long-standing area of controversy, but based upon previous 
research I postulated that DCs were able to migrate from PPs to the MLN 
(Macpherson and Uhr, 2004). By performing this set of experiments I hoped to 
determine the routes of migration of DCs from the SI, SI-associated lymphoid 
tissues, and the colon to the MLN. This will provide new insights into DC biology 
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in the intestine, and is essential to determine the potential for targeting these 
cells to regulate mucosal immune responses. 
  
 66 
Chapter 2:  Materials and Methods 
2.1 Animals 
Mice were maintained under specific pathogen free (SPF) conditions at the 
Central Research Facility (CRF) located at the University of Glasgow or at the 
Central Animal Facility at the Hannover Medical School. Mice were used between 
6 and 20 weeks, unless otherwise stated. C57Bl/6 mice were obtained from 
Harlan (Bicester, Oxfordshire/University of Glasgow), or from Charles River 
(Koln, Sulzfeld/Hannover Medical School). Table 1 outlines mouse strains used 
throughout these studies. All strains were on the C57Bl/6 background. 
Procedures were performed in accordance with UK Home Office Regulations 
(University of Glasgow), or in accordance with institutional guidelines and were 
approved by the institutional review board of the Hannover Medical School. 
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Table 2-1 Details of Mouse Strains 
Strain Source 
C57Bl/6 (B6, CD45.2+) Harlan, Charles River 
C57Bl/6.SJL (CD45.1+; Ly5.1+) Kindly provided by Prof. Allan Mowat 
(University of Glasgow) 
CB57Bl/6 (CD45.1+/CD45.2+) Generated by crossing C57Bl/6 mice with 
C57Bl/6.SJL 
OT-I (CD45.2+) 
C57Bl/6-
Tg(TcraTcrb)1100Mjb/J 
Kindly provided by Prof. Allan Mowat 
(University of Glasgow)(Hogquist et al., 1995) 
OT-I (CD45.1+) Generated by crossing OT-I CD45.2+ mice with 
C57Bl/6.SJL 
OT-I (CD45.1+/CD45.2+) Generated by crossing OT-I CD45.2+ mice with 
C57Bl/6.SJL 
OT-II (CD45.2+) 
B6.Cg-Tg(TcraTcrb)425Cbn/J 
Kindly provided by Prof. Allan Mowat 
(University of Glasgow)(Barnden et al., 1998) 
OT-II (CD45.1+/CD45.2+) Generated by crossing OT-II CD45.2+ mice 
with C57Bl/6.SJL 
OT-II (CD45.1+) Generated by crossing OT-II CD45.2+ mice 
with C57Bl/6.SJL 
Kaede (CD45.2+) 
Tg(CAG-KikGR)33Hadj/J 
Kindly provided by Prof. James Brewer and 
Prof Paul Garside (University of 
Glasgow)(Tomura et al., 2008) 
CX3CR1gfp/gfp 
(B6.129P-Cx3CR1tm1Litt/J) 
Kindly provided by Prof. Allan Mowat 
(University of Glasgow) (Jung et al., 2000) 
RORγtneo/neoCD3ε -/- Kindly provided by Prof. Peter Lane 
(University of Birmingham)(Sun et al., 2000) 
CD3ε -/- Kindly provided by Prof. Peter Lane 
(University of Birmingham)(Wang et al., 1994) 
CCR7-/-  
B6.129P2(C)-Ccr7tm1Rfor/J 
Kindly provided by Dr Oliver Pabst (Hannover 
Medical School)(Forster et al., 1999) 
EDG3-/- 
 
Kindly provided by Dr Oliver Pabst (Hannover 
Medical School)(Kono et al., 2004) 
232-4 
IFABP-tOVA 
Kindly provided by Prof. Leo Lefrancois 
(University of Connecticut)(Vezys et al., 
2000) 
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Generation of Peyer’s Patch Free Mice 
 
HEK293 cells stably transfected with LTβR-Ig were obtained from Dr Oliver Pabst 
at the Hannover Medical School. These cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM, Life Technologies, CA, USA) supplemented with 
5% ultra low IgG foetal calf serum (FCS, Gibco, Life Technologies) and 1% 
penicillin/streptomycin (Gibco) in a cell culture incubator at 37°C with 5% CO2 in 
a tissue culture flask with a surface area of 175 cm2 (Corning, Sigma-Aldrich, 
Poole, UK). Cells were passaged twice a week once they were confluent. Media 
was removed and cells were washed with PBS (Gibco, Life Technologies). Cells 
were detached from the tissue culture flask by treatment with 4mls 0.25% 
trypsin and 0.5 mM Ethylenediamineteraacetic acid (EDTA) (Life Technologies) 
for 1 minute, before adding 10ml DMEM (Life Technologies) supplemented with 
5% FCS (Gibco) and 1% penicillin/streptomycin (Gibco). Cells were collected, 
centrifuged at 400g for 5 minutes and resuspended in DMEM supplemented with 
5% ultra low IgG FCS (both Gibco) and dilutions of 1/5 to 1/10 were passaged 
into new tissue culture flasks (Corning). Supernatants were then sterilised by 
passing them through a 0.2µm cell filter (Corning). 
 
The LTβR-Ig was purified from the supernatants of cell cultures using protein A 
sepharose columns (Amersham Biosciences, NJ, USA). LTβR-Ig was loaded onto a 
protein A sepharose column (Amersham Biosciences) containing approximately 
2ml of protein A beads (Amersham Biosciences) by running 5-10l of cell culture 
supernatant through the column. The column was washed with PBS and the 
loaded protein was eluted by 4ml of 0.1M Citrate, pH 3.5, into a mixture of 700 
µl of 0.5 M Na2HPO4 and 300µl Tris, pH9.5. The buffer conditions were changed 
by using gel filtration desalting columns (PD-10 GE Healthcare, Life Sciences, 
Buckinghamshire, UK) eluting the protein in pure PBS. The protein solution was 
concentrated by ultra-filtration with Microsep centrifugal devices (PALL Life 
Sciences, NY, USA) with a 30kDa cut off, centrifuged at 7,500xg. Protein 
concentration was determined by bicinchonicic acid assay (BCA) protein assay, 
performed as per manufacturers instructions (Thermo-Fisher Scientific, MA, 
USA). Briefly, Bovine Serum Albumin (BSA) standards (Thermo-Fisher Scientific) 
from 0 to 25µg/ml in 0.5 µg/ml steps were prepared and 300µl of the Coomassie 
Reagent from the BCA (Thermo-Fisher Scientific) was added to the BSA standards 
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(Thermo-Fisher Scientific) and sample for 10 minutes at room temperature. The 
absorbance of each of the samples was determined using a plate reader at 
595nm. The protein concentration was then determined based upon the standard 
curve. The integrity of the LTβR-Ig was confirmed using SDS-PAGE. Briefly, 
samples were loaded onto a Nu-PAGE Bis-Tris Pre-cast gel (Life Technologies) 
along with a molecular weight ladder (Life Technologies). The sample was run in 
Nu-PAGE MES SDS running buffer (Life Technologies). The gel was washed in 
deionised water and the protein was detected by incubation with 20mls 
SimplyBlue SafeStain (Life Technologies) at room temperature with gentle 
shaking. The gel was washed again and photographed. To deplete mice of PPs, 
two intravenous injections of 200 µg of purified LTβR-Ig, into pregnant females 
at E14 and E16 were performed. 
 
2.2 Surgical Procedures 
2.2.1  Mesenteric Lymphadenectomy  
The MLNx procedure was adapted from established protocols (Milling and 
MacPherson, 2010) (Cerovic et al., 2012). Animals underwent anaesthesia via 
inhalation of isolflurane (Abbot Laboratories Ltd, IL, USA), subsequently shaved 
and treated with subcutaneous analgesics Carprofen (Rimadyl; Pfizer, NY, USA) 
and Buprenorphine (Vetergesic; Reckitt Benckiser Healthcare, Berkshire, UK); 
diluted to dose rates of 0.1ml/100g and 0.15 ml/100g respectively. An 
abdominal midline incision was made in mice aged 5-6 weeks, and the intestine 
exposed. During MLNx, all visible MLNs located above the superior mesenteric 
vein were removed by blunt dissection with the intestine being replaced upon 
completion. For partial MLNx specific parts of the MLN, which drain either the SI 
(siMLNx) or colon (coMLNx), were removed and the intestine replaced. The 
muscle layer was sutured with 6.0 vicryl absorbable sutures (Johnson and 
Johnson, NJ, USA) and the skin closed using surgical clips (Autoclip Wound Clip 
System, Harvard Apparatus, MA, USA).  
 
2.2.2  Thoracic Duct Cannulation  
5-6 weeks after the MLNx procedure, thoracic duct cannulation (TDC) was 
performed. Except in RORγtCD3ε deficient mice, as these were already lacking 
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MLNs therefore MLNx was not performed in these animals. Mice were gavaged 
with 300µl olive oil (Tesco, Hertfordshire, UK) 30 minutes prior to the procedure 
to assist lymphatic visualisation. Animals underwent inhalation anaesthesia, as 
previously described, and an incision of around 2-3cm was made from the 
xiphisternum towards the spine. A polyurethane cannula (2Fr, Harvard 
Apparatus) was inserted into the thoracic duct, fixed in place using surgical 
glue, and exteriorised between the ears. The muscle layer was then stitched, 
and the skin was held together with surgical glue. The cannula was then fed into 
a Covance harness (Harvard Apparatus). Pseudo-afferent lymph was collected on 
ice overnight in PBS supplemented with (25U/ml) Heparin (Wockhardt, Mumbai, 
India). 
 
2.2.3  Photoconversion of Kaede Mice 
Following laparotomy and reflection of the SI onto a sterile swab as described 
for the MLNx procedure, photoconversion was performed. This technique was 
adapted from established protocol (Schmidt et al., 2013). For PP 
photoconversion all visible and accessible PPs were converted. Black card with a 
density greater than 280 microns (Rymans, Cheshire, UK) was used to cover 
intestinal tissues and to prevent exposure of the UV light source (405nm UV LED, 
Amazon, WA, USA) to the surrounding LP. Every accessible PP was exposed to 
the UV light source for 2 minutes. This process is represented in Figure 2.1. For 
SI or colon photoconversion, the PPs and any superfluous tissue were protected 
from UV light using black card (Rymans). 2-3cm sections of SI or colon were 
exposed to UV light for 2-3 minutes, as depicted in Figure 2.2. The intestine was 
replaced; the muscle layer sutured and the skin closed using surgical clips as 
previously described. 
 
 71 
 
Figure 2-1 Peyer’s Patch Photoconversion 
Following the induction of anaesthesia via inhalation of isolflurane the intestine was exposed and 
reflected onto a sterile swab. The intestine was manipulated with cotton swabs to ensure that 
the Peyer’s patch (PP) to be photoconverted was lying at the outermost edge of the small 
intestine (SI), without any SI underneath the PP. Black card was then placed on top of the SI, and 
some of the PP, before UV light was shone on the PP for 2 minutes. This process was repeated 
for every accessible PP in the SI. The intestine was then replaced, the muscle layer stitched, and 
the wound closed with surgical clips. The animal was then allowed to recover.  
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Figure 2-2 Small Intestine Photoconversion 
Following the induction of anaesthesia via inhalation of isolflurane the intestine was exposed and 
reflected onto a sterile swab. The intestine was manipulated with cotton swabs to ensure that 
the Peyer’s patches (PP) were lying at the outermost edge of the small intestine (SI). Black card 
was then placed on top of the PPs, mesentery and colon before UV light was shone on the 
section of the SI for 2-3 minutes. This process was repeated for the length of the SI or colon. The 
intestine was then replaced, the muscle layer stitched, and the wound closed with surgical clips. 
The animal was then allowed to recover. 
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2.2.4  FITC Injections 
For the injection of FITC into PPs, mice were first anaesthetised using Ketamine 
and Rompun (both Bayer Healthcare, Leverkusen, Germany) (100mg/kg and 
10mg/kg for Ketamine and Rompun respectively administered by intraperitoneal 
injection). Laparotomy was performed and intestines reflected onto a sterile 
swab. 1mg/ml FITC (Sigma Aldrich) was microinjected using a CO2 powered 
micro-injector (PLI-100, Harvard Apparatus) into every visible PP. The intestine 
was replaced, and the muscle layer and skin sutured. Gavage of cholera toxin 
(CT) (10µg, Sigma Aldrich), R848 (10µg, Sigma Aldrich) or Fingolimod (FTY720) 
(20µg, LC Laboratories, MA, USA) where appropriate was performed after FITC 
injection was completed and the animal was recovered.  
 
2.2.5  Subserosal Injections of Evan’s Blue 
 
Animals were anaesthetised with Isoflurane as previously described, a midline 
incision was made and intestines were reflected onto a dampened swab. The 
intestine was held gently with fine forceps and Evans Blue (2% solution, Sigma 
Aldrich), up to 30µl per injection site, was injected into the subserosal layer 
using a Micro-fine syringe (30G, BD Biosciences, NJ, USA).  
 
2.2.6  Swiss Roll Sections of Intestine 
 
Swiss roll sections of intestines were prepared as previously described 
(Moolenbeek and Ruitenberg, 1981; Pabst et al., 2006). Briefly, mice were 
anaesthetised using Isoflurane as previously described, 7-8cm sections of 
intestine were excised, cut longitudinally along the anti-mesenteric axis, 
intestinal contents were gently removed and a layer of Tissue-Tek O.C.T (Bayer) 
was applied to the luminal side of the intestine. Sections of intestine were rolled 
and snap frozen in O.C.T over isopentane (VWR, PA USA) on dry ice. Animals 
were then sacrificed. Blocks were stored at -80°C until use. 
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2.3 Reagents 
Where indicated, cells were cultured in complete RPMI consisting of: RPMI 1640 
medium supplemented with 5% FCS, 2mM L-glutamine, 100U/ml penicillin, 
100µg/ml streptomycin and 50µM 2-mercaptoethanol (all Gibco). FACS buffer 
was used to re-suspend cells for FACS staining, this consisted of PBS 
supplemented with 2mM EDTA and 1% FCS (all Gibco). 
 
Recombinant human Flt3L (Amgen, Seattle, USA) was injected intraperitoneally 
at 10µg per mouse per day for 10 days. 
 
2.4 Cell Isolation 
2.4.1  Isolation of Thoracic Duct Leukocytes 
Lymph collected overnight on ice in PBS and 20U/ml Heparin was passed through 
a 40-µm-cell strainer (BD Biosciences), and red blood cells (RBCs) were lysed 
with 3ml ammonium chloride potassium (ACK) lysis buffer (Sigma Aldrich) for 1 
minute and lysis was quenched by the addition of 20mls complete RPMI. Cells 
were washed twice in complete RPMI and stained and analysed by flow 
cytometry or sorted by fluorescence-activated cell sorter using the FACSAria cell 
sorter (BD Biosciences). 
 
2.4.2  Isolation of Small Intestine Lamina Propria Cells 
To obtain leukocytes from the siLP, I used the established isolation laboratory 
protocol developed by the laboratory of Prof. Allan Mowat. The SI was excised 
and washed in Hanks’ Balanced Salt Solution (HBSS, Gibco) supplemented with 
2% FCS (Gibco), PPs and fat were excised from the tissue. The intestine was cut 
longitudinally, then further cut into 0.5cm sections. Tissue was shaken 
vigorously in HBSS/2% FCS and the supernatant was removed by pouring tissue 
and supernatant through a 50µm Nitex mesh (Cadisch and Sons, London, UK) 
with the tissue subsequently collected from the top of the mesh. The intestines 
were incubated twice in HBSS with 2 mM EDTA at 37°C with vigorous shaking for 
20 minutes, with the tissue being washed in HBSS between each incubation by 
removal of the supernatant by pouring onto Nitex mesh and re-collection of the 
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tissue. Tissue was then digested with 1 mg/ml of Collagenase VIII (Sigma Aldrich) 
in complete RPMI at 37°C with vigorous shaking until the tissue was fully 
digested (approximately 15 minutes). Cells were passed through a 100µm filter 
(BD Biosciences) followed by a 40µm filter (BD Biosciences), washed twice in 
complete RPMI and kept on ice until use. 
 
2.4.3  Isolation of Colonic Lamina Propria Cells 
To obtain leucocytes from the cLP, pieces of colon were soaked in ice cold PBS. 
After removing all fat and faeces, the colon was opened longitudinally and cut 
into 0.5 cm sections. Tissue was shaken vigorously in HBSS/2% FCS and the 
supernatant was removed by pouring tissue and supernatant through a 50µm 
Nitex mesh (Cadisch and Sons) with the tissue sections subsequently collected 
from the top of the mesh. The intestines were incubated twice in HBSS with 2 
mM EDTA at 37°C with vigorous shaking for 15 minutes, with the tissue being 
washed in HBSS between each incubation by removal of the supernatant by 
pouring onto Nitex mesh and re-collection of the tissue. Tissue was digested 
with 1.25mg/ml collagenase D, 0.85mg/ml collagenase V, 1mg/ml dispase and 
30U/ml DNase in complete media for 30-40 minutes while shaking at 37°C. The 
resulting cell suspension was passed through a 40µm cell strainer (BD 
Biosciences) and then washed twice in complete RPMI. Cells were kept on ice 
until use. 
 
2.4.4  Isolation of Lymph Node and Spleen Cells 
LN and spleens were collected from mice and excess fat was removed. To obtain 
DCs, samples were collected in serum free RPMI, cut into small pieces, and 
digested using 50µg/ml of DNase and 0.4WunchUnits/ml of liberase (Roche) for 
45 minutes in a shaking incubator at 37°C. After this, cells were passed through 
a 40µm cell strainer, washed, stained with antibodies and analysed by flow 
cytometry. RBCs in the spleen preparations were lysed by incubation with 5mls 
RBC lysis buffer (Sigma) for 5 minutes. Lysis was quenched with 40ml complete 
RPMI. To obtain T cells from LN and spleens, tissue was mashed through a 40µm 
filter (BD Biosciences), which was washed with 10ml complete RPMI. These 
samples were then treated in a similar manner to samples that had been 
digested using DNase and liberase. 
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2.5 Flow Cytometry  
Cell surface staining was performed on freshly isolated cells resuspended in FACS 
buffer (PBS supplemented with 2mM EDTA and 5% FCS). Samples were stained in 
12x75mm polystyrene tubes (BD Biosciences) with up to 10x106 cells per 200µl of 
FACS buffer. Non-specific binding of antibodies to Fc receptors was blocked by 
the addition of Fc block (anti-CD16/CD32, Biolegend) diluted 1:200 for 10 
minutes at 4°C. Required antibodies or isotype controls were then added to 
samples for 30 minutes at 4°C. Cells were then washed twice in FACS buffer. 
Where a biotin-conjugated antibody was used, cells were washed with FACS 
buffer, and further stained with a streptavidin-fluorochrome conjugate for 15 
minutes at 4°C, and washed again before analysis. For a full list of antibodies 
see Table 2.2. To determine proportions of live and dead cells 20µl of 7-
aminoactinomycin D (7AAD, Biolegend) was added to samples just prior to 
analysis. Alternatively, 1µl of fixable viability dye eFluor 780 (eBioscience) was 
added to samples in 1ml of azide and FCS free PBS for 30 minutes at 4°C prior to 
staining with antibodies. Samples were washed in FACS buffer and stained with 
antibodies as outlined above. All samples were acquired using either MACS Quant 
analyser (Miltenyi), or an LSR II (BD Biosciences), or sorted and analysed using 
the BD FACS Aria (BD Biosciences). All data analysis was carried out using FlowJo 
software (Tree Star). 
 
Cells were prepared for sorting as described for flow cytometry analysis but 
under sterile conditions. When sorting DC subsets, cells were kept at all times in 
complete RPMI on ice. Cells were kept in complete RPMI for the entire duration 
of the sort, and they were sorted into complete RPMI.  
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Table 2-2 List of Antibodies 
Antibody Clone Isotype Source 
CD3 17A2 Rat IgG2b Biolegend 
CD4 GK1.5 Rat IgG2b Biolegend 
CD8α 53-6.7 Rat IgG2a Biolegend 
CD11b M1/70 Rat IgG2b Biolegend 
CD11c N418 Hamster IgG Biolegend 
CD19 1D3 Rat IgG2a Biolegend 
CD45 30-F11 Rat IgG2b Biolegend 
CD45.1 A20 Rat IgG2a Biolegend 
CD45.2 104 Rat IgG2a Biolegend 
CD45R M5/114.15.2 Rat IgG2b Biolegend 
CD64 X54-5/7.1 Mouse IgG1 Biolegend 
CD80 16-10A1 Hamster IgG BD Biosciences 
CD86 GL1 Rat IgG2a BD Biosciences 
CD172a P84 Rat IgG1 Biolegend 
CD199 (CCR9) 9B1 Rat IgG2a Biolegend 
F4/80 BM8 Rat IgG2a Biolegend 
MHCII M5/11.4.15.2 Rat IgG2b Biolegend/ 
eBioscience 
TCRVα2 B20.1 Rat IgG2a Biolegend 
Ly6C HK1.4 Rat IgG2c Biolegend 
PDCA-1 129c Rat IgG2b eBioscience 
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2.6 Induction of DSS Colitis 
An established protocol was used to induce colitis; mice received 2% dextran 
sodium sulphate (DSS) salt (reagent grade; MW 6,000-50,000kDa; MP Biomedicals 
Ohio, USA), in sterile drinking water for three days. Mice were monitored daily 
for weight change, rectal bleeding and diarrhoea. Mice that lost >20% of their 
initial bodyweight were sacrificed immediately in accordance with Home Office 
regulations. Some groups of mice were returned to normal drinking water 
following three days of the addition of DSS to drinking water to assess the 
recovery phase of disease. Mice were continually monitored daily for weight 
change, rectal bleeding and diarrhoea. 
 
2.7 Adoptive Transfers 
T cells were isolated from the spleen and MLN of donor OT-II CD45.1+ mice or 
OT-I CD45.1+/CD45.2+ mice as previously described. Donor cells were labelled 
with 5µM Carboxyfluorescein succinimidyl ester (CFSE, Life Technologies) for 15 
minutes at 37°C (Invitrogen). 5x106 CFSE-labelled donor cells were injected 
intravenously into congenic recipient mice in 100µl sterile PBS. 24 hours later 
the animal was gavaged with 10 mg of OVA protein. Proliferation was assessed 
by CFSE dilution by flow cytometry. 
 
2.7.1  Proliferation Assay 
To assess the ability of DC to prime naïve T cells, populations of DCs were FACS-
purified from the lymph or MLN and described above and co-cultured with FACS-
purified naïve (CD62L+) CD4+ or CD8+ T cells of OT-II or OT-I mice respectively. 
Prior to co-culture, T cells were labelled with 5µM CFSE (Life Technologies) for 3 
minutes before washing in complete RPMI. DC populations, except for DCs from 
232-4 mice, were pulsed with 2mg/ml OVA protein for 2 hours, washed twice in 
complete RPMI and then co-cultured at varying ratios with 100,000 T cells for 3-4 
days at 37°C with 5% CO2. Following co-culture samples were stained with 
antibodies as described above. Samples were analysed by FACS and T cell 
proliferation was determined by CFSE dilution.  
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2.8 Generation of Bone Marrow Dendritic Cells 
BM cells were isolated by flushing tibias and femurs from mice with complete 
RPMI, using a 26G needle attached to a 20 ml syringe. Cells were centrifuged at 
380g for 5 minutes and the supernatant discarded. RBCs were lysed by 
resuspending the pellet in 3 mls RBC lysis buffer (Sigma) for 5 minutes. 40mls of 
complete RPMI was added and cells were centrifuged at 380 g for 5 minutes, the 
supernatant was discarded and cells were resuspended in 10mls of complete 
media. An aliquot of live cells was counted and cells were plated out in a 6 well 
plate at 1x107 cells/well in the presence of 10% Flt3L-containing supernatant 
from CHO Flt3L cells. Cells were cultured at 37°C at 5% CO2 for 7-9 days. 
 
Mouse Flt3L transfected Chinese hamster ovary (CHO) cells were grown in flasks 
in ProCHO4 media (Lonza, Basel, Switzerland) supplemented with 1x ProHT 
(Lonza), 2 mM L-glutamin, 100 U/ml penicillin and 100 µg/ml streptomycin (all 
Invitrogen) until confluence was achieved. Supernatant was harvested from the 
flasks, and filtered through a 0.2 µM filter (Millipore). The filtered supernatant 
was aliquoted and placed at -20°C until use. 
 
For photoconversion studies, after 7 days of culture with FLt3L, BMDCs were 
harvested and spun down. The pellet was photoconverted for two minutes 
before being resuspended in 5mls of complete media and being returned to a 
flat-bottomed 6-well plate. 24 hours later cells were assessed by flow 
cytometry. 
 
2.9 Preparation of Blood and Tissue Samples 
Tail samples were prepared for PCR using the DNeasy blood and tissue kit 
(Qiagen) as per the manufacture’s guidelines. Tail samples were digested 
overnight at 56°C with Proteinase K. DNA was purified by binding to the spin 
column membrane provided, washing and eluting in the elution buffer supplied. 
Samples of genomic DNA were stored at -20°C until use. Blood samples were 
incubated with 5mls RBC lysis buffer (Sigma) for 5 minutes at room temperature. 
Adding 40mls PBS subsequently quenched lysis. The sample was centrifuged at 
380 g for 5 minutes and the pellet resuspended in 200µl PBS supplemented with 
2% FCS. Cells from the blood sample were then labelled for FACS. 
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2.10 Polymerase Chain Reaction  
 
RORγtneo/neoCD3ε-/- and CD3ε-/- mice were genotyped before use for breeding. 
Genomic DNA was isolated from tail tips and was diluted by 50% prior to use in 
all polymerase chain reaction (PCR). Primers for the amplification of RORγt and 
neomycin were designed from the published murine RORγt and neomycin 
sequences using Primer-BLAST, the online primer design software. The 
sequences of the primers used are shown in Table 2.3. All PCR primers were 
synthesised by Integrated DNA Technologies. PCR reactions were performed in 
25µl volumes using the Go-Taq PCR mix (Promega, WI, USA). Each PCR mix 
contained genomic DNA, 100nM primers (Integrated DNA Technologies, IA, USA), 
0.2mM dNTPs, 5U/µl Go Taq polymerase, 5X reaction buffer and nuclease free 
water (all Life Technologies). The optimal annealing temperature of each primer 
was determined using an online biomath calculator for determining the Tm of 
oligomer (Table 2.3). Cycling parameters were: 95°C for 1 minute followed by 
annealing at the optimal annealing temperature (Table 2.3) for 30 seconds and 
elongation for 30 seconds at 72°C for 35 cycles. The PCR products were 
visualised by gel electrophoresis on a 1% agarose gel (Sigma-Aldrich) in 1X TAE 
with 2µl ethidium bromide (Life Technologies) per 100 ml gel. 10µl of the PCR 
reaction with 2µl of 6X loading dye (Life Technologies) were loaded into the gel 
along with 5µl DNA ladder (Life Technolgies) and 1µl 6X loading dye. Gels were 
run in 1X TAE buffer for approximately 1 hour, or until bands had reached the 
bottom of the gel, at 100mV. Gels were visualised by UV transillumination. 
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Table 2-3 List of Primer Sequences For Genotyping 
Product Forward Primer (5’-3’) Reverse Primer (5’-3’) Optimal 
Annealing 
Temperature 
RORγt ACAGAGACACCACCGGACA
TCT 
TCGCTCCTACCTCACCG
CTTT 
52°C 
Neomycin AGCACTACTCGGAATGGAA
G 
AATATCACGGGTAGCCA
ACG 
48°C 
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2.11 Immunohistochemical Labelling of Slides 
Cryosections were cut at 8µm from blocks that had been snap frozen and kept in 
the -80°C using a cryotome (Thermo Electon Corporation, MA, USA) and mounted 
on slides which were stored at -80°C until use. For immunohistochemical 
labelling of slides, slides were fixed in ice-cold acetone for 10 minutes. The 
slides were allowed to air dry for 10 minutes before being rehydrated in PBS for 
10 minutes. To prevent non-specific staining sections were blocked in PBS 
(Gibco) with 1% FCS (Gibco) for 15 minutes then washed in PBS for 10 minutes. 
To block endogenous biotin on sections an Avidin/Biotin blocking kit (Vector 
Laboratories, CA, USA) was applied to sections. Breifly, sections were blocked 
for 15 minutes with Avidin (Vector), washed in PBS (Gibco) for 10 minutes and 
blocked for a further 15 minutes with biotin (Vector). Slides were washed again 
in PBS for 10 minutes. Sections were then stained with 400-600 µl biotinylated 
anti-B220 diluted 1:200 or isotype control in PBS (Gibco) for at least 30 minutes 
at 4°C. Binding was detected using streptavidin Alexa Fluor 647 (BD 
Biosciences), diluted 1:200 in PBS (Gibco) for at least 30 minutes at 4°C in the 
dark. Slides were washed twice in PBS (Gibco) and allowed to dry before 
Vectasheild mounting medium with DAPI (Vector) was applied to sections and a 
coverslip placed on top. Sections were examined on an epifluorescence 
microscope (Imager Z.1, Carl Zeiss, Herts, UK) using AxioVision software (version 
4.7). 
 
2.12 Statistical Analysis 
For comparison of means between two groups, data were analysed using a 
Student’s t-test. For comparisons involving more than two data sets, a one way 
analysis of variance (ANOVA) was used with a Bonferroni post test. For multiple 
data sets with independent variables a two way ANOVA was used, with a 
Bonferroni post test to compare selected data sets. P-values <0.05 were 
considered significant. All statistical analysis was performed using Graphpad 
Prism (Graphpad). 
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Chapter 3:  Comparison of Dendritic 
Cell Migration in the Small Intestine 
and Colon 
The SI and colon are vastly different environments. Functionally, the SI is 
specialised for the uptake of food while the colon acts largely to reabsorb water. 
There is also a vast difference between the microbial load in the SI and colon, 
with up to 10, 000 times more bacteria present in the colon compared to the 
ileum (Hooper and Macpherson, 2010). Furthermore, diseases affecting each 
area vary; inflammatory bowel diseases mostly affect the colon, ulcerative 
colitis affects only the colon, and Crohn’s Disease affects the colon and the 
terminal ileum. 
 
Another specific difference between the SI and colon is in the type of immune 
responses induced in each area. For example the tolerance induced in the SI to 
food proteins generates both a local and a systemic response, while in the colon 
there is no systemic response to bacteria, meaning the immune system is only 
acting locally (Pabst and Mowat, 2012). 
 
The MLN forms the largest group of lymph nodes in the body; they are not only 
the key site for induction of oral tolerance but also preserve systemic ignorance 
to intestinal commensal bacteria. Lymphatic drainage from the intestine was 
first examined over 50 years ago (Carter and Collins, 1974; Tilney N, 1971); it 
was suggested that afferent lymphatic vessels from different areas of the 
intestine drained to distinct parts of the MLN. These early findings describe only 
the lymphatic drainage and movement of lymphocytes; DCs had not yet been 
identified. 
 
Due to differences between the SI and colon it is likely that the DC populations 
migrating from each area are different. However, much previous work has failed 
to make this distinction and has examined the whole MLN to understand the 
immune environment in both the SI and the colon (Cerovic et al., 2012; Laffont 
et al., 2010). An up to date investigation of lymphatic drainage is essential to 
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fully elucidate which nodes of the MLN drain lymph from the SI and colon, and to 
understand differences between DCs migrating from each of these tissues.  
 
Practical difficulties make cells in the intestine difficult to label and track over 
extended periods of time, and enzymatic isolation of DCs from the intestine may 
affect their functions (Milling et al., 2010). Furthermore, there are challenges in 
elucidating the roles intestinal DCs and macrophages due to an overlap of 
phenotypic and functional features (Rivollier et al., 2012) (Bain et al., 2013) 
(Schulz et al., 2009) (Cerovic et al., 2012). Recent technical advances now 
enable us to investigate the anatomical segregation between the SI and colon, in 
the context of recent studies that describe four functionally distinct subsets of 
DCs (Cerovic et al., 2012). 
 
3.1 Results 
3.1.1  Identification of Small Intestinal and Colonic Draining 
Mesenteric Lymph Nodes 
Due to differences in the primary function, immune responses, associated 
immune organs, diseases, and cell populations between the SI and colon it is 
likely that the type of DC migrating from each area will be different. Therefore, 
to investigate these differences in DC populations, it is essential to understand 
the anatomical details of the lymphatic drainage from the SI and colon.  
 
To identify which part of the intestine supplies lymph to each of the nodes of 
the MLN chain, we examined the lymphatic drainage from the SI and colon. To 
achieve this, Evans blue dye was injected into the subserosal layer of either the 
SI or the colon of live anaesthetised mice. This allowed direct examination of 
the intestinal afferent lymphatic system and the draining MLNs. Five minutes 
after injection of dye into the SI, the draining afferent lymphatics and the three 
central LNs of the MLN chain stained blue and the afferent lymphatics were blue 
showing the draining lymphatics (Figure 3.1 B), compared to the control animal 
which did not contain any Evans blue dye (Figure 3.1 A). This identified these 
LNs as the SI draining LNs, the siMLNs. When Evans blue was injected 
subserosally into the proximal colon, the dye first reached the MLN located 
directly adjacent to the caecum (Figure 3.1 C). A second MLN also stained blue 
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following injection of dye into the proximal colon. This second colon-draining 
MLN was at the opposite end of the main MLN chain (Figure 3.1 C). Following 
Evans blue injection into the distal colon, the first MLN to stain blue was the 
lymph node located adjacent to the abdominal aorta (Figure 3.1 D). Together, 
these three nodes, at opposite ends of the MLN chain, adjacent to the caecum 
and the abdominal aorta, will be referred to as colonic MLN, coMLN. These 
draining MLNs are depicted in Figure 3.1 E. 
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Figure 3-1 Subserosal Injection of Evans Blue Distinguishes Distinct Parts of the MLN Drain 
the Small Intestine and Colon. 
The SI and colon of mice under terminal anaesthesia were visualised. Control mice that were not 
injected (A) or mice injected with Evans blue dye into the subserosal layer of the SI (B), proximal 
colon (C) and distal colon (D). 5 to 10 minutes after subserosal injection draining MLNs and the SI 
and colon were visualised and photographed. Blue Arrows indicate direction of lymph flow. 
Pictures represent 5-6 individual animals. Diagram depicting draining MLNs is shown in E, SI 
draining MLN (siMLN) are shown in blue and colonic draining MLN (coMLN) are shown in purple. 
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The coMLN and siMLN reproducibly acquired Evans blue after subserosal injection 
of the dye into the colon or SI. This indicated that these MLNs are each 
responsible for draining lymph from different regions of the intestine. As antigen 
is carried to the MLN by DCs, which then drive differentiation of antigen-specific 
naïve T cells, we next sought to identify the route of migration of DCs from the 
SI and colon to the MLN. In order to precisely observe the migration of DCs to 
specific regions of the MLN we used transgenic mice that constitutively express 
the photoconvertible kaede protein (Tomura et al., 2008).  
 
Exposure of kaede to UV light induces a specific peptide cleavage and 
subsequent formation of a double bond within the kaede chromophore that 
changes its excitation and emission wavelengths. This results in a permanent 
change in the structure of the protein, resulting in the permanent labelling of 
these cells (kaede-red+ cells). However, cell proliferation can dilute the of 
photoconverted kaede with non-photoconverted kaede protein (kaede-green+ 
cells). Transgenic mice carry kaede cDNA under the CAG promoter; this results 
in the expression of kaede in all cells, with no abnormality in their growth and 
reproduction. The expression of kaede, combined with the photoconversion 
technique, has no effect upon the homing capacity of lymphocytes (Tomura et 
al., 2008). 
 
Therefore, kaede mice were used here to investigate DC migration from the SI 
and colon to the MLN. After laparotomy, all accessible parts of the SI were 
exposed to low intensity UV light for two to three minutes. The PPs, MLN and 
the colon were not exposed to UV light. The siMLN and coMLN were examined 24 
and 48 hours after exposure of kaede SI to UV light. Briefly, separate parts of 
the MLN were removed and enzymatically digested. Cells were stained with 
antibodies for flow cytometry and analysed. The gating strategy was consistent 
throughout the experiment. First large cells were gated, and live and B220- cells 
were selected. Single, F4/80- cells were further selected and MHCIIhiCD11c+ 
migratory DCs were gated (Figure 3.2 A). Previous reports have suggested that 
migratory DCs fall into the MHCIIhiCD11c+ group, while blood-derived DCs are 
MHCII+CD11chi (Lambrecht et al., 1998). The expression of kaede-red+ on DCs was 
then observed (Figure 3.2 B) and compared to non-photoconverted MLNs (Figure 
3.2 C). 24 hours after exposure of the SI to UV light, significantly more 
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photoconverted kaede-red+ DCs were present in the siMLN than in the coMLN 
after 24 hours (Figure 3.2 D and E). There were also significantly more kaede-
red+ DCs in the siMLN compared to the coMLN after 48 hours (Figure 3.2 D) The 
percentage, but not number, of migratory DCs in the siMLN was decreased after 
48 hours (Figure 3.2 D and E).   
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Figure 3-2 DCs Originating in the Small Intestine Drain to Specific Parts of the MLN. 
The SI of photoconvertable kaede mice were exposed to UV light for 2-3 minutes, avoiding PP, 
and animals allowed to recover. The siMLN and coMLN were removed digested separately and 
stained for flow cytometry 24 hours and 48 hours later. Migratory DCs were gated as large, live, 
B220-, single, F4/80-, CD11c+MHCIIhi cells (A) and the number of photoconverted migratory DCs 
was observed (B). Gates for photoconverted cells were drawn based upon a non-converted 
control (C). Number and percentage of photoconverted DCs was compared between the siMLN 
and coMLN (D and E respectively). Results are representative of two separate experiments with 
similar results. A Two-Way ANOVA was performed and a Bonferroni posttest applied showing a 
significant difference between the siMLN and coMLN. Data are means and S.E.M, n=4, not 
significant (n.s), *p<0.05, ** p<0.01. 
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These data show that DCs from the SI preferentially drain to the siMLN. Next, 
DCs migrating from the colon were investigated. In this experiment, the colon 
was exposed to UV light for 2-3 minutes and the MLN and entire SI were 
protected from light. As before, the siMLN and coMLN were removed and 
digested 24 and 48 hours after exposure of the colon to UV light. The gating 
strategy was as follows; large, live, B220-, single, F4/80- cells were selected and 
migratory DCs were gated (MHCIIhiCD11c+) (Figure 3.3 A). The expression of 
kaede-red+ in the migratory DCs was then investigated (Figure 3.3 B) and 
compared to the non-converted MLN (Figure 3.3 C). 
 
24 hours after the exposure of the colon to UV light, significantly more kaede-
red+ cells were found in the coMLNs than in the siMLN. This result was mirrored 
after 48 hours, with there being significantly more kaede-red+ cells present in 
the coMLNs than in the siMLNs (Figure 3.3 D and E). Therefore, as indicated by 
the data from the Evans blue experiments, DCs that originate in the SI drain to 
the centremost MLNs, while DCs that originate in the colon drain the specific 
MLN we describe here as coMLN.  
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Figure 3-3 Dendritic Cells Originating in the Colon Drain to Specific Nodes of the MLN.    
The colon of photoconvertable kaede mice was exposed to UV light for 2-3 minutes and animals 
allowed to recover. The siMLN and coMLN were removed digested separately and stained for flow 
cytometry 24 hours and 48 hours later. Migratory DCs were gated as large, live, B220-, single, 
F4/80-, CD11c+MHCIIhi cells (A) and the number of photoconverted migratory DCs was observed 
(B). Gates for photoconverted cells were drawn based upon a non-converted control (C). Number 
and percentage of photoconverted DCs was compared between the siMLN and coMLN (D and E 
respectively). Results are representative of two separate experiments with similar results. A 
Two-Way ANOVA was performed and a Bonferroni posttest applied showing a significant 
difference between the siMLN and coMLN. Data are means and S.E.M, n=4, not significant (n.s), 
*p<0.05, ** p<0.01. 
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3.1.2  Evaluation of Transgenic Kaede Mice to Monitor Dendritic 
Cell Migration 
Previous reports using kaede mice suggest there are no effect of 
photoconversion upon the activation status of T cells and B cells (Tomura et al., 
2008). However, previous work has concentrated upon lymphocytes and the 
effect of photoconversion upon these cells rather than DCs. Furthermore, the 
source of low power UV light differs between our experiments and others 
(Schmidt et al., 2013; Tomura et al., 2008). Therefore it was important to assess 
the level of activation induced by photoconversion of kaede DCs in our hands. 
The level of activation of DCs can be assessed by investigating the levels of 
expression of the co-stimulatory molecules CD80 and CD86 on DCs, which act to 
provide the necessary accessory signals for T cell activation. In order to perform 
this experiment, BMDCs were generated by the isolation of BM from the tibias 
and femurs of kaede mice. BM was cultured for seven days at 37°C with 
humanised Flt3L, to generate BMDCs (Naik et al., 2005). After seven days, BMDCs 
were harvested and either untreated, photoconverted, or stimulated with 
1µg/ml or 10µg/ml of LPS.  DCs were harvested 24 hours later and analysed by 
flow cytometry. Large live cells were gated and pDCs were removed by gating 
out B220+ cells. Single cDCs were selected by gating MHCII+CD11c+ cells (Figure 
3.4 A). The presence of kaede red was then analysed upon BMDCs (Figure 3.4 B), 
and the levels of the costimulatory molecules CD80 and CD86 were investigated 
on each group (Figures 3.4 C and D respectively). The percentage of CD80+ and 
CD86+ DCs were compared between DCs from animals that did not undergo 
photoconversion kaede-green+ DCs, or animals that did undergo photoconversion 
kaede-red- DCs and kaede-red+ DC fractions, and cells stimulated with LPS 
(Figures 3.4 E and F respectively). This showed that there was a significant 
increase in the expression of both CD80 and CD86 on DCs that were stimulated 
with LPS compared with unstimulated cells. DCs that were exposed to UV light 
did not upregulate the expression of CD80 or CD86. Furthermore, the 
photoconversion of kaede in kaede-red+ DCs did not change the expression of 
CD80 or CD86. Therefore, the photoconversion of cells in kaede mice does not 
activate DCs.  
 
 93 
 
Figure 3-4 Photoconversion of kaede bone marrow derived DCs does not upregulate the 
expression of CD80 or CD86. 
BM was isolated from tibias and femurs of kaede mice, and cultured with Flt3L for 7 days 37. 
BMDCs were harvested, not converted (NC) photoconverted (PC) or stimulated with 1 µg/ml or 10 
µg/ml LPS. Photoconversion was performed on harvested cells in culture media for 2 minutes. All 
groups were returned to cell culture at 37°C and 24 hours later cells were analysed by flow 
cytometry. Selecting large, live, B220- single cells that were also MHCII+ CD11c+ gated DCs (A). 
The expression of kaede-red was compared on groups (B) and the levels of CD80 (C and E) and 
CD86 (D and F) were compared for each group. A One-Way ANOVA was performed with a 
Bonferroni post test, data are means and S.E.M, n=3, *p<0.05 and **p<0.01. 
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3.1.3  Comparison of Levels of MHCII Expression Upon Migratory 
and Resident Dendritic Cell Subsets in the Mesenteric Lymph 
Nodes 
These results indicate that the low power UV light we used to switch the kaede 
cells is unlikely to affect DC activation. The kaede mice therefore appear to be a 
useful tool to monitor the constitutive DC migration from the intestine. In our 
previous gating strategy in the MLN we selected MHCIIhiCD11c+ DCs as migratory 
DCs. Previous work with lung and dermal DCs has suggested that the 
MHCIIhiCD11c+ DCs present in lymph nodes represent a migratory subset of DCs 
(Kamath et al., 2002). This gating strategy has also been used in the MLN to 
identify migratory DCs (Persson et al., 2013). However there is no direct 
evidence that the MHCIIhiCD11c+ DCs in the MLN have actually migrated from the 
intestine. Therefore, to confirm the phenotype of the migratory DCs in the MLN, 
the presence of kaede-red+ DCs within the phenotype of the “migratory” 
MHCIIhiCD11c+ DC gate was compared with the presence of kaede-red+ DCs within 
the “resident” MHCII+CD11chi gate. Photoconversion was performed on either the 
SI or colon. 24 or 48 hours later the siMLN and coMLN were removed, digested, 
and analysed by flow cytometry. Cells were gated as before, with large, live, 
B220-, single F4/80- cells were defined as DCs. Migratory MHCIIhiCD11c+ DCs and 
resident, blood derived, DCs MHCII+CD11chi were gated separately (Figure 3.5 A). 
The presence of kaede-red+ DCs amongst migratory and blood derived DCs after 
SI or colonic photoconversion was observed (Figure 3.5 B) and compared 
between groups (Figure 3.5 C). In the siMLN there were significantly more 
kaede-red+ DCs in the migratory gate compared to the resident gate 24 and 48 
hours after photoconversion of the SI. This was mirrored in the coMLN where 
significantly more kaede-red+ DCs were found in the migratory DC gate 
compared to the resident DC group after 24 and 48 hours. Therefore, migratory 
DCs do express MHCII at higher levels than resident DCs, thus supporting the 
enrichment of migratory DCs based upon their expression of high levels of MHCII. 
In these experiments, there are no kaede-red+ DCs among the resident DCs in 
the MLN. Thus, all kaede-red+ DCs are derived from the intestinal tissue itself; 
photoconversion of DC precursors in blood vessels overlying intestinal tissue and 
subsequent migration to the MLN does not contribute the numbers of kaede-red+ 
cells in the MLN. 
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Figure 3-5 Migratory Photoconverted kaede-Red+ DCs in the Small intestine and Colon 
Express Higher Levels of MHCII in the MLN. 
The SI and colon of photoconvertable kaede mice were exposed to UV light for 2-3 minutes and 
animals allowed to recover. The siMLN and coMLN were isolated, digested separately, stained 
and analysed by flow cytometry 24 and 48 hours after photoconversion. DCs were gated as large, 
live, B220-, single, F4/80- cells and migratory (Mig) DCs were CD11c+MHCIIhi and resident (Res) 
DCs were gated as CD11c+MHCII+ (A). The presence of kaede-red+ DCs in photoconverted animals 
was compared between Mig and Res DCs based and gates were drawn based upon a non-
converted control (NC) (B). Total numbers of kaede-red+ DCs were compared between Mig and 
Res DC populations in the SiMLN and CoMLN (C). A Two-Way ANOVA was performed and a 
Bonferroni posttest applied. Data are means and S.E.M, n=4, not significant (n.s), *p<0.05, *** 
p<0.001. 
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3.1.4  Comparison of Dendritic Cell Subsets in the Small 
Intestine, Colon, Small Intestinal and Colonic Draining Mesenteric 
Lymph Nodes  
As our previous work indicated that there was anatomical segregation between 
the SI and colonic draining lymph nodes, we sought to determine if there were 
differences between the DC populations within these lymph nodes. To provide 
necessary background information, we first examined the DC subsets in the SI 
and colon, from which the MLN DCs migrate. To examine the SI DCs, the SI was 
isolated, PPs were removed, the SI was digested and a single cell suspension 
generated. This was labelled for flow cytometry; large cells were gated, then 
CD45+ live cells were selected, F4/80+ macrophages were excluded and MHCII+ 
and CD11c+ single cells were selected (Figure 3.6 A). Four distinct DC subsets 
were then identified, based upon their expression of CD11b and CD103 (Figure 
3.6 B). Our previous work identified four functionally distinct subsets of DCs 
migrating in pseudo-afferent lymph (Cerovic et al., 2012). Four phenotypically 
similar subsets were also identified in the small intestinal lamina propria (siLP). 
The most numerous siLP DC population was the CD103+CD11b+ subset. The 
second largest population was the CD103+CD11b- that also expressed CD8α+. 
These two populations have previously been described in the siLP (Fujimoto et 
al., 2011). There were also two distinct populations of CD103- DCs in the siLP, 
the CD103-CD11b+ and the CD103-CD11b- DCs. We showed these populations were 
genuine migratory DCs, present in pseudo-afferent lymph (Cerovic et al., 2012). 
There remains significant confusion regarding the precise identification of bona 
fide CD103- DC populations in the siLP. However using a macrophage specific 
markers such as F4/80, combined with data from TDC we are able to definitively 
identify four distinct DC subsets present in the siLP. 
 
Next, DC populations in the colon were investigated. The colon was removed and 
a single cell suspension was generated by enzymatic digestion. A similar gating 
strategy to the SI was performed in order to identify DCs (Figure 3.7 A). This 
revealed three distinct subsets of DCs based upon the expression of CD103 and 
CD11b (Figure 3.7 B); these subsets have previously been described in the 
colonic lamina propria (cLP) and were similar to subsets in the siLP (Rivollier et 
al., 2012). However, there were some key differences between DC populations 
in the SI and colon. Firstly, the CD103-CD11b- population was reduced in the 
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colon. This suggests that migratory DCs in the MLN with the CD103-CD11b- 
phenotype are likely to have originated in the siLP. There are also differences 
between the SI and colon in the proportions of each subset. In the siLP the 
CD103+CD11b+ DCs were the most numerous, while in the cLP the CD103+CD11b- 
is the largest population.   
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Figure 3-6 Four Distinct Subsets of DCs are Present in the Small Intestinal Lamina Propria. 
Single cell suspension of SI lamina propria (siLP) cells were generated by the digestion of the SI 
without PPs and cells were analysed by flow cytometry. Large cells were gated and live 
leukocytes (7AAD-CD45+) were identified, F4/80+ cells were excluded and MHCII+ were gated. 
Doublets were excluded and CD11c+ cells were gated and F4/80+ DCs were excluded again (A). 
The resulting DCs were then further split into 4 populations based upon the expression of CD103 
and CD11b (B). The percentage of each DC subset was compared. Data are means and S.E.M. 
n=6. 
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Figure 3-7 Three Distinct Subsets of DCs are Present in the Colonic Lamina Propria. 
Single cell suspension of colonic lamina propria (cLP) cells were generated by the digestion of 
the colon and cells were analysed by flow cytometry. Large cells were gated and live leukocytes 
(7AAD-CD45+) were identified, and MHCII+ were gated. Doublets were excluded and CD11c+ cells 
were gated and F4/80+ DCs were excluded (A). The resulting DCs were then further split into 4 
populations based upon the expression of CD103 and CD11b (B). The percentage of each DC 
subset was compared. Data are means and S.E.M. n=6. 
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Having now defined the DC populations in the SI and colon, the DCs in the siMLN 
and coMLN were compared. The siMLN and coMLN were removed separately and 
digested. Using flow cytometry DC subsets were identified as follows; large, 
7AAD-, CD3-, CD19-, single cells (Figure 3.8 A). MHCIIhiCD11c+ cells were defined 
as migratory DCs (Figure 3.8 B) and MHCII+CD11chi cells were defined as resident 
DCs (Figure 3.8 C). Migratory and resident DCs were further separated into 
subsets based upon their CD103 and CD11b expression and compared with the 
siLP and the cLP DCs (Figure 3.8 D and 3.8 E, migratory and resident DCs 
respectively). The percentage of DCs in each subset, as a proportion of total 
cells, was compared between the siMLN and coMLN, for both migratory DC and 
resident DC (Figure 3.8 E and 3.8 F, migratory and resident DCs respectively). 
There was a significantly higher percentage of CD103-CD11b+ and CD103-CD11b- 
among the migratory DCs in the siMLN compared to the coMLN. The reduction in 
CD103-CD11b- DCs in the coMLN was unsurprising, as this subset of DCs was also 
missing from the cLP. Furthermore, there was a significantly higher percentage 
of CD103-CD11b- DCs in the resident DC compartment of the coMLN compared to 
the siMLN. Again this was foreseeable finding; as this population of DCs was not 
migrating from the colon any CD103-CD11b- DCs present in the coMLN had to be 
resident DCs from blood-derived precursors.  
 
Our previous work showed that the CD103-CD11b+ subset of DCs migrating in 
lymph expressed intermediate levels of CX3CR1. As previously described, not all 
the investigators agree that intestinal DCs express CX3CR1 (Bain et al., 2013; 
Diehl et al., 2013; Rivollier et al., 2012; Schulz et al., 2009). However, as our 
TDC experiments data identify bona-fide migratory DCs, we can be confident in 
our observation that some DC subsets indeed express CX3CR1 (Cerovic et al., 
2012). Using CX3CR1+/GFP mice, in which one of the genes encoding CX3CR1 has 
been replaced with GPF, the level of CX3CR1 expression on DC subsets in the 
siMLN and coMLN can be compared. siMLN and coMLNs were removed, digested 
and stained for flow cytometry. Migratory and resident DCs were gated as large, 
live, B220-, CD64-, MHCIIhiCD11c+ or MHCII+CD11chi single cells. Four distinct 
subsets of DCs were identified and the levels of CX3CR1 were compared between 
DC subsets in the siMLN and coMLN on migratory (Figure 3.9 A) or resident DCs 
(Figure 3.9 B). In both the migratory and resident DC subsets there was no 
significant difference between the expression of CX3CR1 in CD103+CD11b- DCs or 
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in CD103-CD11b- DCs in the siMLN or coMLN. Previously, we identified the CD103-
CD11b+ DCs as expressing intermediate levels of CX3CR1. Consistent with this 
result, we found CD103-CD11b+ DCs to be expressing intermediate levels of 
CX3CR1 in the siMLN, the percentage of CD103-CD11b+ DCs expressing CX3CR1 
significantly increased in the coMLN in both migratory and resident DCs. 
Although there was a significant increase in CX3CR1 expression in the coMLN, the 
levels of expression were at least one log lower than CX3CR1 expression on 
macrophages that can be described as CX3CR1hi. Additionally, a significantly 
higher percentage of CD103+CD11b+ DCs in the coMLN expressed of CX3CR1 
compared to the siMLN in both migratory, and to some extent the resident DC 
subsets. This was a surprising finding as our previous work had described 
CD103+CD11b+ DCs as CX3CR1 negative. This observation, however, was made 
using pseudo-afferent lymph from animals that retained some coMLN. Therefore, 
it is possible this phenotypic difference was not observed using our previous 
methods. An increase in the percentage of cells expressing CX3CR1 could 
represent an important difference in DCs from the SI and colon. Although the 
exact role of CX3CR1 remains to be established there is some evidence 
suggesting it is involved in cell survival (Landsman et al., 2009), therefore DCs 
from the colon may reflect environmental differences during the development of 
DCs from siMLN DCs via the expression of CX3CR1. 
 
In order to confirm that there were differences in the migrating subsets of DCs 
from the siMLN and coMLN, partial MLNx was performed, followed by TDC. 
Partial MLNx involved the removal of only specific parts of the MLN. Although 
gating CD11c+MHCIIhi cells in the MLN allows us to identify DCs that are likely to 
be migratory, this is not definitive. For example, under conditions of 
inflammation all DCs in the MLN upregulate MHCII expression so that resident 
and migratory subsets can no longer be distinguished (Persson et al., 2013). 
MLNx followed by TDC is routinely performed our laboratory in order to isolate 
all migratory DCs from the intestine. Previously, during MLNx we removed all 
MLNs found adjacent to the proximal colon (Figure 3.10, lymph nodes routinely 
removed during MLNx marked in purple). Work described here, however, 
suggests these MLN are likely to drain both the SI and the proximal colon. 
Therefore, partial MLNx procedures were developed in order to allow the 
isolation of DCs from only the SI or colon by TDC. Briefly, siMLNx is the removal 
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of MLNs that drain the SI while the remaining coMLN are left intact. In contrast, 
coMLNx involves the removal of the MLNs that drain the colon, while the siMLN 
remain undamaged. Five to six weeks following partial MLNx TDC was performed 
as described and pseudo-afferent lymph was collected on ice overnight (Cerovic 
et al., 2012). Lymph cells were processed and analysed by flow cytometry, for 
the presence of DCs. DCs were observed by selecting large, live CD19-, 
MHCII+CD11c+ cells (Figure 3.11 A), and the composition of DC subsets was 
compared between siMLNx and coMLNx animals (Figure 3.11 B and C). First the 
presence of DCs confirmed that the partial MLNx technique was effective. The 
MLNx procedure relies upon the reanastamosis of the afferent lymphatics from 
the intestine to the efferent lymphatics, this allows the flow of cells into the 
thoracic duct. As DCs are present following siMLNx and coMLNx this suggests that 
reanastamosis enables afferent lymphatics to drain to thoracic duct, allowing 
the isolation of migratory DCs even after removal of only a portion of the MLNs. 
Therefore, MLNs are connected to the lymph supply in parallel, not serially. 
There were significant differences between DC subsets from the siMLNx and 
coMLNx. First, there were significantly fewer CD103+CD11b-CD8α+ in the siMLNx 
lymph compared with coMLNx. This is a reflection of the composition of DC 
subsets in the SI and colon, where the numbers of CD103+CD11b-CD8α+ is far 
higher in the cLP compared to the siLP. Although there was not a significant 
difference in the MLN, there were fewer CD103+CD11b- DCs in the siMLN 
compared to the coMLN. Additionally, there were more CD103+CD11b+ DCs in the 
siMLNx lymph compared to the coMLNx lymph. Although there were no 
significant differences between the numbers or percentages of either of the 
CD103- subsets, examination of DC subsets in the coMLNx lymph indicates that 
the CD103-CD11b- subset is missing. This is the smallest subset and a bigger 
sample size may demonstrate that this loss is statistically significant. This may 
be expected because few CD103-CD11b- DCs are found in the colon and coMLN. 
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Figure 3-8 Dendritic Cell Subsets in Small Intestinal Draining MLN and Colonic Draining MLN. 
Cells from the siMLN and coMLN were isolated and analysed by flow cytometry. Large, live cells 
were gated, CD3+ CD19+ cells and doublets were excluded (A). Migratory DCs (MHCIIhiCD11c+, B) 
or resident DCs (MHC+CD11chi, C) were selected and DC subsets, identified by their the 
expression of CD103 and CD11b, were compared between siMLN and coMLN migratory DCs (D) or 
resident DCs (E). The percentage of each DC subset of total cells was compared between DC 
subsets from the siMLN and coMLN in the migratory and resident DC compartments (F and G 
respectively). Data are means and S.E.M. The proportions of these populations were compared 
and results were analysed by Students t test, asterisks demote statistical significance, *p<0.05, 
**p<0.01, ***p<0.001, n=5.  
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Figure 3-9 Expression of CX3CR1 on Migratory and Resident Dendritic Cell Subsets in siMLN 
and coMLN. 
Cells from the siMLN and coMLN were isolated from CX3CR1GFP/+ mice, digested and analysed by 
flow cytometry. Migratory and resident DCs were gated as B220-, CD64-, MHCIIhiCD11c+ or 
MHCII+CD11chi single cells respectively. Four distinct DC subsets were identified by their 
expression of CD103 and CD11b. The expression of CX3CR1 was compared between migratory DC 
subsets (MHCIIhiCD11c+, A and C) or resident DC subsets (MHC+CD11chi, B and D). The percentage 
of CX3CR1+ cells were compared and results were analysed by Students t test, asterisks denote 
statistical significance each point represents an individual animal, *p<0.05, **p<0.01. Histograms 
are representative of 4 biological replicates.  
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Figure 3-10 Small Intestine and Colon with Draining Mesenteric Lymph Nodes Normally 
Removed Following Mesenteric Lymphadenectomy. 
The SI and colon drain to distinct parts of the MLN. Afferent lymphatics are depicted in blue. 
MLN normally removed during MLNx depicted in purple. 
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Figure 3-11 Dendritic Cell Subsets in the Lymph of siMLNx and coMLNx Mice. 
Pseudo-afferent lymph was collected from mice that had undergone siMLN lymphadenectomy 
(siMLNx) or coMLN lymphadenectomy (coMLNx). Cells were analysed by flow cytometry; CD19-, 
CD11c+MHCII+ single cells were selected (A) and DC subsets based upon the expression of CD103 
and CD11b were compared (B). The percentage of the four distinct subsets was compared 
between siMLNx and coMLNx animals (C). Results were analysed by Students t test, asterisks 
denote statistical significance (p*<0.05, n=5). Data are means and S.E.M. FACS plots 
representative of 5 independent biological replicates. 
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3.1.5  Comparison of Antigen Presentation by Small Intestinal 
and Colonic Draining Mesenteric Lymph Node Dendritic Cells in 
Vitro 
To examine whether the siMLN and coMLN DCs have different functions, the 
ability of DCs from either the siMLN or coMLN were assessed for their ability to 
present antigen to naïve T cells. The ability to present antigen to naïve T cells is 
a defining property of DCs. Therefore, we chose to investigate if this property 
was dependent upon the anatomical origins of the DCs. Due to small numbers of 
DCs isolated following partial MLNx procedures, particularly coMLNx, total DCs 
from siMLNx’d or coMLNx’d animals were investigated rather than sorting each 
specific subset. Although specific DC subsets from the siMLN and coMLN are 
likely to be phenotypically and functionally different, functional differences 
arising due to differential subset composition in DCs from the siMLN or coMLN 
should be apparent as we are using DC subsets at ratios that are migrating to the 
lymph node. DCs isolated from following TDC of siMLNx and coMLNx animals 
were FACS purified, pulsed with OVA, washed and co-cultured with CFSE labelled 
FACS sorted naïve (CD62L+) CFSE labelled OVA specific CD8α+ OT-I T cells. 
Proliferation was assessed three days later by measuring CFSE dilution (Figure 
3.12 A). DCs from the siMLNx and coMLNx lymph were able to present antigen 
equally well to CD8+ naïve T cells (Figure 3.12 B). Additionally, DCs from the 
siMLN and coMLN were able to drive the same percentage of cells to undergo at 
least three divisions (Figure 3.12 C). 
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Figure 3-12 Migratory Dendritic Cells From the Small Intestine and Colon are Able to Present 
Antigen to Naïve T Cells. 
MHCII+CD11c+ DCs from mice that had undergone siMLNx or coMLNx were FACS sorted and 
incubated for 2 hours with 2mg/ml ovalbumin protein at 37°C. DCs were then washed extensively 
and co-cultured with CFSE labelled FACS sorted CD8+CD62L+ OT-I cells for 3 days. Proliferation 
was assessed by CFSE dilution (A). The percentage of proliferating T cells was compared between 
migrating DCs from the SI and colon (B). The percentage of T cells that had undergone 3 or more 
divisions was also compared between siMLNx and coMLNx animals (C). Data are means and S.E.M. 
Results were analysed by Student’s t test. FACS plots representative of at least 3 independent 
biological replicates. 
.  
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T cell activation by DCs not only causes the proliferation of naïve T cells, but it 
also leads to the upregulation or retention of homing molecules, allowing T cells 
to traffic to peripheral non-lymphoid tissues. DCs from the SI and MLN cause the 
retention of CCR9 on T cells, resulting in these T cells having the capacity to 
home to the SI. CD103+ DCs from the colon have been shown to be unable to 
cause the retention of CCR9+ gut tropic T cells, making the ability to generate 
CCR9+ T cells being described as SI specific feature (del Rio et al., 2010) 
(Jaensson et al., 2008). Therefore, we sought to determine if the ability to 
cause the retention of CCR9 expression in responding T cells was different 
between DCs from the siMLN and coMLN lymph. DCs were isolated by TDC 
performed in siMLNx and coMLNx animals as previously described. These DCs 
were co-cultured at varying numbers with OT-I T cells, as before, and CFSE 
dilution (Figure 3.13 A) and CCR9 expression was determined after three days 
(Figure 3.13 B and C). DCs from the siMLN and coMLN lymph were able to cause 
proliferation of naïve T cells; interestingly they were also both able to cause the 
retention of CCR9 on responding T cells equally well. Therefore, DCs from the 
siMLN and coMLN lymph can generate gut homing T cells. 
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Figure 3-13 Migratory Dendritic Cells From the Small Intestine and Colon are Able to Induce 
CCR9 Expression in Responding T Cells. 
MHCII+CD11c+ LDCs from mice that had undergone siMLNx or coMLNx were collected by thoracic 
duct cannulation FACS sorted and incubated for 2 hours with 2mg/ml ovalbumin protein. DCs 
were then washed extensively and co-cultured with CFSE labelled FACS sorted CD8+CD62L+ OT-I 
cells for 3 days. Single T cells were gated (A) and CCR9 expression on proliferating T cells was 
compared between migrating DCs from the SI and colon (B). The percentage of T cells that 
expressed CCR9 was compared between siMLNx and coMLNx animals at a range of DC:T cell 
ratios (C). 
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3.1.6  Dendritic Cell Subsets in the Small Intestinal and Colonic 
Draining Mesenteric Lymph Nodes Following Experimental Colitis 
In order to investigate DC populations in the siMLN and coMLN under conditions 
of inflammation, a model of experimental colitis was used. In this model, colitis 
was induced by the addition of DSS to drinking water. This specifically induces 
colonic inflammation, while having little effect on the SI (Geier et al., 2009). 
The initiation and propagation of the inflammation induced by DSS colitis has 
been widely attributed to macrophages in the colon (Bain et al., 2013) 
(Tamoutounour et al., 2012). As there is anatomical segregation of lymphatic 
drainage to the MLN, any changes in DC populations in this model may have been 
overlooked. Therefore, DC populations were assessed using a recovery model of 
experimental colitis in the siMLN and coMLN. 2% DSS was added to drinking 
water at day -3, at day 0 animals were culled or allowed to recover for 3 or 10 
days before siMLNs and coMLNs were isolated (Figure 3.14 A). Samples taken at 
day 0, referred to as DSS, had not yet begun to show weight loss normally 
associated with experimental colitis. However, there was evidence of 
inflammation upon examination of the colon (C.Bain, personal communication). 
The siMLN and coMLN were removed from animals at each time point, digested 
and analysed by flow cytometry. Migratory and resident DCs were gated as 
following; large, B220-, 7AAD-, single, CD64- cells. Migratory DCs were 
MHCIIhiCD11c+ while resident DCs were defined as MHCII+CD11chi (Figure 3.14 B). 
The total numbers of migratory (Figure 3.14 C) or resident DCs (Figure 3.14 D) in 
the siMLN or coMLN were compared between steady-state (SS), DSS, and day 3 
recovery DSS (R3DSS) and day 10 recovery DSS (R10DSS). There was no significant 
difference in the number or percentage of DCs at any time in either the siMLN or 
coMLN. This was somewhat surprising, as there was significant inflammatory 
infiltrate in the colon caused by the break down of the epithelial barrier. 
Although DCs are not thought to mediate the disease, the inflammatory 
conditions of the colonic environment were predicted to lead to an increase in 
DC migration to the MLN. 
 
Although there were no changes to overall DC numbers in the siMLN or coMLN we 
decided to investigate if there were changes in DC subsets that migrate to the 
siMLN or coMLN. As DC subsets are functionally distinct, we hypothesised that 
there may be an increase in the CD103-CD11b+ DC subset, as this has been shown 
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to be an inflammatory subset (Cerovic et al., 2012). Furthermore, cells of a 
similar phenotype were reported to be increased in intestinal lymph during DSS 
colitis (Zigmond et al., 2012). Migratory (Figure 3.15) or resident DCs (Figure 
3.16) from each time point were split into four subsets based upon their 
expression of CD103 and CD11b. The total number of cells in each DC subset was 
compared between SS, DSS, R3DSS and R10DSS from the siMLN and coMLN. There 
were no significant differences in the number or percentage of any DC subset 
examined.  
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Figure 3-14 Dendritic Cell Populations are Comparable in Small Intestinal and Colonic 
Draining MLN During and After Experimental Colitis. 
Mice received 2% DSS-supplemented drinking water at day -3, at day 0 animals with acute colitis 
were assessed (DSS) or drinking water was returned to normal. Animals were allowed to recover 
for 3 (R3 DSS) or 10 days (R10 DSS). siMLN or coMLNs were isolated, digested and analysed by 
flow cytometry. Migratory or blood derived DCs were gated as follows: large, B220- live, single 
cells were selected. CD64+CD11b+ cells were excluded and migratory DCs (MHCIIhiCD11c+) and 
blood derived DCs (MHCII+CD11c+) (A). Total numbers of migratory DCs were compared between 
steady state (SS), DSS, R3 DSS and R10 RSS in the siMLN (C left panel) and coMLN (C right panel). 
Resident DCs were also compared in the siMLN (D left panel) and coMLN (D right panel). Each 
point represents an individual animal. Results were analysed by a two way ANOVA.  
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Figure 3-15 Migratory Dendritic Cell Subsets are Comparable in Small Intestinal and Colonic 
Draining MLN During and After Experimental Colitis 
siMLN or coMLNs were isolated, digested and analysed by flow cytometer from SS, DSS, R3DSS 
and R10DSS animals. DC subsets from migratory DCs (MHCIIhiCD11c+) were analysed based upon 
their expression of CD103 and CD11b. Total numbers of DC subsets from migratory DCs were 
compared between steady state (SS), DSS, R3 DSS and R10 RSS in the siMLN (A) and coMLN (C). 
Total numbers of each subset were compared between SS, DSS, R3 DSS and R10 DSS in migratory 
siMLN DCs (B) and in migratory coMLN DCs (D). Results were analysed by a One-Way ANOVA, with 
a Bonferroni post-test. Data are means and S.E.M. FACS plots representative of 4 independent 
biological replicates, n=4. 
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 Figure 3-16 Resident Dendritic Cell Subsets are Comparable in Small Intestinal and Colonic 
Draining MLN During and After Experimental Colitis 
siMLN or coMLNs were isolated, digested and analysed by flow cytometer from SS, DSS, R3DSS 
and R10DSS animals. DC subsets from resident DCs (MHCII+CD11chi) were analysed based upon 
their expression of CD103 and CD11b. Total numbers of DC subsets from resident DCs were 
compared between steady state (SS), DSS, R3 DSS and R10 RSS in the siMLN (A) and coMLN (C). 
Total numbers of each subset were compared between SS, DSS, R3 DSS and R10 DSS in migratory 
siMLN DCs (B) and in migratory coMLN DCs (D). Results were analysed by a One-Way ANOVA, with 
a Bonferroni post-test. Data are means and S.E.M. FACS plots representative of 4 independent 
biological replicates, n=4. 
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Recent work in the Jung laboratory identified a population of CX3CR1int 
population of inflammatory monocytes that expand in the colon of mice with 
experimental colitis. They report that the Ly6Clo subset of these CX3CR1+ 
monocytes are able to migrate in the afferent lymphatics and are then able to 
present antigen to naïve T cells in the MLN (Zigmond et al., 2012). The Powrie 
laboratory also reported a similar population of E-Cadherin+ cells, although their 
analysis showed this population to be blood derived (Siddiqui et al., 2010). As 
experimental colitis only affects the colon, we postulated that this population of 
inflammatory monocytes would specifically migrate to and expand in the coMLN. 
Therefore, we identified a population of CD64+CD11b+CX3CR1int cells in the siMLN 
and coMLN of SS, DSS, R3DSS and R10DSS (gating as in Figure 3.14 B, CX3CR1 
expression 3.17 A). The number of total CD64+CD11b+CX3CR1+ monocytes was 
compared between SS, DSS, R3DSS and R10DSS groups in the siMLN and coMLN. 
There was no change in the number of these CD64+CD11b+CX3CR1+ monocytes in 
the siMLN (Figure 3.17 B) or coMLN (Figure 3.17 C) at any time during our 
recovery model of DSS colitis. 
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Figure 3-17 CD64+CD11b+CX3CR1+ Cells are Unchanged in Small Intestinal and Colonic 
Draining MLN During and After Experimental Colitis. 
siMLN or coMLNs were isolated, digested and analysed by flow cytometry from SS, DSS, R3DSS 
and R10DSS animals. CD64+CD11b+ cells were identified and expression of CX3CR1 was 
investigated (A). Total numbers of CD64+CD11b+ cells from the siMLN (B) and coMLN (C) were 
compared between steady state (SS), DSS, R3 DSS and R10 RSS. Each point represents an 
individual animal. Results were analysed by a two way ANOVA. 
 118 
3.1.7  Antigen Presentation by Small Intestinal and Colonic 
Draining Mesenteric Lymph Node Dendritic Cells in Vivo 
Although there were no differences in DC migration to the siMLN or coMLN 
following a model of experimental colitis, I wanted to further investigate the 
functional significance of anatomical segregation of lymphatic drainage and DC 
migration. Rather than concentrating upon the consequences of an inflammatory 
situation, antigen presentation in the steady-state was investigated. The SI is 
specialised for the uptake of protein, and DC are essential in the transport of 
antigen to the MLN where they present this to naïve T cells. Therefore, we 
sought to design an experiment to determine in which parts of the MLN antigen 
from the SI are presented to T cells. To this end, CD45.1 OT-II cells were CFSE 
labelled and adoptively transferred into a CD45.2 host. 24 hours later the CD45.2 
animal was fed with 10mg of OVA. Three days later the siMLN, coMLN and ILNs 
were removed (Figure 3.18 A) and CD45.1+CD4+ T cells were identified in the 
lymph nodes (Figure 3.18 B). Levels of CFSE dilution were investigated as a 
measure of T cell proliferation. Proliferating T cells were only present in the 
siMLN (Figure 3.18 C), suggesting that ovalbumin which would have been taken 
up in the SI is only being presented to T cells in the siMLN. This is the first direct 
evidence that the siMLN and coMLN have specific and distinct functions.  
 
In order to gain further insight into the preferential presentation of SI derived 
antigen to T cells in the siMLN we modified the previous experiment. CD45.12 
OT-I T cells were CFSE labelled and adoptively transferred into a CD45.2 host. 
24, 48 or 72 hours later the siMLN, coMLN and ILNs were removed (Figure 3.19 
A). CD8α+TCRvα2+, CD45.1+CD45.2+ single cells were selected (Figure 3.19 B) and 
levels of proliferation were assessed by CFSE dilution in the siMLN, coMLN and 
ILNs were assessed after 24, 48 and 72 hours after the host was fed ovalbumin 
(Figure 3.19 C). After 24 hours there was no proliferation of transferred T cells, 
presumably as there was not enough time for the antigen to have been taken up 
by the DC, travel to the MLN and be presented to an OT-I T cell causing its 
proliferation. After 48 hours CFSE dilution was observed in the siMLN, and to 
some extent in the coMLN. However, levels of proliferation in the coMLN were 
significantly lower than in the siMLN. The small amount of proliferation of OT-I T 
cells in the colon may have been observed for a number of reasons. Firstly, OVA 
may have been taken up into the colon. This could have possible as it is water-
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soluble and OVA which was not fully adsorbed in the SI could have travelled to 
the colon. This, combined with the extreme in sensitivity of the OT-I system may 
have lead us to see some proliferation of T cells in the coMLN, although to a 
lower extent than was observed in the siMLN. Alternatively, the lymphatics may 
not exclusively drain the nodes, and some siMLN afferent lymphatics may drain 
to the coMLN.  After 72 hours CFSE was completely diluted in the siMLN, coMLN 
and ILN. At this this point, the antigen and T cells are likely to have been 
transferred into the systemic circulation. Taken together, although these data 
are not definitive, as the previous experiment was, support the idea that the 
siMLN and coMLN are functionally, as well as anatomically, separate. 
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Figure 3-18 Orally Administered Antigen Preferentially Causes Proliferation of CD4+ T Cells in 
Small Intestinal Draining Lymph Nodes. 
Cells from the MLN and spleen of an OT-II CD45.1 donor were CFSE labelled and transferred to a 
WT CD45.2 host. 24 hours later 10 mg ovalbumin was administered orally to hosts. Three days 
later siMLN, coMLN and inguinal LNs (ILNs) were removed and analysed by flow cytometry (A). 
CD4+CD45.1+ transferred cells were identified in siMLN, coMLN and ILNs, by gating large, single 
CD4+CD45.1+ cells (B). Proliferation was analysed by CFSE dilution in each lymph node, siMLN 
(black line), coMLN (red line) and ILN (blue line) (C). 
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Figure 3-19 Orally Administered Antigen Causes Proliferation of CD8α+ T Cells Specifically in 
Small Intestinal Draining Lymph Nodes. 
Cells from the MLN and spleen of an OT-I CD45.12 donor were CFSE labelled and transferred to a 
WT CD45.2 host. 24 hours later ovalbumin was administered orally to hosts, 24, 48 and 72 hours 
later siMLN, coMLN and ILNs were removed and analysed by flow cytometry (A). CD8α+TCRVα2+, 
CD45.1+CD45.2+ single transferred cells were identified by gating large leukocytes, 
CD8α+TCRVα2+, CD45.1+ CD45.2+ single cells (B). Proliferation was analysed by CFSE dilution in 
each lymph node at day 3, day 4 and day 5. siMLN (black line), coMLN (red line) and ILN (blue 
line) (C). 
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To examine the functional consequences of the anatomical 
compartmentalisation of lymphatic drainage to distinct parts of the MLN we used 
transgenic 232-4 mice that express low levels of a cytoplasmic form of OVA only 
in SI enterocytes (Vezys et al., 2000). We isolated the siMLNs and coMLNs 
separately, stained and FACS sorted DCs. We then co-cultured the purified DCs 
with naïve CFSE-labelled OVA-specific OT-I (CD8+) TCR-transgenic T cells. Only 
DCs isolated from siMLNs were able to present antigen, derived from the SI, and 
cause the proliferation of naïve T cells. DCs isolated from the colonic draining 
MLNs, were not able to cause the proliferation of naïve OT-I T cells (Figure 
3.20). Together, these data demonstrate that, within the MLN chain, there is 
anatomical segregation of presentation of antigen derived from the SI and the 
colon.  
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Figure 3-20 Small Intestinal Derived Ovalbumin is Only Presented to T cells in Small intestinal 
Draining Lymph Nodes 
Small intestinal draining MLN and colonic draining MLNs were removed from 232-4 mice which 
express OVA only in the epithelium of the small intestine, cells were digested, and CD8α+ DCs 
were sorted using a FACSAria. DCs were co-cultured at a 1:8 DC:T cell ratio with 105 sorted, CFSE 
labelled OT-I T cells. T cells were selected by gating large, single, CD45.1+CD8α+TCRVα2+ cells 
(A). Levels of proliferation were assessed by CFSE dilution and analysed 3 days later each point 
represents an individual animal (B and C).  Results were analysed by student’s t test, asterisks 
denote statistical significance (p<0.05). 
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3.2 Discussion 
It is not widely recognised that specific nodes within the MLN drain lymph from 
different regions of the intestine. Indeed, the vast majority of recent reports 
assume that changes in the SI and colon are reflected in the whole MLN chain. 
Identification of the precise LNs that drain lymph from the SI and colon is 
essential in order to gain an accurate understanding of the immune response. 
Indeed, without proper investigation of relevant LNs, important changes in cell 
populations may be missed entirely. 
3.2.1  Identification of Draining Lymph Nodes Draining the Small 
Intestine and Colon 
To identify which parts of the intestine supply lymph to each of the nodes of 
MLN chain, we first examined the lymphatic drainage from the SI and colon. To 
achieve this, Evans blue dye was injected into the subserosal layer of either the 
SI or the colon of live anaesthetised mice. This allowed direct examination of 
the intestinal afferent lymphatic system and the draining MLNs. Following the 
injection of Evans blue into the subserosal tissue of the SI, the central LNs of the 
MLN chain stained blue, identifying them as draining the SI, the siMLN (Figure 
3.1 A). This phenomenon had previously been observed, with the identification 
of the middle mesenteric nodes draining the jejunum and ileum. (Balic et al., 
2009; Carter and Collins, 1974; Tilney N, 1971) Previous work also identified 
upper MLNs, located near the pancreatic lymph nodes, that were thought to 
drain the stomach and duodenum (Carter and Collins, 1974). In our hands, the 
primary LNs draining the entire SI were the central MLNs, upper MLNs were not 
involved. This may be because our subserosal injections were carried out too low 
down the GI tract; we did not investigate the stomach, therefore cells may drain 
from the stomach to the upper MLNs, as is the case in rats (Tilney N, 1971). 
Another key difference between our work and previous studies is in the strain of 
animal used. We used only C56Bl/6 animals, while studies identifying upper 
MLNs made use of DBA/2J mice. A more recent study indirectly identified the 
central MLNs as draining the SI, observing a reduction of CD8αint DCs specifically 
in siMLN following the infection with Nippostongylus brasiliensis (Balic et al., 
2009). Similarly the central MLNs from mice infected intragastrically with S. 
enteritidis, which mainly colonises the ileum, were the first lymph nodes to be 
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infected (Carter and Collins, 1974). These data are consistent with our 
observations regarding lymphatic drainage from SI to the siMLN.  
Following subserosal injection of dye into the proximal colon, dye first reached 
the MLN located directly adjacent to the caecum (Figure 3.1 B). This was 
consistent with previous reports in mice and rats (Carter and Collins, 1974; 
Tilney N, 1971), which identify the caecum and ascending colon draining to this 
“distal” MLN. Interestingly, a second LN also stained blue following injection of 
dye into the proximal colon. This second colon-draining MLN was at the opposite 
end of the main MLN chain (Figure 3.1 B). Previous studies did not identify this 
as draining the colon; it may have been overlooked due to its small size and 
unexpected location, or perhaps due to anatomical differences between mouse 
strains used. Previous work showed the “upper” MLNs, near the pancreas, to be 
draining the transverse colon (Carter and Collins, 1974). These LNs were 
identified as draining the colon on only one occasion in our hands. Therefore 
they were not routinely included in our analysis of the coMLN, as the possibility 
of contamination could not be ruled out and we were unable to replicate the 
result. Following Evans blue injection into the distal colon, the first MLN to stain 
blue was the LN located adjacent to the abdominal aorta (Figure 3.1 C). This 
was previously identified in both mice and rats, but there has been no recent 
investigation into this MLN (Carter and Collins, 1974; Tilney N, 1971). Although 
we identified one additional LN draining the colon, the majority of our work is in 
agreement with previous findings. Using new technology that was unavailable to 
earlier investigators, we then validated these observations and examined their 
functional relevance.  
Previous studies, and our observations using Evans Blue dye, can only reveal the 
patterns of lymphatic drainage. They do not allow the investigation of cellular 
emigration from tissue or the investigation of specific populations of cells. 
Therefore, we further explored the anatomical segregation of lymphatic 
drainage from the SI and colon using kaede mice. As antigen is carried to the 
MLN by migratory DCs, which are responsible for the initiation of intestinal 
immune responses, the migration of these vital cells was specifically 
investigated. Kaede mice have previously been used to monitor DC migration in 
peripheral LNs (Tomura et al., 2008), as well B cell migration in the intestine 
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(Schmidt et al., 2013). Intestinal DC migration has not been investigated using 
this system. To analyse the migration of intestinal DCs, mice underwent a 
laparotomy and all accessible parts of the SI or colon were exposed to low 
intensity UV light for two minutes. Animals were then allowed to recover, and 
the siMLNs or coMLNs were examined 24 or 48 hours after photoconversion. 24 
hours after exposure of the SI to UV light, significantly more photoconverted 
kaede-red DCs were present in the siMLN than in the coMLN (Figure 3.2). The 
number of kaede-red+ DCs migrating into the siMLN decreased after 48 hours, 
however there were still significantly more kaede-red+ DCs present in the siMLN 
than in the coMLN. Conversely, following exposure of the colon to UV light 
kaede-red+ DCs were found only in the coMLNs, not in the siMLNs after both 24 
and 48 hours (Figure 3.3). Therefore, consistent with the results with Evans 
blue, the anatomy of the afferent lymphatics dictates that DCs that originate in 
the SI drain to siMLNs, while DCs that originate in the colon drain to the coMLN. 
We have now clearly demonstrated, using two methods, that DCs from the SI and 
colon migrate to distinct areas of the MLN. Future investigations can now more 
precisely identify changes in cell populations that occur after interventions that 
specifically affect the immunology of the SI or colon.    
 
3.2.2  Validation of Kaede Mice as a Tool to Observe DC 
Migration 
Initial studies using transgenic kaede mice showed these to be an invaluable 
reagent for the investigation of DC migration. However, an important issue to 
address before further work was performed on these animals was to determine 
whether photoconversion might affect DC functions. There have been multiple 
studies using photoconversion of kaede mice, all of which have shown that 
photoconversion does not cause increased apoptosis or cell activation (Schmidt 
et al., 2013) (Tomura et al., 2008) (Bennett et al., 2013). These studies have 
been completed in either T or B cells. It was therefore essential to investigate 
the effect of photoconversion on DCs, particularly as stimulation of DCs can lead 
to increased migration from tissues to draining LNs (Turnbull et al., 2005; Yrlid 
et al., 2006c). Additionally we made use of a different low power UV light 
source than previous studies. The levels of CD80 and CD86 expression on DCs 
provide a measure for the level of activation of a DC. In this study BMDCs were 
generated using the DC specific growth factor Flt3L (Naik et al., 2005); 
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alternative methods for generating DCs using CSF-2 and IL-4 generate cells with 
a phenotype similar to inflammatory DCs rather than steady-state DCs (Naik et 
al., 2005). Photoconversion did not cause an increase in cell death (data not 
shown), or an increase in the expression of CD80 or CD86 (Figure 3.4). This 
suggests that photoconversion does not result in increased activation of DCs.  
 
Another important concern regarding our experiments using kaede mice is how 
the laparotomy will influence DC behaviour. Previous experiments in our 
laboratory have investigated how MLNx affects DC activation. Although MLNx is a 
more invasive procedure, it begins with a laparotomy, similar to our 
photoconversion experiments. During these experiments there was no significant 
difference in the numbers of DCs in the siLP following MLNx (V. Cerovic, 
personal communication). In collaboration with the Mowat laboratory we 
investigated a model of post-operative ileus, we did not find any significant 
changes in the percentage of DC subsets in the SI following this procedure (C. 
Scott, personal communication). Therefore, it is unlikely that this less invasive 
photoconversion procedure will result in changes to DC populations migrating 
from either the SI or colon.  
 
As we have established that kaede mice provide a suitable model to investigate 
DC migration in the intestine, we then investigated MHCII expression on 
migratory DCs in the MLN. Several groups have observed higher levels of MHCII 
expression in migratory DCs in LNs. It was first noted by Salomon et al. who 
identified that MHCIIhiCD11c+ cells were the only cells able to transport FITC to 
draining LNs following FITC painting in the skin (Salomon et al., 1998). In 
comparison the MHCII+CD11chi population were labelled with FITC following i.v 
injection with FITC dextran, suggesting they were derived from blood borne 
precursors (Salomon et al., 1998). Although they claimed that the MHCIIhiCD11c+ 
population was not responsive to Flt3L, suggesting this is not a bona-fide 
population of DCs, the authors only completed a relatively short-term exposure 
to Flt3L, only seven days. In order to observe an expansion of DCs in intestinal 
tissue exposure to Flt3L for up to nine days is required, therefore I suggest with 
longer exposure to Flt3L this MHCIIhiCD11c+ population may expand. In the lung 
only MHCIIhiCD11c+ cells were observed carrying FITC conjugated 
macromolecules to the thoracic LNs following intratracheal instillation 
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(Vermaelen et al., 2001). The convention of gating migratory DCs as 
MHCIIhiCD11c+ has been continued in the MLN (Persson et al., 2013), although 
there has been no direct evidence that migratory DCs all belong to the MHCIIhi 
phenotype in the intestine. Therefore, we sought to determine if migratory DCs 
in the intestine also displayed higher levels of MHCII in the MLN compared to 
resident DCs. Following photoconversion of the SI or colon, kaede-red+ cells were 
found only in the MHCIIhiCD11c+ gate not the MHCII+CD11chi gate (Figure 3.5). 
This confirms that migratory DCs in the intestine have higher expression of 
MHCII, similar to migratory DCs in the skin and lung. Previous work in the 
intestine has also shown that following DC stimulation via LPS and αCD40 the 
distinction between MHCIIhiCD11c+ and MHCII+CD11chi is lost (Persson et al., 
2013). As the distinction between MHCIIhiCD11c+ and MHCII+CD11chi was apparent 
in the MLN following photoconversion, it further suggests that there is no overt 
inflammation caused by photoconversion (Figure 3.5). Another important 
conclusion that can be drawn from this experiment is the lack of kaede-red+ DCs 
in the MHCII+CD11chi blood derived DC population in the MLN. This shows that all 
kaede-red+ DCs are derived from intestinal tissue, not from photoconversion of 
DC precursors in blood vessels overlying intestinal tissue that may then be 
photoconverted and migrate to the MLN (Figure 3.5). Indeed, in our hands, 
photocoversion of CD45+ cells in blood was extremely inefficient with no 
photoconverted cells detected after two minutes (data not shown). In fact, after 
24 and 48 hours there were no kaede-red+ DCs in other peripheral LNs such as 
the CLN or PLN. This would suggest that DC precursors in the blood are not 
converted and then migrate to LNs other than the MLN. Furthermore, it suggests 
that DCs do not migrate out of the LN once they reach the MLN. 
 
3.2.3  Identification of DC subsets in the Small Intestine, Colon 
and Draining Lymph Nodes 
Before investigating differences in DC populations between the siMLN and 
coMLN, it was necessary to first identify DC populations in the organ of interest. 
This allowed the comparison of tissues with the draining LNs. There has been 
some confusion in recent years in defining DCs in the both the SI and colon. This 
is due to phenotypic and functional overlap between DCs and macrophages. As 
both populations display the classical DC markers of MHCII and CD11c, it is 
essential that CD64 (Bain et al., 2013; Tamoutounour et al., 2012) or F4/80 (Bain 
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et al., 2013; Cerovic et al., 2012) be included in the analysis to exclude 
macrophages. Previously, CD103 has been used as a de facto marker of DCs in 
the SI and colon (Coombes et al., 2007; Johansson-Lindbom et al., 2005; Schulz 
et al., 2009; Sun et al., 2007). However the collection of pseudo-afferent lymph 
following TDC reveals that there are four phenotypically and functionally 
distinct subsets of DCs, identified by their expression of CD103 and CD11b, 
including two CD103- subsets (Cerovic et al., 2012). After excluding B cells, DCs 
are the only MHCIIhiCD11c+ cells migrating in lymph, therefore we can be 
confident that these CD103- cells are genuine DCs. Additionally they are able to 
prime naïve T cells, induce the expression of gut homing molecules on 
responding T cells, expand in response to Flt3L and express CCR7 (Cerovic et al., 
2012). The CD103-CD11b+ subset also expresses intermediate levels of the 
chemokine CX3CR1 (Cerovic et al., 2012). Although the levels of expression on 
CD103-CD11b+ DCs were not as high as intestinal macrophages, the expression of 
CX3CR1 has lead to much confusion in the identification of DCs. We and others, 
do not find CX3CR1hi cells in intestinal lymph (Schulz et al., 2009). However, 
Diehl et al. have recently described CX3CR1hiCD103- cells in intestinal lymph 
both in the steady state and after treatment with antibiotics (Diehl et al., 2013). 
Careful analysis of the data reveals that it is extremely improbable that these 
CX3CR1hi cells represent a population of migratory macrophages. Instead, it is 
likely that the CX3CR1hi cells reported by Diehl et al. have been misidentified, 
and the cells they find are in fact CD103-CD11b+ CX3CR1int migratory DCs.  
Following the isolation of cells from the siLP, and the exclusion of F4/80+ 
macrophages from our analysis by excluding F4/80+ cells, there were four 
distinct subsets of DC present (Figure 3.6). The most numerous were the 
CD103+CD11b+ population, followed by the CD103+CD11b- population of DCs. 
Previous work has identified CD103+ DCs in the intestine (Coombes et al., 2007; 
Johansson-Lindbom et al., 2005; Schulz et al., 2009; Sun et al., 2007). These 
were shown to play essential roles in the generation of Foxp3+ Tregs and in the 
generation of gut homing T cells (Coombes et al., 2007; Jaensson et al., 2008; 
Sun et al., 2007). These CD103+ DCs have also been shown to respond to Flt3L 
and derive from a pre-DC precursor (Bogunovic et al., 2009; Varol et al., 2009). 
Recent work by Farache et al. claimed CD103+ DCs extend dendrites to carry 
bacteria from the SI in the steady-state (Farache et al., 2013). These studies 
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used 2-photon microscopy to identify CD11cYFP+CX3CR1GFP- cells that are 
described as CD103+ DCs. However, they do not directly show that CD103+ DCs 
extend dendrites at any point. While these data may represent an interesting 
way in which particulate antigen can gain access to the LP, further work is 
required to verify what type of cells are mediating antigen uptake. Previous 
studies using 2-photon microscopy have shown there to be marked differences in 
the formation of transepithelial dendrites based upon mouse strain and in the 
location of formation of these dendrites (Chieppa et al., 2006) (McDole et al., 
2012; Vallon-Eberhard et al., 2006). Therefore careful examination of 
observations is required to ensure the formation of dendrites is a genuine 
phenomenon, not a result of the methods used to isolate intestinal tissue for 
observation by 2-photon microscopy. Another recent paper describes how CD103+ 
DCs interact with goblet cells to take up soluble antigen; similar to Farache et 
al. they made use of CD11c-YFP CX3CR1-GFP animals. These do not allow 
adequate identification of CD103+ DCs in the LP, therefore caution should be 
observed when interpreting these results (McDole et al., 2012). Interestingly, 
McDole et al. did not identify the formation of trans-epithelial dendrites, 
although they used the same mouse model as Farache et al. 
CD103+ DC subsets have also been previously identified by their expression of 
CD11b, with CD103+CD11b+ and CD103+CD11b- DCs being described (Bogunovic et 
al., 2009; Schulz et al., 2009; Varol et al., 2009). Recently, the CD103+CD11b+ 
DC population has also been shown to be dependent upon the IRF4, and these 
cells were essential for producing IL-6 in order to drive Th17 cell differentiation 
in the MLN (Persson et al., 2010). In our hands, the CD103+CD11b- LP population 
was also able to express CD8α+. This population is dependent upon the 
transcription factor BatF3 (Edelson et al., 2010) and Jang et al., reported this 
population was depleted in CCR7-/- mice (Jang et al., 2006). However the 
anatomical origin of this population has been a much debated, with many 
identifying it as a population originating in the SILT rather than the siLP due to 
the fact it is not found in Id2-/- animals which lack secondary lymphoid tissues 
(Bogunovic et al., 2009; Ginhoux et al., 2009). This is an issue that will be 
addressed in the following chapters.  
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Consistent with our findings in pseudo-afferent lymph and siLP, we also identify 
two populations of CD103- DCs (Figure 3.6). The CD103-CD11b+ population which 
express intermediate levels of CX3CR1 was identified, and has previously been 
shown to induce not only IFN-γ but also IL-17 expression in responding T cells. 
We also identify CD103-CD11b- DCs in the siLP; these are similar to the CD103-
CD11b+ DCs as they also induce IL-17 but not IFNγ. Furthermore, they are not 
CX3CR1+ (Cerovic et al., 2012). In conclusion, here we are able to conclusively 
identify four distinct populations of DCs in the siLP. 
The identification of DCs in the cLP has been less well documented. Rivollier et 
al. identified two populations of MHCIIhiCD11c+ cells, expressing either 
intermediate or undetectable levels of F4/80 (Rivollier et al., 2012). These 
populations were further analysed for their expression of CD103 and CD11b. The 
F4/80int population contained populations of CD103+CD11b+ and CD103-CD11b+ 
cells while the F4/80- population contained only CD103+CD11b- DCs. All these 
cells were able to present antigen to naïve T cells, but the F4/80int CD103- 
population was shown to be monocyte derived, and accumulated following 
colitis. Varol et al. also identified populations of CD11c+ DCs; CD103+CD11b- and 
CD103+CD11b+ DCs that they showed to be derived from a Flt3 dependent 
pathway, distinct from CX3CR1hi monocyte derived cells (Varol et al., 2009). 
Similarly, I have identified two populations of F4/80-CD103+ DCs in the colon 
(Figure 3.7). In comparison to the SI, the most numerous was the CD103+CD11b- 
population. In the SI this is identified as the CD8α population, however due to 
the enzyme digest required to release these cells from colonic tissue, this 
population it is no longer CD8α+ (A. Aumenier personal communication). The 
CD103+CD11b+ subset was still present, but was a much smaller component of 
the overall DC population than in the SI. In contrast to the previous papers I also 
identify a population of F4/80-CD103-CD11b+. This is phenotypically similar to 
the SI population, and recent work by Bain et al. has shown these do not develop 
from monocytes, but expand in response to Flt3L (Bain et al., 2013). 
In the siMLN and coMLN we identified four distinct populations of both resident 
and migratory DCs (Figure 3.8). Surprisingly, although there was a small increase 
in CD103+CD11b+ DCs in the siMLN compared to the coMLN this was not 
significant. This was unexpected as CD103+CD11b+ DCs are the major population 
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of DCs present in the siLP. Similarly, compared to the siMLN there was an 
increase in coMLN CD103+CD11b- DCs, the most numerous cLP DC population but 
this was not significant. There were significantly more migratory CD103-CD11b+ 
DCs in the siMLN compared to the coMLN. Interestingly there were significantly 
fewer migratory CD103-CD11b- DCs in the coMLN compared to the siMLN, 
mirroring the reduction of this population in the cLP. This CD103-CD11b- 
population appeared to be blood derived in the coMLN, as there were 
significantly more CD103-CD11b- DCs in the MHCII+CD11chi blood-derived 
‘resident’ DC gate than in the MHCIIhiCD11c+ ‘migratory’ gate (Figure 3.8). 
As we have previously shown that CD103-CD11b+ DCs are CX3CR1int, I sought to 
compare levels of CX3CR1 expression between DC subsets in the siMLN and 
coMLN. Consistent with our previous work, migratory CD103+CD11b- and CD103-
CD11b- were CX3CR1-. Surprisingly, we found significantly higher expression of 
CX3CR1 on CD103-CD11b+ migratory DCs in the coMLN than in the siMLN (Figure 
3.9). Furthermore, approximately half of migratory CD103+CD11b+ in the coMLN 
expressed CX3CR1 at intermediate levels, whereas very few CX3CR1+ DCs were 
observed among this subset in the siMLN. The significantly higher proportion of 
CD103+CD11b+ and CD103-CD11b+ DCs expressing CX3CR1 in the coMLN was also 
observed in resident MHCII+CD11chi DCs in the coMLN. Within the resident DC 
population CD103-CD11b- DCs expressed intermediate levels of CX3CR1 in both 
the siMLN and coMLN. The expression of CX3CR1 on DC subsets was an intriguing 
finding; a previous report suggested there was no difference in the proportion of 
CX3CR1+ in CCR7-/- mice (Bogunovic et al., 2009). However, as DCs only express 
intermediate levels of CX3CR1 it is likely they were included in this analysis. 
Furthermore, this analysis may have missed some coMLNs that are not part of 
the main MLN chain, thus mainly analysing the siMLN DC populations. 
Although the exact role of CX3CR1 is unknown, it has been suggested to play a 
role in cell survival in monocytes as the enforced expression of the antiapoptotic 
factor Bcl2 reverses the reduced monocyte phenotype observed in CX3CR1 
deficient animals (Landsman et al., 2009). The role of CX3CR1 in inflammation is 
more complicated, with both pro-inflammatory and anti-inflammatory effects 
reported being reported. Following the stimulation of colonic DCs with CX3CR1 
there is increased release of TNFα and IL-6. Conversely, inflammatory cell 
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infiltration and iNOS expression were reduced following the induction of DSS 
colitis in CX3CR1 deficient mice (Niess and Adler, 2010) (Kostadinova et al., 
2010). However, its differential expression between the siMLN and coMLN is 
likely to be due to environment differences between the SI and colon. A major 
environmental difference between the SI and colon is the increased microbial 
load in the colon. To determine if this is the reason for increased expression of 
CX3CR1, DC subsets could be isolated from newborn mice that have not yet been 
colonised by the microbiota. Adult mice could be given antibiotics to reduce 
their microbial burden, and the levels of CX3CR1 on DC subsets from the siMLN 
and coMLN could be compared. Alternatively the microbial burden in the SI 
could be increased by the infection of bacteria that preferentially colonise the 
SI. Therefore, if the expression of CX3CR1 in DCs was affected by the presence 
of bacteria the levels of CX3CR1 expression in DC subsets from the siMLN would 
be similar to the coMLN. 
3.2.4  Thoracic Duct Cannulation of Partially Mesenteric 
Lymphadenectomised Animals 
Following the identification of these differences between the siMLN and coMLN, 
partial MLNx procedures were carried out. Previously, the MLNx that precedes 
TDC removed the entire MLN chain (Figure 3.10). I have shown these lymph 
nodes collect lymph not only from the SI, but also from some areas of the 
proximal colon. Therefore, partial MLNx procedures were performed to remove 
only the siMLN and others to remove only the coMLN. This will allow the 
unequivocal identification of migratory DC subsets from the SI and colon. TDC of 
mice which had undergone siMLNx revealed a significantly increased proportion 
of CD103+CD11b+ DCs in lymph, while lymph from coMLNx animals had 
significantly more CD103+CD11b- DCs, reflecting the situation in the siLP and 
cLP. In comparison to the MLN, the increase in CD103+CD11b+ DCs in the siMLN 
and the corresponding increase of CD103+CD11b- DCs in the coMLN were now 
significant (Figures 3.11). This may be due the fact that we only analyse cells 
directly migrating from the cLP or siLP, therefore there is likely to be little 
contamination from blood derived precursors. The CD103-CD11b- population of 
DCs appeared to be missing following coMLNx, however the number and 
percentage was not significantly different to siMLNx. As the FACS plots look 
remarkably different, with further repeats I would suggest this would become a 
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statistically significant difference but due to the small size of the population this 
was not reflected with only five replicates. These results show that there are 
significant differences in the phenotypic characteristics of the DC populations 
that continuously migrate to the MLN from the SI and colon. In order to further 
investigate these subsets it could be possible to increase the rate of migration 
from the LP to the MLN using R848, to determine if the ratio of DC subsets in the 
MLNs become more similar to the ratio of DCs in the LP. 
To investigate if there was any difference in the function of DCs from the siLP 
and cLP, total DCs were FACS sorted following TDC. Due to the small number of 
DCs isolated following coMLNx total MHCII+CD11c+ cells were purified to allow 
direct comparison between siMLNx and coMLNx DCs. This does not allow the 
comparison of individual subsets between the SI and colon, due to the small 
number of cells collected. Total lymph DCs were FACS sorted from siMLNx and 
coMLNx animals and cocultured with naive OT-I T cells. DCs from siMLNx and 
coMLNx induced the proliferation of naïve T cells equally well (Figure 3.12). To 
further investigate T cell priming by siMLN and coMLN DCs, the expression of 
CCR9 on responding T cells was compared between lymph DCs from siMLNx’d and 
coMLNx’d animals. DCs from siMLNx and coMLNx animals caused the retention of 
CCR9 on responding T cells equally well (Figure 3.13). DCs from MLN have 
previously been reported to support the expression of gut homing receptors such 
as CCR9 and α4β7 (Annacker et al., 2005; Jaensson et al., 2008; Johansson-
Lindbom et al., 2005; Stagg et al., 2002). However, previous work has shown 
that DCs purified from the colon were unable to cause the retention of CCR9 on 
responding T cells (Jaensson et al., 2008). In this study DCs from the MLN were 
still able to cause the retention of CCR9, and as T cells are essential to resolve 
colitis, I think it is likely that colonic DCs are able to cause the retention of 
CCR9 expression on responding T cells. Therefore the harsh enzymatic digestion 
required for the colon may affect the ability of these cells to interact with T 
cells and cause the retention of CCR9. Alternatively, the ability to cause the 
retention of CCR9 expression on responding T cells may develop in DCs only once 
they leave the cLP. In order to determine the fate of T cells that had been 
primed in the coMLN we could make use of the kaede system. Using these mice 
we could photoconvert entire coMLNs, then follow the journey of responding T 
cells at various time points. 
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3.2.5  Effects of Experimental Colitis Upon Dendritic Cell 
Subsets in the Small Intestinal or Colonic Draining Mesenteric 
Lymph Nodes 
To investigate differences in siMLN and coMLN DCs, adding DSS to the drinking 
water induced colonic inflammation, and DC subsets in the siMLN and coMLN 
were investigated. Although recent work has suggested that DSS colitis is driven 
mainly by Ly6Chi monocytes (Bain et al., 2013), previous work (Rivollier et al., 
2012; Tamoutounour et al., 2012; Zigmond et al., 2012) identified a population 
of monocyte derived inflammatory DCs that increased in number following the 
induction of DSS colitis. We employed a recovery model of DSS colitis, to allow 
us to follow cell populations over an extended period of time. The increase in 
cell number in the colitic colon, observed by many, was not mirrored in the 
coMLN. Furthermore, there was no significant difference in the number of DCs 
isolated in the coMLN of colitic animals compared to the siMLN or to control 
animals (Figure 3.14). Nor was there any change in the composition of DC 
subsets identified by their expression of CD103 or CD11b (Figure 3.15). This and 
other recent work has used CD64 to distinct populations of 
monocytes/macrophages and DCs (Bain et al., 2013; Tamoutounour et al., 2012). 
As these arise from different developmental pathways and have different 
functions it is essential these cells be considered separately from DCs. There was 
no significant difference in the number of CD64+CD11b+CX3CR1+ during colitis, or 
recovery, in the siMLN or coMLN (Figure 3.16). This result is in contrast with the 
data published by Tamoutounour et al. who find a rapid accumulation of blood 
derived CD64+ monocytes in the MLN following T cell mediated colitis 
(Tamoutounour et al., 2012). Similarly, Siddiqui et al. observe an increase in E-
cadherin+ monocytes in the MLN of mice with experimental colitis (Siddiqui et 
al., 2010). The difference between our observations and others may be due to 
the type of colitis induced; we used DSS to induce colitis while other reports 
have used a T cell transfer model (Siddiqui et al., 2010; Tamoutounour et al., 
2012). Another key difference may be the duration of the induced inflammation. 
In our model DSS was added to drinking water for three days. In the T cell 
transfer model of colitis, inflammation was observed four weeks after the 
introduction of CD4+Foxp3- T cells. In contrast to previous reports that suggested 
these CD64+ monocytes were blood derived, Zigmond et al. report a population 
of CX3CR1+ cells that migrate to the MLN via lymph following 9 days of DSS 
 136 
treatment (Zigmond et al., 2012). However, from their data it is unclear if these 
cells have arisen from inflammatory monocytes or are CX3CR1int DCs. The 
elevated ability of CX3CR1+ cells to induce the proliferation of naïve T cells 
suggests these cells have been misclassified as macrophages, and actually 
represent the CX3CR1int DCs we have shown to migrate in pseudo-afferent lymph 
(Cerovic et al., 2012). However, in order to precisely compare the populations of 
cells we find with Zigmond et al. it would be interesting to repeat our DSS model 
with 9 days of recovery. Furthermore by including additional markers, such as 
CD64, we could with confidence determine if these cells are DCs or 
macrophages. 
3.2.6  Comparison of Antigen Presentation By Dendritic Cell 
Populations from the Small Intestinal and Colonic Draining 
Mesenteric Lymph Nodes 
As we could not detect differences in the phenotype of the DCs in the siMLN and 
coMLN following colonic inflammation, we next sought to determine if siMLN and 
coMLN DCs acquired antigen from different anatomical locations. Although the 
exact mechanism by which soluble antigen gains access to the LP is unclear, 
there are many previous reports showing that DCs in the siLP are able to acquire 
soluble antigens (Chirdo et al., 2005). In fact, there is mounting evidence that 
antigen uptake by DCs in the LP is essential for the induction of tolerance to 
soluble antigens (Pabst and Mowat, 2012). We predicted that by orally 
administering only a small amount of antigen, the majority would be taken up in 
the SI before it reached the colon. In the first experiment, CD45.1 OT-II cells 
from the MLN and spleen were transferred into a CD45.2 host. 24 hours later the 
host was fed with OVA (10 mg), and three days after this levels of proliferation 
in the siMLN, coMLN and ILN were investigated. T cell proliferation was only 
detected in the siMLN (Figure 3.17). Thus, soluble OVA appears to be taken up 
preferentially in the SI, and this is presented specifically in the siMLN. This could 
reflect the in vivo situation that leads to generation and maintenance of oral 
tolerance. An interesting comparison could be drawn following the intra-rectal 
administration of OVA, which would presumably be absorbed by the colon. T cell 
proliferation in coMLN could then be compared to siMLN. 
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We modified this experiment to gain further insight into this process. This time 
LNs were analysed 24, 48 and 72 hours after OVA administration. After 24 hours 
there was no OT-II proliferation in any LNs (Figure 3.17). This was not 
unexpected as BrdU experiments indicate migratory DCs take between 24 and 48 
hours to reach the MLN (Liu et al., 1998). Therefore this time point may have 
been too early to detect proliferation. After 48 hours proliferation was detected 
in both the siMLN and coMLN, but not the ILN (Figure 3.17). Although there was 
more proliferation in the siMLN than the coMLN, this was unexpected as our 
previous result suggested that SI DCs in the siMLN would present small amounts 
of soluble antigen and therefore only cause proliferation of T cells in the siMLN. 
The proliferation of T cells in the coMLN was perhaps a result of OVA passing 
into, and being taken up in the colon. Alternatively T cells have already begun 
to migrate back to the intestine. After 72 hours CFSE was completely diluted in 
the siMLN, coMLN and ILN. At this point the antigen and T cells are likely to have 
been transferred to systemic circulation. This dissemination of soluble antigen 
was not completely unexpected, as food protein can be detected in the blood of 
mice and humans after eating (Pabst and Mowat, 2012). 
We decided to make use of transgenic 232-4 mice that express cytoplasmic OVA 
only in SI enterocytes (Vezys et al., 2000). DCs from the 232-4 siMLN were able 
to induce proliferation of OT-I T cells, while DCs from the coMLN were unable to 
induce the proliferation of OT-I T cells. These results demonstrate that antigen 
acquired in the SI is initially only presented to T cells in the siMLN (Figure 3.20). 
These data show that there is not only anatomical segregation between 
lymphatic drainage from the SI and the colon, but also that these distinct MLNs 
are functionally separate. Antigen expressed in the SI is only presented by DCs, 
and only causes proliferation of naïve T cells, in the siMLNs (Figure 3.20). 
Therefore, in future it will be beneficial to isolate and analyse these distinct 
MLNs separately. Independent analysis of the siMLN and coMLN will enable a 
more refined understanding of intestinal immune responses and is likely to lead 
to novel insights regarding the immunological differences between the SI and 
colon.  
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3.3 Conclusions 
Here, using two distinct models, I have shown that the SI and colon drain to 
distinct LNs that can be analysed separately. In the future careful examination 
of populations of cells in these distinct LN may reveal novel phenotypic 
differences in the differences between immune response in the SI and colon. 
 
In terms of DCs, I identified that there were distinct differences in the subset 
composition of DCs migrating from the SI and colon that I have outlined above. 
One of the most striking differences between the siLP and cLP, which was 
reflected in the lymph and coMLN to an extent, was the reduction of CD103-
CD11b- DCs in the colon. We have previously shown that these cells specifically 
induce the production of IL-17 producing T cells in the absence of any overt 
stimulation (Cerovic et al., 2012). Recent work has shown that mice deficient in 
Th17 cells were unable to produce T cell dependent antigen specific IgA (Hirota 
et al., 2013). Therefore the lack of this subset in the colon may reflect a 
difference in the way IgA is produced between the SI and colon. This could 
reflect an interesting difference in the way the SI and colon respond to 
particulate antigen, such as microorganisms. However, much further work should 
be completed in order to determine the functional consequences of this. 
 
Another interesting difference between DC subsets from the siMLN and coMLN 
was in the expression of CX3CR1. Specifically CD103+CD11b+ DCs from the coMLN 
expressing CX3CR1 while siMLN CD103+CD11b+ DCs did not express CX3CR1. This 
could be due to a number of reasons, such as environmental factors including 
the microbial burden. However, recent work in the Mowat laboratory has 
suggested that there may be a developmental continuum between CD103-CD11b+ 
DCs and CD103+CD11b+ DCs in the LP (C. Scott, personal communication). As 
CD103-CD11b+ DC express CX3CR1 in both the SI and colon, the increased 
expression of CX3CR1 in colonic CD103+CD11b+ DCs may reflect the fact that 
these have developed from CD103-CD11b+ DCs but have not yet downregulated 
CX3CR1. An interesting way to test this could be by the adoptive transfer of 
labelled DC precursors with detailed phenotypic analysis of the markers these 
cells begin to express and the markers they begin to downregulate. Further work 
to investigate the factors that trigger this development should be completed. 
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The siMLN and coMLN are functionally distinct with antigen expressed in the SI 
only being presented and causing proliferation of naïve T cells siMLNs. The siMLN 
and coMLN are likely to be exposed to different environmental antigens leading 
to DCs being conditioned differently. For example DCs in the SI are likely to be 
exposed to more dietary ligands, such as vitamin A, which is essential for the 
generation of Foxp3+ Tregs (Mucida et al., 2009). In comparison DCs from the 
colon are likely to be exposed to more microbes than the SI, as the microbial 
burden is highest in the colon. Therefore, DCs from the colon may be better at 
inducing class cell switching of B cells to produce IgA than DCs from the SI, 
which may be better at inducing Tregs. In order to test this DCs from the SI or 
colon could be isolated and co-cultured with naïve T cells and the ability of 
these DCs to induce Foxp3+ Tregs could be determined. The immune response to 
pathogens that preferentially colonise either the SI or the colon is likely to differ 
between the siMLN or coMLN, therefore infection models could be investigated.  
 
Therefore, in future the siMLN and coMLN should be isolated and analysed 
separately. Independent analysis of the siMLN and coMLN will enable a more 
refined understanding of intestinal immune responses and is likely to lead to 
novel insights regarding the immunological differences between the SI and 
colon. 
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Chapter 4:  Dendritic Cell Migration in 
Mice Lacking Peyer’s Patches and 
Isolated Lymphoid Follicles 
The organised lymphoid structures of the intestine, the PPs and ILFs, represent 
unique and distinct immune environments. They form along the antimesenteric 
axis of the SI. Cells in the PPs take up and process both soluble and particulate 
antigen (Kelsall and Strober, 1996). Additionally, PPs and ILFs are the only 
tissues with fully differentiated and functional M cells. They are therefore key 
locations for antigen acquisition in the SI. They also share a similar cellular 
composition, as they are predominantly filled with B cells and have germinal 
centres. Therefore, PPs and ILFs are assumed to be inductive sites for intestinal 
immune reactions. 
Although there are many similarities between PPs and ILFs, a key difference 
between the structures is in their development. Although they share many of the 
same key developmental traits, the timing of their development differs. While 
PPs develop in utero CPs and ILFs develop post-natally. The presence of PPs in 
the SI is stable and is determined pre-natally while the development of ILFs is 
dynamic and may change in response to microbial, parasitic or viral load. 
Therefore, although PPs and ILFs both play important roles in inducing intestinal 
immune responses they must be considered as separate tissues.  
Despite persistent speculation, there has been no definitive evidence to indicate 
whether DCs migrate from PPs and ILFs to the MLN. Recently, we described a 
population of DCs that express CD8α and migrate from the intestine to the MLN 
(Cerovic et al., 2012). Previously, the expression of CD8α was assumed to be 
limited to a population of blood-derived LN resident non-migratory population of 
DCs (Jakubzick et al., 2008) (Edelson et al., 2010). Therefore we sought to 
determine whether DCs are able to migrate from PPs and ILFs to the MLN. We 
were particularly interested in these migratory CD103+CD11b-CD8α+ DCs, as well 
as investigating the three other phenotypically and functionally distinct 
intestinal migratory DC subsets; CD103+CD11b+, CD103-CD11b+ and CD103-CD11b- 
DCs. In order to complete these experiments I used two different mouse models 
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that lack different gut associated lymphoid tissues (GALT). I first used RORγt 
knock out mice that lack both PP and ILFs. Second, mice that lack only PPs but 
retain ILFs were generated by in utero exposure to LTBR-Ig, allowing the 
investigation of DCs migration from ILFs.  
Using these two animal models, the precise anatomical origins of migratory DCs 
can begin to be elucidated. This will provide further insight into how DCs in the 
intestine can be manipulated or targeted for the development of new oral 
vaccines or the treatment of inflammatory bowel disease. 
4.1 Results 
4.1.1  Genotyping of RORγtCD3ε and CD3ε Deficient Mice 
Recently Peter Lane and colleagues have developed a strain of 
CD3εtg26RORγtneo/neo (referred to as RORγtCD3ε mice, or RORγt deficient mice for 
the purposes of this report) mice by crossing RORγtneo/neo mice with CD3εtg26 
(CD3ε) mice (referred to as CD3ε mice for the purposes of this report).  RORγt 
deficient mice lack lymph nodes, PPs, and ILFs, due to the absence of LTi cells. 
Transgenic mice lacking murine CD3ε show completely abrogated T cell 
development.  The combined phenotype of the RORγtCD3ε mice is a lack of T 
cells, NK cells and LTi cells, and the absence of MLNs, PPs and ILFs.  These mice, 
however, still have DCs in the intestine; therefore any DCs migrating to the MLN 
will be LP derived. 
 
Initially it was necessary to ensure the mice we received were of the expected 
genotype and phenotype to set up breeding pairs.  Blood samples were taken 
from the tail vein of RORγtCD3ε and CD3ε deficient mice, the whole blood was 
processed and stained for CD3 and B220 to visualise T and B cells by flow 
cytometry.  T and B cells were gated as live cells (Figure 4.1 A) and the presence 
of CD3+ and B220+ cells was compared (Figure 4.1 B).  A B220+ population was 
observed, however there were no CD3+ cells (Figure 4.1 B).  As there did not 
appear to be a population of T cells in either the RORγtCD3ε or CD3ε deficient 
mice it was assumed that these mice were of the correct phenotype.  
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Figure 4-1 The Absence of CD3+ Lymphocytes in blood samples from RORγtCD3ε  and CD3ε  
deficient mice.   
Blood samples were taken from the tail vein from RORγtCD3ε and CD3ε
 deficient mice, samples 
were processed and analysed by flow cytometry. Live cells were gated (A) and the presence of 
CD3+ and B220+ cells was examined (B).  Data are representative of 16 RORγtCD3ε and 6 CD3ε 
deficent mice. 
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As the mice were of the anticipated phenotype I next wanted to ensure the mice 
were of the expected genotype. Therefore, a PCR was carried out on genomic 
DNA to confirm the genotype of these animals. As mice lacking RORγt instead 
have the neomycin cassette, the presence or absence of RORγt and neomycin 
was investigated. Tissue samples were collected by ear punch from RORγtCD3ε 
and CD3ε deficient mice. Genomic DNA was isolated and PCR was carried out.  
Primers for RORγt were designed using the Primer Blast Program and presented 
in Table 2.3, primers for neomycin were designed from published sequences.  
Primers were aligned against the murine database using BLAST (Pubmed) to 
ensure specificity to only the target sequence.  The RORγt primers gave rise to a 
product with a calculated length of 190 bp and the neomycin primers gave rise 
to a product of 250 bp. The products of the PCR were run on a 2% agarose gel 
(Figure 4.2). This showed the samples from RORγtCD3ε deficient mice had the 
neomycin cassette but not RORγt, while the CD3ε deficient mice expressed RORγt 
but not the neomycin cassette. Therefore, the animals are of the expected 
genotype as well as phenotype.  
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Figure 4-2 The Presence of Neomycin and RORγt Protein in RORγCD3ε  and CD3ε  Deficient 
mice.   
Tissue samples were collected, genomic DNA was isolated and PCR was carried out on RORγtCD3ε 
and CD3ε deficient mice. Products were analysed by gel electrophoresis on a 2% agarose gel. 
Bands indicating expression of neomycin were only detected in RORγtCD3ε deficient mice, while 
RORγt expression was only detected in CD3ε deficient mice. 
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4.1.2  Lymphoid Tissue Development in the Small Intestine of 
RORγt Deficient Animals 
These data allowed us to begin to investigate changes in the intestinal immune 
system of these animals. Firstly, the lack of PPs and ILFs was investigated using 
immunohistochemistry. RORγtCD3ε deficient mice lack LTi cells and therefore 
there should be no PPs or ILFs in the SI. In order to confirm this, longitudinal 
segments of SI were taken from RORγtCD3ε and CD3ε deficient mice and made 
into Swiss-roll sections. This allowed large areas of the SI to be visualised in one 
image and therefore an accurate picture of the architecture could be obtained 
(Moolenbeek and Ruitenberg, 1981; Pabst et al., 2005). Sections were stained 
with DAPI to visualise all cells, and with anti-B220. As PPs and ILFs contain large 
numbers of B cells, the B220 stain assists in the identification of these 
structures. After immunofluorescent staining, multiple overlapping high power 
images were generated and collated to accurately visualise the detailed 
architecture of the small intestine (Figure 4.3). 
 
 146 
 
Figure 4-3 Organised Lymphoid Structures Are Absent From the Small Intestine of RORγt 
Deficient Mice. 
Swiss roll sections were prepared from the small intestine of CD3ε mice and RORγtCD3ε deficient 
mice and stained with B220 to show organised lymphoid structures and with DAPI to show the 
structure of the intestine. Composite images of intestine from CD3ε mice (A) and RORγtCD3ε 
deficient mice (B) were assembled from 100-150 individual high-powered images to allow the 
visualisation of large areas of intestine. White arrows indicate the position of lymphoid 
aggregates. Selected lymphoid aggregates from CD3ε mice depicted at x20 magnification (C), 
taken from (A), area in box. Pictures are representative of 8 separate animals. 
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4.1.3  Dendritic Cell Subsets in Pseudo-Afferent Lymph, Small 
Intestine and Colon of RORγt Deficient Mice 
Immunohistochemical analysis of Swiss-roll sections from RORγtCD3ε and CD3ε 
deficient mice confirmed the absence of PPs and ILFs in RORγtCD3ε deficient 
mice. We next investigated migratory DCs originating from the intestine of 
RORγtCD3ε deficient mice; as there are no GALT, any DCs migrating from the 
intestine will be derived from the conventional villus mucosa. First, migratory 
DCs from the intestine were investigated using TDC. Pseudo-afferent lymph from 
WT, CD3ε and RORγtCD3ε deficient mice were collected. DCs were defined as 
CD19- CD11c+MHCII+ (Figure 4.4 A) and analysis revealed there to be four distinct 
subsets migrating from the intestine in WT and CD3ε deficient mice, identified 
by their expression of CD11b and CD103 (Figure 4.4 B). RORγtCD3ε deficient mice 
had comparable percentages, and numbers of CD103+CD11b+ and CD103-CD11b+ 
DCs to CD3ε and WT mice. However, RORγtCD3ε deficient mice had significantly 
fewer CD103-CD11b- DCs (Figure 4.4 B and C). This suggests that these CD103-
CD11b- DCs are likely to migrate from either PPs or ILFs, the organised lymphoid 
structures that are missing in RORγtCD3ε deficient mice.  
Importantly and somewhat surprisingly, the CD103+CD11b- subset that has been 
reported to express CD8α was still present in the pseudo-afferent lymph of 
RORγtCD3ε deficient mice. In order to determine if CD8α+ DCs are able to 
migrate from the conventional villus mucosa; the expression of CD8α on DC 
subsets in pseudo-afferent lymph in RORγtCD3ε deficient animals was 
investigated (Figure 4.5). Four distinct subsets of DCs were gated as previously 
described and the expression of CD8α on each of these subsets was compared 
between WT (Figure 4.5A) and RORγtCD3ε deficient mice (Figure 4.5B). This 
confirmed that the CD103+CD11b- DC subset was the only subset that was able to 
express CD8α. Furthermore, this subset was present in pseudo-afferent lymph 
from RORγt deficient mice. This shows, for the first time, that CD8α+ DCs are 
present in the non-organised lymphoid structures of the siLP and are able to 
migrate from there. 
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Figure 4-4 CD103-CD11b- DCs Are Missing From The Lymph of RORγtCD3ε - Deficient Mice 
Pseudo-afferent lymph was collected from WT, CD3ε and RORγtCD3ε deficient mice and analysed 
by flow cytometry. Large cells were gated, and CD19-MHCII+ cells were gated, and CD11c+ single 
cells were further selected (A). These DCs were further split into four populations based upon 
the expression of CD103 and CD11b (B) and these four subsets were compared between WT, CD3ε 
and RORγtCD3ε deficient mice (C). Data are means and S.E.M. Results were analysed by ANOVA, 
asterisks denote statistical significance (p<0.05, n=6). 
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Figure 4-5 Expression of CD8α  on Dendritic Cell Subsets in Lymph.   
Pseudo-afferent lymph was collected from WT (A) and RORγtCD3ε deficient (B) mice and 
analysed by flow cytometry. DCs were gated as before and DCs were further split into four 
populations based upon the expression of CD103 and CD11b. Expression of CD8α on each of these 
four subsets was compared between WT, RORγtCD3ε deficient mice. Results are representative 
of at least 4 independent experiments.  
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Having shown that all DC subsets but the CD103-CD11b- subset are present in 
pseudo-afferent lymph of RORγtCD3ε deficient mice, we first sought to 
understand whether this reflected the DC subsets that are present in the SI. 
Thus, the SI was removed, and PPs were discarded from WT and CD3ε mice. Due 
to the small size of ILFs we were unable to remove these before the digestion, 
therefore SI digests from WT and CD3ε mice will contain some contaminating 
ILFs. The SI was digested and a single cell suspension was stained for multi 
colour flow cytometry. First, large cells were gated, then live CD45+, MHCII+, 
CD11c+ cells were selected, and doublets were excluded. Finally F4/80+ 
macrophages were gated out (Figure 4.6 A). DC subsets, identified by their 
expression of CD103 and CD11b were examined (Figured 4.6 B) and the total 
numbers of DCs in each subset were compared between WT, CD3ε and 
RORγtCD3ε deficient mice (Figure 4.6 C). The DC subsets observed in the SI 
digests reflected what was found in pseudo-afferent lymph. First, there was no 
significant difference in the percentage or number of CD103+CD11b+ DCs or 
CD103-CD11b+ DCs. As in pseudo-afferent lymph, the CD103-CD11b- subset was 
significantly reduced only in the SI of RORγt deficient mice, meaning this subset 
is likely to migrate from organised lymphoid structures present in the SI such as 
ILFs.  
CD103+CD11b- DCs were observed in the conventional villus mucosa of RORγtCD3ε 
deficient mice, suggesting that this subset of DCs which express of CD8α is not 
restricted to lymph nodes. We then sought to confirm these CD103+CD11b- DCs 
express CD8α and are present in the siLP. Therefore, we digested and analysed 
DC subsets from the siLP of WT (Figure 4.7 A) and RORγtCD3ε deficient mice 
(Figure 4.7 B) and investigated the expression of CD8α on each of these subsets. 
As observed in pseudo-afferent lymph, the only major population expressing 
consistent levels of CD8α was the CD103+CD11b- DCs. Although, the few cells left 
in the CD103-CD11b- gate from RORγtCD3ε deficient mice also appeared to 
express some CD8α (Figure 4.7).  
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Figure 4-6 CD103-CD11b- DCs Are Missing From Small Intestinal Lamina Propria of RORγt 
Deficient Mice. 
Small intestinal LP cells were isolated as described in the methods section and cells were 
analysed by flow cytometry. Single cells were gated, and live leukocytes (7AAD-CD45+) were 
gated. MHCII+ cells were identified and F4/80+ cells were excluded and CD11c+ cells were 
selected. These DCs were then further split into 4 populations based upon the expression of 
CD103 and CD11b in WT mice (A, left panel). One population of DCs was missing in RORγtCD3ε 
deficient mice (A and B). Data are means and S.E.M. Results were analysed by ANOVA, asterisks 
denote statistical significance (*p<0.05, n=5). FACS plots representative of 5 independent 
biological replicates. 
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Figure 4-7 Expression of CD8α  on Dendritic Cell Subsets in Small Intestinal Lamina Propria.   
siLP cells were isolated and analysed by flow cytometry. Four dendritic cell subsets were 
identified and the expression of CD8α on each of these subsets was compared between WT (A) 
and RORγtCD3ε deficient (B) mice. Results are representative of at least four independent 
repeats. 
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Four DC subsets were identified in WT and CD3ε mice, while RORγtCD3ε deficient 
mice lack one subset of DCs, the CD103-CD11b- DCs. As they are missing in 
pseudo-afferent lymph and SI digests from RORγtCD3ε deficient mice this 
suggests that these cells are likely to originate from GALT. We next investigated 
which cells were present in the cLP as we previously showed that some parts of 
the MLN are likely to drain the colon. PPs are present only in the SI, but ILFs are 
present in both the SI and colon. However colonic ILFs are distinct from those in 
the SI, and are able to form independently of LTi cells. Therefore, ILFs are 
present in the colon of RORγtCD3ε deficient mice. To investigate the DC 
populations therein, colons were removed from mice and single cell suspensions 
were generated. These were then stained with fluorescent antibodies and 
analysed by flow cytometry. A similar gating strategy was employed for the 
colon as was used for the SI; first large cells were selected, then live CD45+ 
leukocytes were identified and MHCII+, F480- cells were selected (Figure 4.8 A). 
Single, CD11c+ cells were examined and the four populations of DCs identified by 
their differential expression of CD103 and CD11b (Figure 4.8 B). CD103+CD11b+ 
DCs were present in similar numbers in each of the mouse groups, although the 
number of these cells is reduced in the colon compared to the SI. CD103+CD11b- 
DCs were also present in WT, CD3ε and RORγtCD3ε deficient in comparable 
numbers and percentages however in comparison to the SI this population is 
expanded in the colon. This subset is usually associated with the expression of 
CD8α, however I was unable to stain for this marker as the colonic digestion 
protocol cleaves the of CD8α antibody epitope. There was also no difference 
between CD103-CD11b+ DCs in the colon; as these were present in all groups of 
mice. In comparison to the SI, there were fewer CD103-CD11b- DCs in WT, CD3ε 
or RORγtCD3ε deficient mice. This indicates that this subset does not migrate 
from the colon, and is specific to the SI particularly the SI GALT as this subset is 
specifically missing from RORγtCD3ε deficient mice. These results show there 
were no significant differences in the number or percentage of any DC subset in 
the colon between WT, CD3ε or RORγtCD3ε deficient mice (Figure 4.8 C).  
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Figure 4-8 CD103-CD11b- DCs Are Fewer In The Colonic Lamina Propria of WT, CD3ε  and 
RORγtCD3ε  Deficient Mice. 
Colonic LP cells were isolated and cells were analysed by flow cytometry. Large cells were 
gated, and live leukocytes (7AAD-CD45+) were identified. MHCII+ and F4/80- cells were gated and 
doublets and CD11c+ cells were gated (A). These DCs were then further split into 4 populations 
based upon the expression of CD103 and CD11b in WT mice (B, left panel), CD3ε (B, middle 
panel) and RORγtCD3ε deficient mice (B, right panel). The total number of these cells were 
compared (C). Data are means and S.E.M. Results were analysed by ANOVA. FACS plots 
representative of 6 independent biological replicates. 
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4.1.4  Dendritic Cell Development in the Spleen and Bone 
Marrow of RORγt Deficient Mice 
It has been previously reported that RORγt deficient mice have a defect in 
splenic DCs, namely that they have fewer CD11b+CD4+ DCs (P Lane, personal 
communication). To confirm this and to assess whether CD3ε and RORγtCD3ε 
deficient mice display any additional defects in resident DC populations that 
might affect our analyses, cells were isolated from spleens of WT, CD3ε and 
RORγtCD3ε deficient mice. The digestion of spleens generated a single cell 
suspension that was stained with fluorescent antibodies and analysed by flow 
cytometry. Large cells were gated then doublets and dead cells were excluded 
from the analysis. The presence of neutrophils and monocytes was investigated 
by pre-gating for CD11b+Ly6C+. Among the CD11b+Ly6C+ cells, neutrophils were 
defined as SSC-Ahi while monocytes were SSC-Alo (Figure 4.9 A). pDCs were also 
investigated, and were identified by their expression of B220 and Ly6C. CD11b-, 
CD11c+ cells were then defined as pDCs (Figure 4.9 B). For DCs, CD11c+B220- 
cells were selected and the MHCII+ cells were selected. DC subsets were then 
classified as CD8α+, CD11b+CD4+ or CD11b+CD4-. There was no significant 
difference in the numbers or percentages of monocytes, neutrophils, or pDCs 
between WT, CD3ε or RORγtCD3ε deficient mice (Figure 4.9 F). There was also 
no significant difference between the number or percentage of CD11c+MHCII+ 
cells (Figure 4.9 D). We also did not see a significant difference amongst DC 
subsets, although there appeared to be fewer CD11b+CD4+ DCs. This suggests 
that RORγtCD3ε deficient mice do not have systemic defect in DC development 
that would have caused the lack of CD103-CD11b- DCs in the SI and lymph.  
 
To investigate whether there was a systemic defect in the development of 
RORγtCD3ε deficient DCs, we generated DCs and pDCs using BM cultured with the 
DC specific growth factor Flt3L. Therefore, if there were any defects in the 
generation of specific populations of DCs these would be detected. Cells from 
the femurs and tibias were isolated from WT, CD3ε and RORγtCD3ε deficient 
mice. These cells were cultured in the presence of Flt3L for 7 days. The 
phenotypes of the BMDCs generated were compared by flow cytometry. Briefly, 
live cells were gated and the B220+ population was further gated upon PDCA-1 to 
identify pDCs (Figure 4.10 A and B). DCs were gated as the B220- fraction of cells 
 156 
that were further gated as CD11b+ or CD11b- (Figure 4.10 A and C). Both subsets 
were present in similar number and proportion in WT, CD3ε and RORγtCD3ε 
deficient mice. This confirms that there is no detectable defect in the 
development of DCs from precursors in RORγtCD3ε deficient mice, at least in 
Flt3L cultures.   
 157 
 
 
Figure 4-9 Characterisation of Cell Subsets in the Spleen of WT, CD3ε  and RORγtCD3ε  
Deficient Mice. 
Cells from the spleen of WT, CD3ε and RORγtCD3ε deficient were digested and stained for flow 
cytometry. Large, live, single cells were gated (A) and CD11b+Ly6C+ cells were selected and SSChi 
cells were then identified, as neutrophils while SSClo cells were monocytes (B). Alternatively, 
live single cells were gated as Ly6Chi B220+ cells and the CDllc+CD11b- cells were then identified 
as pDCs (C). Conventional DCs were identified as CD11c+B220- and MHCII+ (D), and these cells 
were further separated by upon their expression of CD11b, CD8α and CD4 (E). The percentage of 
total cells was compared (F and G) Data are means and S.E.M. and results were analysed by 
ANOVA, asterisks demote statistical significance (n=3). FACS plots are representative of 6 
independent biological replicates.  
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Figure 4-10 Characterisation of Cell Subsets Generated from Bone Marrow of WT, CD3ε  and 
RORγtCD3ε  Deficient Mice After Culture with Flt3L. 
Cells from the bone marrow of WT, CD3ε and RORγtCD3ε deficient animals were isolated and 
cultured for seven days with Flt3-Ligand at 37°C. Cells were harvested and stained for flow 
cytometry, large single cells were gated and B220+ PDCA-1+ cells were identified as pDCs, while 
B220- cells were identified as cDCs. cDCs were further gated as CD172a+ and CD172a-. The 
percentage of DCs of cells were compared (B and C) Data are means and S.E.M. and results were 
analysed by ANOVA. FACS plots representative of 3 independent biological replicates. Similar 
results were obtained from 3 independent experiments.  
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4.1.5  Generation of Lymphotoxin-β Receptor Fusion Protein  
The second system we used to investigate the anatomical origins of migratory 
DCs in the intestine involved prenatal exposure of mice to LTβR-Ig, which can 
inhibit lymphoid tissue organogenesis. During lymphoid tissue formation, LTo 
cells express the LTβR, and the LTi cells that seed the developing lymph node 
express the LT ligand LTα1β2.  Interaction between these two molecules is 
required for the development of LNs and is blocked by LTβR-Ig. As lymphoid 
organs develop sequentially, the timing of the exposure of LTβR-Ig is crucial; 
injections at E14 and E16 prevent development of PPs but mesenteric, 
cervical, brachial and axillary lymph nodes all develop normally (Mebius, 
2003).  ILFs are induced to develop after birth, therefore mice exposed to 
LTβR-Ig at E14 and E16 lack PPs only, and while MLN and ILF formation is 
unaffected.  Consequently, any DCs migrating to the MLN from these animals 
must be LP or ILF derived.   
 
LTβR-Ig was produced from HEK293 cells stably transfected with murine LTβR-Ig 
expressing plasmid; the supernatant from these cells was purified by a 
Sepharose-protein G affinity column before being sterilised by filtration. The 
integrity of the protein was confirmed by SDS-PAGE (Figure 4.11). Supernatant 
from HEK293 containing LTβR-Ig before filtration, purified LTβR-Ig, and a 
molecular weight ladder were loaded into a polyacrylamide gel and coomassie 
blue staining was performed in order to visualise proteins. This revealed that the 
sterilised LTβR-Ig showed a single band of between 50 and 40 kDa, corresponding 
to the LTβR-Ig (48kDa). In comparison the non-purified LTβR-Ig showed a faint 
band corresponding to LTβR-Ig as well as smaller bands representing impurities.  
Once the purity of LTβR-Ig had been established, a Bradford Assay was 
performed to determine the concentration of protein that was produced. 
Standards of BSA, and LTβR-Ig, were incubated with the Bradford reagent and 
their absorption of light at 562 nm was determined. Values were used to draw a 
standard curve (Figure 4.12), and the equation of the standard curve was used 
to determine that the protein concentration of LTβR-Ig was 1343.7µg/ml.  
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Figure 4-11 SDS-PAGE Gel of Purified LTβR-Ig. 
Purified LTβR-Ig and the supernatant of the cells that produce LTβR-Ig pre purification were 
separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Lane 1 
shows standard proteins, lane 2 purified LTβR-Ig and lane 3 shows LTβR-Ig pre-purification. 
Coomassie brilliant blue was performed following SDS-PAGE to visualise protein bands. 
 
 
Figure 4-12 The Concentration of Purifed LTβR-Ig by Bradford Assay. 
A Bradford Assay was performed on serial dilutions of BSA and purified LTβR-Ig and absorption 
was determined. Values were recorded, a standard curve was drawn, and the concentration of 
LTβR-Ig was determined. 
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4.1.6  Lymphoid Tissue in the Intestine of Lymphotoxin-β 
Receptor Fusion Protein Treated Progeny 
Once the purity and concentration of LTβR-Ig was established, LTβR-Ig was 
injected intravenously into pregnant females at E14 and E16, to specifically 
block the development of PPs. Live intestinal tissue of untreated and LTβR-Ig 
treated progeny was examined macroscopically to check that PPs appeared to be 
absent and MLNs present in the LTβR-Ig treated animals as expected (Figure 
4.13).  
In order to confirm that LTβR-Ig progeny lack PPs, and to show that they retain 
ILFs, Swiss-roll sections of SI were prepared. These preparations enable detailed 
examination of a large area of the intestine. Sections were stained with DAPI 
and anti-B220 to assist in the identification of ILFs. Following immunofluorescent 
staining, multiple (>100) overlapping high power images were generated and 
manually collated to visualise the detailed architecture of the SI (Figure 4.14). 
This showed that WT mice contained both PPs and ILFs, while LTβR-Ig treated 
animals contained only ILFs, but not PPs.  
  
 162 
 
 
Figure 4-13 Progeny of Mice Injected With LT-βR-Ig at Embryonic Day 14 and 16 Lack Peyer’s 
Patches But Retain Mesenteric Lymph Nodes. 
Pregnant females were injected intravenously with LTβR-Ig fusion protein at embryonic days 14 
and 16. 6-week-old progeny were examined for the presence of Peyer’s patches PPs and MLNs 
and images of live intestine were captured. Visible PPs are present in WT progeny (A) and circles 
highlight PPs, which are missing in LT-βR-Ig progeny (B). MLNs are present in both WT and LT-βR-
Ig progeny. Images are representative of 7 independent biological replicates. 
 
 163 
 
Figure 4-14 Peyer’s Patches Are Absent From the Small Intestine of LTβR-Ig Treated 
Progeny. 
Swiss roll sections were prepared from the small intestine of 6-week-old WT mice and 6-week-
old LTβR-Ig treated progeny and stained with B220 to show organised lymphoid structures and 
DAPI to show the structure of the intestine. Composite images of intestine from WT mice (A) and 
LTβR-Ig Progeny (B) were assembled from 100-150 individual high-powered images using an 
epifluoresent microscope. WT PP depicted in (C), area indicated by white box in (A) and LTβR-Ig 
treated progeny ILF in (D) area indicated by white box in (B). Pictures are representative of 8 
separate animals. 
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4.1.7  Dendritic Cell Subsets in the Mesenteric Lymph Nodes, 
Small Intestine, Colon and Migrating in Pseudo -Afferent Lymph of 
Lymphotoxin-β Receptor Fusion Protein Treated Progeny  
As I have confirmed the absence of PP, but the presence of ILFs in LTβR-Ig 
treated progeny, the DC subsets migrating from the intestine were investigated. 
As there are no PPs in LTβR-Ig treated progeny, any DCs migrating from the 
intestine must have originated in ILFs, siLP or the cLP or colonic patches. First, 
migratory DCs from the intestine were investigated by TDC. Following MLNx, 
pseudo-afferent lymph from WT or LTβR-Ig progeny was collected overnight and 
was stained for flow cytometry. DCs, (CD11c+MHCII+, CD19-, Figure 4.15 A) were 
gated and subsets were defined based upon their expression of CD103 and CD11b 
(Figure 4.15 B). This showed that four distinct DC subsets were present in similar 
numbers and percentages in both WT and LTβR-Ig progeny. In comparison to 
RORγtCD3ε deficient mice, the CD103-CD11b- DC subset was present. This shows, 
for the first time, that all four phenotypically and functionally distinct 
populations of DCs that migrate from the intestine are derived from either the 
conventional villus mucosa or ILFs. 
 
In order to confirm that injections of LTβR-Ig did not affect development of the 
MLN, or any cell populations in the MLN, the MLN was taken, digested and 
stained for flow cytometry. Live, single leukocytes (7AAD-CD45+ Figure 4.16 A) 
were gated and CD3- B220+CD19+ cells were identified as B cells (Figure 4.16 C), 
alternatively the CD3- fraction was gated into CD19-CD11c+ cells. These were 
further selected as CD4+ pDCs (Figure 4.16 B). Alternatively single live 
leukocytes were further gated as CD3+ cells and populations of T cells were 
identified (Figure 4.16 D).  The total numbers of cells in the MLN were also 
investigated. There was no significant difference in the number of cells in the 
MLN of LTβR-Ig progeny compared to WT mice (Figure 4.16). The numbers of 
pDCs, B cells, CD4+T cells and CD8α+ T cells were compared between WT mice 
and LTβR-Ig progeny. There was no significant difference between any of the 
cell populations we investigated in the MLN. This suggests that the injection of 
LTβR-Ig at E14 and E16 did not affect the development of the MLN, making this 
an excellent model in order to investigate DC migration from the intestine. 
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We used similar procedures to analyse cDC populations in the MLN of the LTβR-Ig 
treated PP null mice. This time DCs were gated; large, single leukocytes (7AAD-
CD45+) MHCII+CD19- cells were gated (Figure 4.17 A). DCs were then analysed in 
three ways; as migratory DCs, which have a higher expression of MHCII; blood 
derived DCs that have a higher expression of CD11c; or total DCs were gated 
(Figure 4.17 B). This allows a more detailed analysis of DC subsets in the MLN as 
migratory DCs coming from the SI and blood derived DCs can be analysed 
separately. Therefore, any LTβR-Ig induced defect in DCs arriving from the 
intestine or in DC precursors seeding the MLN should be identifiable by this 
gating strategy. DC subsets were defined by their expression of CD103 and CD11b 
for migratory (Figure 4.17 C), blood derived (Figure 4.17 D) or total DCs (Figure 
4.17 E). There were no significant differences between the total number or 
percentage of any subset of DC between WT or LTβR-Ig. 
 
Previously I identified that distinct areas of the MLN drain lymph from the SI and 
colon. Therefore in order to ensure that injections of LTβR-Ig in utero do not 
affect the siMLN or coMLN, an effect that could have been missed by looking at 
the entire MLN, the siMLN and coMLN were isolated and examined separately. 
These were then digested and stained for flow cytometry. Large, live leukocytes 
were gated, and the CD11c+B220- population was then selected. The CD3+B220+ 
and CD64+ populations were excluded, as were doublets (Figure 4.18 A). The 
remaining populations of DCs were then gated as migratory or as blood derived 
DCs (Figure 4.18 B), and the four DC subsets, identified by their expression of 
CD103 and CD11b, were compared between siMLN and coMLN in WT mice and 
LTβR-Ig progeny (Figure 4.18 C and D). This analysis revealed no differences 
between DC populations from WT or LTβR-Ig progeny in either the siMLN or 
coMLN.  
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Figure 4-15 Four Subsets of DCs Are Present In The Lymph of Mice Treated in Utero With 
LTβR-Ig. 
Pseudo-afferent lymph was collected from WT mice and mice treated with LTβR-Ig in utero and 
analysed by flow cytometry. Large CD19-CD11c+ cells were gated, CD11c+MHCII+ single cells were 
further selected as DCs (A). These DCs were further split into four populations based upon the 
expression of CD103 and CD11b (B) and these four subsets were compared between WT mice and 
mice treated in utero with LTβR-Ig (C). Data are means and S.E.M. Results were analysed by 
students t test, n=4. 
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Figure 4-16 Characterisation of Cell Subsets in the MLN of WT mice and Mice Treated with 
LTβR-Ig in Utero. 
Cells from the MLN of WT and 6-week-old LTβR-Ig progeny were digested and stained for flow 
cytometry. Large, single, live leukocytes (7AAD-CD45+) cells were gated (A) CD3-CD11c+CD19- 
cells were selected and CD4+CD11b- cells were identified as CD4+ pDCs (B). Alternatively live 
single CD3- B220+CD19+ leukocytes were identified as B cells (C). Single, live CD3+leukocytes were 
gated into CD4+ T cells and CD8α+ T cells (D). The percentages of these cells of total cells were 
compared (E and F), as was total cell number (G) Data are means and S.E.M. results were 
analysed by students t test. Data are means and S.E.M.  FACS plots representative of 2 
independent experiments, n=3. 
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Figure 4-17 Characterisation of Migratory and Blood Derived Dendritic Cell Subsets in the 
MLN of WT and LTβR-Ig Progeny. 
Cells from the MLN of WT and 6-week-old LTβR-Ig progeny were isolated, digested and stained 
for flow cytometry. Large, single, live leukocytes (7AAD-CD45+) were gated, and CD11c+ CD19- 
cells were gated (A). Migratory (MHCIIhiCD11c+) (C), blood derived (MHCII+CD11chi) (D) and total 
(CD11c+MHCII+) (E) dendritic cells were further gated into four subsets based upon the expression 
of CD103 and CD11b. The percentage of dendritic cell subsets of total dendritic cells were 
compared for each type of dendritic cell and results were analysed by students t test. Data are 
means and S.E.M.  FACS plots representative of 2 independent experiments, n=3.  
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Figure 4-18 Characterisation of Dendritic Cells in Small Intestinal Draining and Colonic 
Draining MLN of WT and LTβR-Ig-treated Progeny. 
Cells from the MLN of WT and 8-week-old LTβR-Ig-treated progeny were isolated, digested and 
stained for flow cytometry. Large, single, live leukocytes (7AAD-CD45+) were gated, and CD11c+ 
CD19- cells were identified (A). Migratory (MHCIIhiCD11c+), blood derived (MHCII+CD11chi), and 
total (CD11c+MHCII+) dendritic cells were each divided into four subsets based upon the 
expression of CD103 and CD11b. The percentages of each of the DC subsets of total dendritic 
cells were compared for each class of dendritic cell and results were analysed by students t test. 
FACS plots representative of 8-10 independent biological replicates. Data are means and S.E.M. 
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Having demonstrated that all DC subsets are present in the pseudo-afferent 
lymph and in siMLN and coMLN of LTβR-Ig treated progeny I sought to compare 
these with the DC subsets that are present in the SI. The SI was removed (PPs 
were excised from WT mice), the SI was digested and a single cell suspension 
was stained for multi colour flow cytometry. As described previously, ILFs were 
not removed due to their size. First, large cells were gated, then live CD45+, 
CD11c+CD64- cells were selected and doublets were excluded. Finally 
CD11c+MHCII+ cells were selected and B220+ cells were excluded (Figure 4.19 A). 
The remaining DCs subsets were compared between WT and LTβR-Ig treated 
progeny (Figure 4.19 B). The DC subsets in the SI reflected the populations in 
migrating in pseudo-afferent lymph. There were no significant differences in the 
number or percentage of any of the SI DC subsets between WT and LTβR-Ig 
treated mice. 
We next investigated the DCs in the cLP (Figure 4.20). Colons were removed and 
a single cell suspension was generated. This was stained with fluorescent 
antibodies and analysed by flow cytometry. A similar gating strategy was 
employed for the colon as was used for the SI. DCs were then gated and four DC 
populations were identified in both WT and LTβR-Ig treated progeny, at similar 
numbers and percentages. RORγtCD3ε deficient mice also did not display any 
differences in the DC populations present in the colon.  
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Figure 4-19 Four Dendritic Cell Subsets Are Present In The Small Intestinal Lamina Propria of 
Mice Treated with LTβR-Ig in Utero. 
Cells from the siLP were isolated and cells were analysed by flow cytometry from WT and 8-
week-old LTβR-Ig treated animals. Large cells were gated, and live leukocytes (7AAD-CD45+) 
were selected. CD11c+CD64- MHCII+ cells were then selected. These DCs were split into 4 
populations based upon their expression of CD103 and CD11b (B). All four populations were 
present in mice treated with LTβR-Ig in utero (C). Data are means and S.E.M. and results were 
analysed by students t test. FACS plots representative of 6 independent biological replicates.  
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Figure 4-20 DCs from The Colonic Lamina Propria of WT, and LTβR-Ig mice. 
Cells from the cLP were isolated and analysed by flow cytometry from WT and 8-week-old LTβR-
Ig treated animals. Large cells were identified, and live leukocytes (7AAD-CD45+) were gated. 
MHCII+ and CD11c+ cells were gated and doublets and F4/80+ cells were excluded (A). These DCs 
were then further split into 4 populations based upon their expression of CD103 and CD11b in WT 
mice (B, left panel) and LTβR-Ig –treated progeny (B, right panel). The total number of these 
cells were compared (C) Data are means and S.E.M. and results were analysed by students t test, 
(n=6). FACS plots representative of 6 independent biological replicates. 
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4.1.8  Development of Lymph Nodes, Spleen and Dendritic Cells 
in Lymphotoxin-β Receptor Fusion Protein Treated Progeny 
Previously it has been shown that treatment with LTβR-Ig disrupts splenic 
architecture, furthermore previous work suggested there were reduced CD4+ DCs 
in the spleen of RORγt deficient mice (P Lane, personal communication). In 
order to understand what effects this may have on DCs and other immune cells, 
we isolated the spleens of WT and LTβR-Ig treated progeny. The digestion of 
spleens generated a single cell suspension that was stained with fluorescent 
antibodies and analysed by flow cytometer. Large, live leukocytes were gated 
and single cells were selected (Figure 4.21 A). CD19+B220+ cells were then 
defined as B cells (Figure 4.21 B), B220+CD19-CD11c+ cells were defined as pDCs 
(Figure 4.21 C). Alternatively, CD3+ large live leukocytes were gated and CD4+ T 
cells and CD8α+ T cells were identified (Figure 4.21 D). The numbers and 
percentages of these cells were then compared between WT and LTβR-Ig treated 
progeny (Figure 4.21 E and F). There were no significant differences between 
any of these cell populations, suggesting that LTβR-Ig did not have a general 
effect upon the formation of immune cells in the spleen. To specifically 
investigate DCs, large, live, single CD11c+B220-, MHCII+ cells were gated (Figure 
4.22 A). DC subsets were then classified as CD8α+, CD11b+CD4+ or CD11b+CD4- 
DCs (Vremec et al., 2000) (Figure 4.22 B). There was no significant difference in 
the number of any of the DC subsets (Figure 4.22 C). This indicates that there is 
not a systemic defect in the development of DCs in the LTβR-Ig treated mice.  
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Figure 4-21 Characterisation of Cell Subsets in the Spleen of WT mice and mice treated in 
Utero with LTβR-Ig. 
Spleens from WT and LTβR-Ig mice were digested and cells stained for flow cytometry from WT 
and 8-week-old LTβR-Ig treated animals. Large, single, live leukocytes (CD45+7AAD-), were gated 
(A). B220+CD19+ cells were defined as B cells (B) and B220+CD11c+ cells were identified as pDCs 
(C). Alternatively live single leukocytes were gated as CD3+ cells, and CD4+ T cells and CD8α+ T 
cells were identified (D). The total numbers of these cells were compared (E and F) Data are 
means and S.E.M. and results were analysed by students t test. (n=4). FACS plots are 
representative of 6 independent biological replicates. 
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Figure 4-22 Characterisation of Dendritic Cell Subsets in the Spleen of WT and LTβR-Ig-
treated mice. 
Spleens of WT and LTβR-Ig-treated mice were digested and cells stained for flow cytometry from 
WT and 8-week-old LTβR-Ig treated animals. Large, live, single CD11c+B220-cells were gated (A) 
and these cells were further divided based upon their expression of CD11b, CD8α and CD4 (B). 
The total numbers of these DC populations were compared (C) Data are means and S.E.M. and 
results were analysed by students t test, (n=6). FACS plots representative of 6 independent 
biological replicates. 
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Injections of LTβR-Ig at E11 and E14 resulted in the complete inhibition of lymph 
node development (Mebius, 2003). Therefore, in order to determine whether the 
lymph nodes that develop at a similar time to PPs were unaffected by the 
injection of LTβR-Ig at E14 and E16 inguinal lymph nodes (ILN) and cervical 
lymph nodes (CLN) were examined. Cells were enumerated after digestion of the 
ILN and CLN of WT and LTβR-Ig treated mice. There were no significant 
differences in cell numbers between the ILN and CLNs of WT or LTβR-Ig treated 
mice (Figures 4.23 A and 4.24 A), suggesting that injections of LTβR-Ig did not 
affect the development of ILNs or CLNs. To confirm that the development of DCs 
in the ILN or CLNs was not affected by injections of LTβR-Ig, the DC subsets were 
investigated. Large, live leukocytes (CD45+7AAD-) were identified, and B220- 
CD11c+ single cells were gated. MHCII+ cells were then gated and DC subsets 
were examined based upon the expression of CD11b and CD8α (Figure 4.23 B and 
4.24 B). There were no differences in DC subsets between the ILNs and CLNs of 
WT and LTβR-Ig treated (Figure 4.23 C and 4.24C).   
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Figure 4-23 Characterisation of Dendritic Cell Subsets in the Inguinal Lymph Nodes of WT and 
LTβR-Ig mice. 
ILNs of WT and LTβR-Ig mice were digested and cells stained for flow cytometry from WT and 8-
week-old LTβR-Ig treated animals. The numbers of total cells were analysed (A). Large, live 
leukocytes (CD45+7AAD-), were gated and CD11c+B220- were further selected, single MHCII+CD11c+ 
cells were identified as DCs and were divided into subsets based upon their expression of CD11b 
and CD8α (B). The percentages of CD11b+ DCs and CD8α+ DCs were compared (C) Data are means 
and S.E.M. and results were analysed by students t test, (n=6). FACS plots representative of 6 
independent biological replicates. 
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Figure 4-24 Characterisation of Dendritic Cell Subsets in the Cervical Lymph Nodes of WT and 
LTβR-Ig-treated mice. 
CLNs of WT and LTβR-Ig-treated mice were digested and cells stained for flow cytometry from 
WT and 8-week-old LTβR-Ig treated animals. The numbers of total cells were analysed (A). 
Large, live leukocytes (CD45+7AAD-), were gated and CD11c+B220- were further selected. Single 
MHCII+CD11c+ cells were identified as DCs and were further divided into subsets based upon their 
expression of CD11b, CD8α (B). The percentages of CD11b+ DCs and CD8α+ DCs were compared 
(C) Data are means and S.E.M. and results were analysed by students t test. FACS plots 
representative of 6 independent biological replicates.  
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To investigate if there was a systemic defect in DCs, particularly in their 
development we generated DCs from BM grown in the DC specific growth factor 
Flt3L. Therefore, if there were any gross defects in the generation of specific 
populations of DCs these would be detected. Cells from the femurs and tibias 
were isolated from WT and LTβR-Ig treated mice. These cells were cultured in 
the presence of Flt3L for 7 days. The phenotypes of the BMDCs generated was 
compared by flow cytometry. Live cells were gated and the CD11c+ population 
was further gated upon MHCII+B220-. The percentages of DCs were compared 
between WT and LTβR-Ig treated progeny (Figure 4.25 A and B). There were no 
significant differences in the development of DCs from BM when cultured with 
Flt3L. This confirms that there is no obvious defect in the development of DCs 
from precursors, in vitro, in LTβR-Ig progeny.  
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Figure 4-25 Characterisation of Dendritic Cells Generated from Bone Marrow of WT and Mice 
Treated in Utero with LTβR-Ig. 
Bone Marrow Cells were isolated and cultured for seven days with Flt3L from WT and 6-week-old 
LTβR-Ig treated animals. Cells were harvested and stained for flow cytometry. Large, live (7AAD-
) CD11c+F4/80- cells were gated, MHCII+ B220- cells were identified as DCs (A). The percentage of 
DCs of total cells was compared (B) and results were analysed by students t test (n=6). FACS 
plots representative of 3 independent biological replicates.  
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4.2 Discussion 
I have used two separate models lacking in specific intestinal organised lymphoid 
tissues to determine the origin of DC subsets in the intestine. Determining the 
origin of migrating DC subsets will provide key information regarding how DCs 
begin to initiate an immune response. The data presented here represent a 
significant step towards a definitive characterisation of the anatomical location 
of migratory DCs in the intestine. 
 
Lymphoid tissue in the SI can be divided into effector sites that consist of 
lymphocytes scattered throughout the LP, or organised lymphoid tissue. Within 
the SI there are two distinct types of organised lymphoid tissue PPs and ILFs. PPs 
are formed before birth and remain fully developed throughout life; in 
comparison ILFs represent a spectrum of differentially developed lymphoid 
structures, they are a continuum of differentially developed lymphoid tissue. 
CPs are able to fully develop into mature ILFs in response to signals from the 
commensal flora, a process that is likely to continue throughout life although 
the function of ILFs may change with aging (Lorenz et al., 2003) (McDonald et 
al., 2011; Pabst et al., 2006). 
  
The situation in the colon is remarkably different; apart from the caecal patch, 
PPs are completely missing. Additionally, organised colonic lymphoid structures 
are developmentally different to those in the SI. They can be efficiently 
generated in the absence of LTi cells (Lochner et al., 2011), and require 
different developmental signals (Knoop et al., 2011). Furthermore, the 
formation of ILFs in the colon does not respond to commensal flora, while ILFs in 
the SI are responsive to flora (Fagarasan et al., 2002; Kweon et al., 2005). 
Therefore, lymphoid aggregates differ between the SI and colon and should be 
considered separately. 
 
4.2.1  Abrogated Lymphoid Tissue But Normal Dendritic Cell 
Development in RORγtCD3ε Deficient Mice 
To determine the anatomical origins of each of the DCs subsets, PP-free mice 
were investigated.  Several strains of transgenic mice have been described which 
lack PPs but still have intestinal DCs.  Recently Peter Lane and colleagues have 
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developed a strain of “CD3εRORγt” mice by crossing CD3εtg26 mice (CD3ε) with 
RORγt deficient mice. In the intestine RORγt is required for the development of 
lymph nodes, PPs, CPs and therefore ILFs (Eberl and Littman, 2003).  During 
foetal life, RORγt is exclusively expressed in LTi cells, a cell type that localises 
in developing lymph nodes, including MLNs, PPs and ILFs. Mature LTi cells 
interact with LTo cells, resulting in subsequent maturation of lymphoid tissue 
and the recruitment of monocytes and lymphocytes (Eberl and Littman, 2003).  
Therefore, because RORγt deficient mice lack LTi cells, they also lack LNs, PPs, 
and ILFs in the SI. However, they still posses lymphoid aggregates in the colon 
(Lochner et al., 2011). The combined phenotype of the RORγtCD3ε deficient 
mice is a lack of T cells, NK cells and LTi cells and the absence of MLNs, PPs and 
ILFs.  Although these mice lack lymph nodes, PPs and ILFs they still have DCs in 
the SI (P Lane, personal communication). Therefore any DCs migrating in the 
afferent lymph of these mice must be derived from the siLP or colon, as there 
are no PPs or ILFs.   
 
Due to the well-documented function of RORγt in LTi cells, we predicted there 
would be no PPs or ILFs in the intestine of RORγt deficient animals. In order to 
check this, Swiss-roll sections of intestine were prepared. This enabled large 
areas of SI to be investigated for the presence of PP or ILFs. As both PPs and ILFs 
are predominantly filled with B cells, sections were stained with B cell-specific 
B220, allowing visualisation of both PPs and ILFs. B220+ structures were 
identified in the intestine of CD3ε deficient mice, but not RORγtCD3ε deficient 
mice (Figure 4.3). PPs and ILFs were easily distinguished from one another by 
their size, with the larger PPs containing many more germinal centres than ILFs. 
ILFs are much smaller than PPs, being shorter but roughly twice as thick as villi 
with very closely packed lymphocytes (Kanamori et al., 1996). The lack of B220+ 
structures in the SI confirmed that RORγtCD3ε deficient mice do not contain any 
organised lymphoid tissue in the SI. 
 
Previous reports suggested that RORγt deficient mice had a reduced number of 
CD11b+CD4+ DCs in the spleen (P.Lane, personal communication). To verify this, 
cells in the spleen of RORγtCD3ε deficient mice were compared to CD3ε deficient 
and WT mice. There were no significant differences between the numbers of 
neutrophils, monocytes, pDCs and cDCs between RORγtCD3ε, CD3ε and WT mice 
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(Figure 4.9). There were also no significant difference amongst DC subsets in the 
spleens of RORγtCD3ε, CD3ε deficient mice and WT mice (Figure 4.9). These 
results contrasted with previous reports, as we detected no significant 
difference between the numbers of CD11b+CD4+ DCs in the spleens of these 
animals. The previous reports of a specific decrease of CD11b+CD4+ DCs in the 
spleen of RORγtCD3ε deficient mice were important because DC subsets arise 
from a common precursor. Therefore this could indicate that RORγtCD3ε 
deficient mice have a universal DC defect, causing there to be a defect in DC 
generation throughout the body. Splenic CD11b+CD4+ DCs normally reside in the 
marginal zone of the spleen. As there is likely to be a LTα1β2 component in the 
development to splenic white pulp, which would likely be affected in RORγCD3ε 
deficient mice due to the lack of LTi cells (Vondenhoff et al., 2008), this specific 
defect in CD11b+CD4+ DCs may be due to a lack of appropriate signals in their 
environment. However, there is a level of plasticity in the development of the 
spleen that may explain why some DCs are able to develop normally (Glanville et 
al., 2009). In contrast to previous reports, we did not find a decrease in 
CD11b+CD4+ DCs. Therefore, this previously reported decrease may represent a 
transient change in the population and that there is some flexibility in the LN 
organisation of RORγtCD3ε deficient mice. Our data suggest that there was no 
systemic defect in DC development in RORγtCD3ε deficient mice, making these 
animals a useful model to investigate DC subsets in the intestine.  
 
In order to further confirm that RORγtCD3ε deficient mice did not have a 
developmental defect in the generation of DCs, we isolated BM from RORγtCD3ε 
deficient mice and used this to generate BM DCs using Flt3L. There was no 
difference in the ability of RORγtCD3ε deficient animals to generate DC 
populations from BM in response to Flt3, compared to CD3ε and WT mice (Figure 
4.10). Therefore, these animals do not appear to have a systemic defect in DC 
development, supporting their utility for investigations of DC subsets in the 
intestine. Despite these results it remains possible that a small defect in DC 
development exists. To formally exclude this possibility, precursors could be 
sorted and injected into WT recipients. 
 
Although these mice provide a useful model for investigating DC subsets in the 
intestine, they lack all secondary lymphoid organs except a spleen. This may 
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cause specific effects in the intestine, for example the lack of MLNs has been 
shown to cause a reduction in oral tolerance. Therefore the absence of the MLN 
can change the immunological setting in the intestine, and may cause different 
subsets of DCs to migrate. Alternatively without lymphoid tissue to migrate 
towards, DCs may not migrate into the thoracic duct in the conventional 
manner. Therefore, it is important to use more than one method to investigate 
the anatomical origins of the DC subsets. It is also essential that DC subsets in 
the BM and spleen are investigated to determine if the lack of RORγtCD3ε results 
in a defect in the development of DC subsets in other tissues. 
 
4.2.2  Abrogated Peyer’s Patch But Normal Lymph Node and 
Dendritic Cell Development in LTβR-Ig Treated Progeny 
In order to elucidate the difference between DCs migrating from PPs and ILFs we 
generated mice that lack only PPs. As previously described i.v injection of LTβR-
Ig into pregnant mice at E14.5 and E17.5 results in PP-null progeny (Rennert et 
al., 1996; Rennert et al., 1998; Taylor et al., 2007). LTβR-Ig blocks interactions 
between membrane bound LTα1β2, present on the surface of lymphocytes, NK 
cells and LTi cells and the LTβ receptor that is expressed upon non-
haematopoietic cells, such as LTo cells (Tumanov et al., 2003). Mice deficient in 
LTα or LTβR lack PPs and LNs, demonstrating that this interaction is essential for 
the development of LNs and PPs. As lymphoid organs develop sequentially, 
transiently blocking this interaction with LTβR-Ig allows development of specific 
lymphoid organs to be inhibited, without affecting other LNs. LTβR blockade on 
or before E17 prevents PP development, without affecting the development of 
the MLN. These animals will retain ILFs; in fact gestational LTβR-Ig treatment is 
reported to result in enhanced ILF development (Lorenz et al., 2003). 
Additionally, these animals retain colonic lymphoid aggregates (Lorenz et al., 
2003). 
 
In comparison to RORγtCD3ε deficient mice, which lacked all secondary lymphoid 
organs, mice treated with LTβR-Ig at E14 and E16 (LTβR-Ig mice) will only lack 
PP; other lymphoid organs will be intact. Use of LTβR-Ig provides a more precise 
way to remove specific lymphoid organs. However, previous studies using LTβR-
Ig to remove PPs have shown that in the case of IgA producing B cells, there was 
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some compensation for the lack of PPs via the expansion of ILFs (Lorenz and 
Newberry, 2004). This potential expansion of ILFs should be borne in mind while 
analysing results from these animals, as it may also affect to DC subsets present 
in the PPs and ILFs. 
 
Next, we used LTβR-Ig to treat pregnant female mice and confirmed that PPs 
were absent and ILFs were present in the offspring of the treated animals. Initial 
macroscopic examination of the SI revealed the presence of complete MLN and 
the absence of PPs in all animals treated with LTβR-Ig fusion protein in utero 
(Figure 4.13). To ascertain whether in utero exposure to LTβR-Ig fusion protein 
affected the development of ILFs, we generated multiple Swiss-roll sections of 
SI, which were examined using immunofluorescence microscopy. Similar to 
Swiss-roll sections from RORγtCD3ε and CD3ε deficient mice, sections were 
stained with B220 to reveal B cell rich PPs and ILFs. Examination of these 
sections confirmed that ILF development was not affected by in utero exposure 
to LTβR-Ig fusion protein but that PP development was abrogated (Figure 4.14). 
Previously it has been reported that in utero exposure to LTβR-Ig caused an 
increase in the number of ILFs after birth (Lorenz et al., 2003). Although the 
numbers of ILFs were not assessed here, it is possible that there was an increase 
in their numbers in line with previous reports.  
 
As the development of all LNs involves the interaction between LTβR and 
LTα1β2 and therefore could be affected by injections of LTβR-Ig, it was essential 
to investigate if other LNs and cell populations within them were affected by the 
injection of LTβR-Ig. The numbers of neutrophils, monocytes, pDCs and other 
cells were not affected in the spleen of LTβR-Ig treated progeny (Figure 4.21). 
Furthermore, there were also no differences in the numbers or percentages of 
any of the DC subsets in either the ILN, CLN or spleen of mice treated with 
LTβR-Ig (Figures 4.23, 4.24 and 4.22 respectively). Therefore, as there was also 
no defect in the ability of these animals to generate DCs or other cells, this 
mouse model provides an excellent way to investigate the anatomical origins of 
DC subsets in the intestine.  
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4.2.3  Dendritic Cell Subsets In The Intestine of Mice Lacking 
Peyer’s Patches or Peyer’s Patches and Isolated Lymphoid 
Follicles 
We next investigated DCs migrating from the intestine of RORγtCD3ε deficient 
animals and mice treated with LTβR-Ig in utero. As RORγtCD3ε deficient mice do 
not have PPs or ILFs, any DCs migrating from the intestine must originate from 
the siLP or colon. In comparison, animals treated with LTβR-Ig will lack only PPs, 
ILFs are retained, and so in these animals DCs migrating from the intestine 
originate from the siLP, ILFs or the colon. In order to investigate migratory DCs 
from the intestine, TDC was performed. There are four distinct subsets of DCs 
that are able to migrate in pseudo-afferent lymph from WT untreated mice, 
identified by their expression of CD103 and CD11b. The functions of these DC 
subsets was previously discussed in Chapters 1 and 3, therefore I will here 
concentrate upon their anatomical origins in the intestine.  
 
In pseudo-afferent lymph, SI digests and colonic digests, RORγtCD3ε, CD3ε 
deficient mice and WT mice had similar percentages, and numbers of 
CD103+CD11b+ DCs. The pseudo-afferent lymph, SI and colonic digests of mice 
treated with LTβR-Ig in utero also had similar numbers and percentages of 
CD103+CD11b+ DCs. Furthermore, in mice treated with LTβR-Ig, the MLN 
CD103+CD11b+ DC population was unchanged compared to WT animals. CD103+ 
DCs have been extensively investigated in the intestine, with many groups 
showing the majority of DCs in the both the siLP and cLP are CD103+ (Jaensson 
et al., 2008; Johansson-Lindbom et al., 2005; Rivollier et al., 2012; Schulz et al., 
2009; Varol et al., 2009). Some CD103+ DCs have also been identified in PPs and 
in ILFs. In contrast to the LP, the majority of DCs in the GALT are CD103- 
(Bogunovic et al., 2009; Jaensson et al., 2008). CD103+CD11b+ DCs have 
previously been identified by immunohistochemistry in the siLP of mice and 
humans (Persson et al., 2013). The fact that CD103+CD11b+ DCs have been 
frequently identified in the siLP and the MLN makes their presence in the lymph 
of RORγtCD3ε deficient and LTβR-Ig treated mice unsurprising, as the majority of 
lymph cells are likely to be siLP derived. As RORγtCD3ε deficient mice do not 
have any SI GALT the only place from which these DCs can originate is the 
conventional villus mucosa. In contrast, colonic patches are still able to form in 
RORγtCD3ε deficient mice, and were present following digests, therefore in the 
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colon these CD103+CD11b+ DCs may be derived from either the cLP or from the 
colonic patches that will be present in the digest. However, they are likely to be 
derived mainly from the siLP as this was the largest population present in the 
migratory DC gate in the siMLN and there are fewer CD103+CD11b+ DCs in the 
colon. 
CD103+CD11b- DCs were also present in pseudo-afferent lymph in comparable 
percentages and numbers in RORγtCD3ε, CD3ε deficient and WT mice (Figure 
4.4). Furthermore they were also able to migrate from the intestine of mice 
treated with LTβR-Ig (Figure 4.15). They were present in siLP and cLP digests of 
RORγtCD3ε deficient mice and LTβR-Ig treated animals. Additionally, they were 
present in the MLN of mice treated with LTβR-Ig (Figure 4.17). Our work has 
shown these migratory CD103+CD11b- also express CD8α+ in WT mice (Cerovic et 
al., 2012). This was perhaps surprising as previous work had suggested that 
CD8α+ DCs were not present in the LP, but were a contaminant of resident DCs 
within secondary lymphoid organs, and so are not a migratory population 
(Jakubzick et al., 2008). More recently, however, CD11b- DCs have been 
identified in the LP (Fujimoto et al., 2011; Jang et al., 2006). CD8α+ DCs have 
been identified in PPs, although the majority of these are likely to be CD103- as 
there are few CD103+ DCs in PPs (Kelsall, 2008). In order to confirm the lymph 
CD103+CD11b- subset in our experiments was still reproducibility CD8α+, lymph 
from RORγtCD3ε deficient mice was stained with the CD8α specific antibody. The 
CD103+CD11b- subset was the only subset that expressed CD8α in the lymph and 
SI of RORγtCD3ε deficient mice (Figures 4.5 and 4.7 respectively). We show here 
that CD103+CD11b-CD8α+ DCs were present in pseudo-afferent lymph from 
RORγtCD3ε deficient mice and mice treated with LTβR-Ig. These data from the 
RORγtCD3ε deficient mice conclusively show, for the first time, that CD8α+ DCs 
are able to migrate from the effector site of siLP in lymph.  
These CD103+CD11b-CD8α+ DCs were also present in the lymph of LTβR-Ig treated 
animals. Therefore, it is possible that some of these cells may also be migrating 
from the ILF or colon, as well as the LP. Although, if this is possible it is likely to 
be a small number of cells as the percentages of CD103+CD11b- cells was 
comparable between RORγtCD3ε deficient mice and LTβR-Ig treated animals. 
The majority of DCs in SILT have been reported to be CD103- (Jaensson et al., 
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2008). However, CD103+CD11b-CD8α+ DCs were still present in the SI digests from 
RORγtCD3ε deficient mice (Figure 4.6). This definitively shows, for the first 
time, that these cells are present in the siLP, as RORγtDE3ε deficient animals 
have no lymphoid tissue in the SI.  
CD103-CD11b+ DCs were also identified migrating in pseudo-afferent lymph of 
RORγtCD3ε deficient mice and LTβR-Ig treated animals in comparable 
percentages and numbers to CD3ε deficient mice and WT mice (Figures 4.4 and 
4.15 respectively). They were also present in SI digests and colonic digests of 
RORγtCD3ε deficient mice and LTβR-Ig treated mice. As outlined in Chapter 3, 
the majority of previous work that identified CD11c+MHCII+CD103- cells in the LP 
has misclassified these cells as DCs. Work in our laboratory has identified a 
genuine population of CD103-CD11b+ DCs that migrate in intestinal lymph, 
expand in response to Flt3L and prime naïve T cells (Cerovic et al., 2012). The 
majority of DCs in PPs and ILFs have also been identified as being CD103-; in PPs 
there is population of CD11b+CD8α- DCs that are able to migrate from the 
subepithelial dome to the inter-follicular region after stimulation with 
Toxoplasma gondii (Cook et al., 2000). Therefore it is possible that some of 
these PP or ILF-derived cells are able to migrate in pseudo-afferent lymph. The 
published data have not yet addressed this question. However as CD103-CD11b+ 
DCs are present in the lymph of PP-null mice, they must also migrate from the 
conventional villus mucosa. This is supported by the fact these cells were also 
detected in SI digests from RORγtCD3ε deficient mice. 
CD103-CD11b- DCs were present in similar numbers and percentages in mice 
treated with LTβR-Ig and untreated WT mice (Figures 4.15 and 4.19). In 
comparison, this subset was significantly reduced in RORγtCD3ε deficient mice 
(Figures 4.4 and 4.6). Interestingly the few cells left in the CD103-CD11b- DC 
gate in RORγtCD3ε deficient mice appeared to express some CD8α (Figure 4.7), 
although this was not the case in pseudo-afferent lymph where CD103-CD11b- 
DCs were completely missing and were not analysed for their expression of CD8α 
(Figures 4.4 and 4.5) This may represent a false positive result as there are very 
few cells which were analysed for their expression of CD8α. Alternatively it may 
be that in the siLP these CD103-CD11b- DCs represents a heterogeneous 
population of cells, containing a non-migratory CD8α+CD103-CD11b- population of 
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cells that were not present in pseudo-afferent lymph. This CD103-CD11b- DC 
subset from RORγtCD3ε deficient animals should be further investigated by 
analysis of surface marker expression and sorting this population and 
determining more about its function by microarray.  
As RORγtCD3ε deficient mice lack both PPs and ILFs in the SI, while mice treated 
with LTβR-Ig are missing only PPs, data from pseudo-affererent lymph suggests 
that the CD103-CD11b- DC is likely to be derived from SI ILFs. Specifically SI ILFs 
as this population also appeared to be reduced in the colon of WT mice (Figures 
4.8, 4.20). Previously, the phenotype of ILF DCs has been investigated by 
manually separating ILFs from all other intestinal tissues followed by flow 
cytometry, or by immunohistochemistry (Jaensson et al., 2008; McDonald et al., 
2010). McDonald et al. showed that the majority of CD11c+ cells within the ILF 
were CD11b- although the expression of CD103 was detected in the ILF-derived 
DCs (McDonald et al., 2010). Jaensson et al. showed the majority of DCs in the 
SILT are CD103-, however CD11b and CD8α expression were not investigated. ILFs 
are distinct anatomical structures in the intestine, in which DCs and B cells are 
closely associated with epithelial cells. The DCs that originate here are likely to 
have been exposed to a different immune environment than LP- or PP-derived 
DCs. For example, ILFs develop only as required in response to changes in the 
enteric flora or dietary signals (Bouskra et al., 2008; Lee et al., 2012; Lorenz et 
al., 2003); once the challenge has been resolved it is likely they they regress to 
their precursor stages (Hu et al., 2011). Therefore, ILFs can be thought of as a 
dynamic response to the luminal microbial burden. This specialised environment 
could generate the features that distinguish the ILF-DCs from the other 
migrating intestinal DC populations; the presence of four DC subsets in PP null 
animals combined with our previous findings suggest that ILF DCs possess the 
CD103- CD11b- surface phenotype. We have previously shown that only CD103-
CD11b- DCs drive differentiation of naïve antigen-specific T cells towards an IL-
17-secreting phenotype, even in the absence of exogenous stimulation (Cerovic 
et al., 2012). These properties make the CD103-CD11b- ILF DCs an intriguing 
population to target for future manipulation of the intestinal immune response.  
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4.3 Conclusions 
Here I have shown that different subsets of DCs in the intestine originate from 
different anatomical origins. This provides an interesting insight into the 
organisation of the intestinal immune response, as well as providing potential 
avenues by which to target specific DC subsets with defined functions. 
 
We identified CD103+CD11b+ DCs migrating from the intestine in RORγtCD3ε 
deficient mice and PP-null LTβR-Ig treated mice. Therefore, these CD103+CD11b+ 
DCs are present in the siLP. This finding was somewhat expected as they have 
previously been identified as the most numerous subset in the siLP and were 
identified by immunofluorescence (Persson et al., 2013; Schulz et al., 2009). 
Earlier work has shown that migratory CD103+ DCs are essential in the induction 
of oral tolerance to soluble antigen, via the production of RA inducing gut-
homing receptors on antigen-specific T cells and promoting TGF-β dependent 
Foxp3+ Tregs (Coombes et al., 2007; Pabst et al., 2007; Sun et al., 2007). 
Indeed, the induction of oral tolerance has been associated with an increase in 
the percentage of CD103+CD11b+ DCs (Shiokawa et al., 2009). As DCs in the siLP 
are able to sample small soluble antigen (Chirdo et al., 2005), the presence of 
CD103+CD11b+ DCs in the siLP fits with the reported ability of this cell type to 
gain access to small soluble molecules, migrate to the MLN and produce a 
tolerogenic response. More recent work has shown that CD103+CD11b+ DCs in the 
intestine are able to play a role in Th17 cell differentiation via the production of 
IL-6, under conditions of inflammation (Persson et al., 2013). Th17 cells play an 
essential role in protecting the intestine against extracellular bacteria and fungi 
in the intestine, and promoting tissue repair (Reviewed by (Huber et al., 2012)). 
If there is a breach in the integrity of the epithelial barrier by an infectious 
agent, this abundant subset of DCs is able to respond. Therefore this 
CD103+CD11b+ DC subset is able to not only induce a tolerogenic response to 
soluble antigens, but can also induce an immunogenic response in certain 
conditions. Thus, they are ideally located in the siLP to achieve their function. 
  
We have also confirmed the presence of CD103+CD11b-CD8α+ DCs migrating in 
the intestine, and have shown that these originate from the LP. Previously, 
CD8α+ DCs were presumed to de derived only from lymphoid tissue. However we 
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and others, have now shown that these are located in the siLP (Cerovic et al., 
2012; Fujimoto et al., 2011). In lymphoid tissues the functions of CD8α+ DCs is to 
cross present exogenous antigen to CD8+ T cells, which is essential in order for 
the generation of a CTL response. In the intestine CD103+CD11b-CD8α+ DCs are 
also likely play a role in the cross presentation of peripheral antigen, such as 
intestinal epithelial cells, directly to CD8α+ T cells (V. Cerovic, personal 
communication). Therefore if the function of CD8α+ DCs is to detect apoptotic or 
virally infected cells they would have to be located in the siLP, as well as other 
peripheral tissues such as the lung (Desch et al., 2011). Here I have confirmed 
that CD103+CD11b-CD8α+ DCs are present in the siLP, making them ideally 
located for the uptake of apoptotic intestinal epithelial cells. This constantly 
overturning population of cells is the front line of the mucosal barrier, therefore 
the presence of CD103+CD11b-CD8α+ DCs is likely to represent a constant immune 
supervision of these vulnerable cells. 
 
We recently described a genuine population of CD103-CD11b+ DCs that were able 
to migrate in pseudo-afferent lymph (Cerovic et al., 2012). Here I have shown 
that these cells are present in the siLP, as they were observed migrating in both 
RORγtCD3ε deficient mice and LTβR-Ig treated animals. As this is a newly 
described subset of migratory DCs, there is less information regarding its 
function in vivo. However some theories of its function, and why this subset is 
present in the siLP can be can be speculated from in vitro studies. CD103-CD11b+ 
DCs in the intestine represent only around 15% of migratory DCs, they can 
present antigen to naïve T cells and induce the presence of gut homing receptors 
on responding T cells. CD103-CD11b+ DCs were the only subset able to induce 
IFN-γ producing T cells in the absence of overt stimulation, as well as this they 
were are induce IL-17 producing T cells (Cerovic et al., 2012). As the majority of 
LP DCs are specialised to produce a tolerogenic response to harmless antigens, 
these DCs could represent a robust way in which the immune response can 
quickly respond to pathogenic challenge. Therefore their presence in the siLP 
alongside CD103+ DCs would be essential, however a tolerogenic response would 
be favoured due to the larger numbers of CD103+ DCs. 
 
CD103-CD11b- DCs are also a newly described population of genuine DCs in the 
siLP (Cerovic et al., 2012). Here, I have shown that CD103-CD11b- DCs migrate 
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from SI ILFs, as these were missing in RORγtCD3ε deficient mice but present in 
LTβR-Ig progeny. Furthermore, this population did not appear to be present 
following cLP digests of WT mice. This is the smallest population of DCs in the 
siLP, accounting for less than 10% of total DCs. It also exclusively induced IL-17 
producing T cells in the absence of overt stimulation (Cerovic et al., 2012). 
Recent work has shown that mice deficient in Th17 cells were unable to produce 
T cell dependent antigen specific IgA (Hirota et al., 2013). As ILFs are a dynamic 
lymphoid tissue that are able to produce antigen specific IgA, an IL-17 producing 
subset of CD103-CD11b- DCs originating from here is a reasonable conclusion. 
 
The data I have presented here show that three functionally distinct subsets of 
DCs are able to migrate from the siLP, while one subset of CD103-CD11b- DCs are 
likely to migrate from ILFs. However, it does not discount the possibility that 
some DCs may also originate from PPs.  
 
  
 193 
Chapter 5:  Dendritic Cell Migration 
From Peyer’s Patches to the 
Mesenteric Lymph Nodes 
 
PPs are secondary lymphoid organs that form part of the GALT. They are sites 
for the initiation of both immunostimulatory and immunomodulatory responses 
in the SI (Sato and Iwasaki, 2005). They share common features with other 
secondary LNs, such as the presence of follicular B cell and T cell regions. 
However they also have unique features such as the presence of M cells for the 
capture and processing of particulate luminal antigen, and the ability to initiate 
antigen specific immune responses against M cell derived antigen (Kraehenbuhl 
and Neutra, 2000). DCs are present throughout the PPs, where they are essential 
for the processing and presentation of antigen. Iwasaki and Kelsall identified 
three populations of DCs based upon their expression of CD11b and CD8α. They 
showed these different subsets had distinct functions, and were present in 
discrete parts of the PP (Iwasaki and Kelsall, 2001). In contrast others have used 
CD103 and CD11b to define DC subsets in the PPs, where they also identify three 
subsets (Bogunovic et al., 2009). 
 
Although we have shown that no specific MLN or intestinal lymph DC subset was 
missing from PP-free mice, we did not directly investigate whether migration of 
DCs from PPs to MLN was possible. This is a long-standing area of uncertainty in 
the field. Previous reports have suggested that there may be some migration 
from the PP to the MLN in rodents, however this has not been directly assessed 
(Macpherson and Uhr, 2004). MacPherson and Uhr demonstrated commensal 
bacteria were able to gain access to the MLN, however they did not show if this 
was via the PP or the siLP. Similarly, Pron et al. demonstrated in rats that 
Listeria monocytogenes was present in the MLN following intra luminal 
administration (Pron et al., 2001). Although, similar to MacPherson and Uhr, 
they did not provide direct evidence that PP DCs were transporting bacteria to 
the MLN.  
 
 194 
It is important to understand if PP DCs are able to migrate to the MLN for a 
number of reasons. Firstly PP and LP DCs are likely to transport antigen acquired 
via different routes, fully functional M cells are only present in GALT therefore 
PPs are specialised for the uptake of particulate antigen (Knoop et al., 2009; 
McDole et al., 2012). Secondly, the microenvironment differs between the PPs 
and the MLN. For example, PPs DCs have been shown to produce higher levels of 
TGF-β than MLN DCs; upon bacterial stimulation this was present with a 
concomitant rise in IL-6 that may promote the synthesis of secretory IgA (Fink 
and Frokiaer, 2008). Therefore DCs from PPs may be specialised for class 
switching to IgA and have been shown to preferentially induce a Th2 type 
response (Iwasaki and Kelsall, 1999). Although DCs from the PP and MLN share 
considerable functional overlap, there are some key differences meaning they 
likely to play different physiological roles. For example delayed-type 
hypersensitivity responses were not inhibited by the adoptive transfer of PP DCs 
from OVA fed mice, but upon transfer of DCs from siLP this delayed type 
hypersensitivity was inhibited (Chirdo et al., 2005). Therefore MLN DCs are 
required for systemic tolerance to orally administered antigen, PP DCs alone 
appear unable to generate this type of response. Furthermore, there have been 
reports that PP mononuclear cells were not as proficient in causing proliferation 
of naïve T cells as MLN mononuclear cells (Jump and Levine, 2002). Therefore, it 
is essential to determine if DCs can migrate to the MLN and identify these cells 
in the context of recent advances in the identification of phenotypically and 
functionally distinct DC populations in the mucosa. 
 
5.1 Results 
5.1.1  Dendritic Cells from the Peyer’s Patches Migrate to the 
Mesenteric Lymph Nodes in Kaede Mice 
To determine if DCs are able to migrate from PPs to the MLN, we used a PP-
photoconversion protocol similar to a recently-described method (Cyster and 
Schwab, 2012) for the photoconversion of PP in kaede mice. As described in 
Chapter 3 kaede mice express the kaede protein that is irreversibly 
photoconverted by UV light. This makes them an excellent tool to investigate DC 
migration in the intestine. In this experiment, all visible PPs were 
photoconverted for 2 minutes each while the MLN and LP were shielded from the 
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violet light. The animal was allowed to recover and 24 hours later siMLN and 
coMLN were removed, digested separately, and the numbers and percentage of 
kaede-red+ DCs were assessed. Cells were stained with antibodies for flow 
cytometry and analysed. The gating strategy was consistent throughout the 
experiment. First, large cells were gated, and dead B220+ cells, and doublets 
were excluded. MHCII+CD11c+ DCs were selected (Figure 5.1 A), and kaede-red+ 
DCs were identified in the siMLN (Figure 5.1 B). They were not present in the 
coMLN (Figure 5.1 C). This was the first direct evidence that DCs are able to 
migrate from PPs to the MLN. Specifically, DCs migrate from the PP to the 
siMLN, which I have shown to specifically drain the SI, where the PPs are 
located. 
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Figure 5-1 DCs Originating in the Peyer’s Patches Migrate to Specific Parts of the Mesenteric 
Lymph Node. 
The PPs of photoconvertible kaede mice were exposed to violet light for two minutes each, 
avoiding the surrounding SI. The siMLN and coMLN were removed 24 hours later and digested. 
DCs were gated as F4/80-B220-, single MHCII+CD11c+ cells (A) and kaede-red+ DCs were observed 
and analysed in the siMLN (B) and coMLN (C). Results are representative of three separate 
experiments with similar results and each point represents and individual animal. A students t 
test was performed **p<0.01. 
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To interpret these data, it was important to investigate how efficient 
photoconversion was in PPs. This would allow an estimation of how effective the 
photoconversion technique was for PP DCs. Thus, PPs were removed from mice 
that had not undergone photoconversion, from mice immediately after 
photoconversion was performed, and from mice that had undergone 
photoconversion 24 hours previously. PPs were carefully isolated from the SI and 
digested to produce a single cell suspension. These cells were labelled for flow 
cytometry and DCs were gated as large, live, B220-, single cells, MHCII+CD11c+ 
cells (Figure 5.2 A). The percentage of kaede-red+ cells amongst these DCs was 
assessed (Figure 5.2 B). There were significantly more kaede-red+ DCs in PPs 
immediately after photoconversion (70%) than in to mice that had not undergone 
photoconversion. The percentage, and the total number (data not shown), of 
kaede-red+ DCs significantly decreased to around 50% after 24 hours (Figure 5.2 
C). Therefore, approximately 70% of DCs were photoconverted in the PP. 
Subsequently; approximately 1% of DCs in the siMLN became photoconverted, as 
shown above. Thus, we can conclude that around 1.4% of DCs in the siMLN were 
of PP origin at 24 hours. 
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Figure 5-2 Peyer’s Patch DCs Express Kaede-Red After Photoconversion. 
The PPs of photoconvertible kaede mice were exposed to violet light for two minutes each, 
avoiding the surrounding SI. PPs were isolated, pooled and digested from individual animals that 
either did not undergo photoconversion, immediately after photoconversion, or 24 hours after 
photoconversion. DCs were gated as F4/80-B220-, single MHCII+CD11c+ cells (A) and the presence 
of kaede-red+ DCs was observed and analysed for each group (B and C). Each point represents 
PPs pooled from an individual animal. A one way ANOVA was performed, *p<0.05,  ***P<0.001. 
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In order to confirm there was no contamination from the siLP during the 
photoconversion of PPs, resulting in kaede-red+ DCs from the siLP contaminating 
our analysis, I digested the SI immediately after photoconversion. Any DCs in the 
siLP that were accidentally labelled should be evident in the siLP digestion. 
Once the SI was isolated, PPs were carefully removed and the SI was digested. 
Cells were labelled and analysed by flow cytometry. Large, live, CD45+, B220-, 
CD64- cells were selected. MHCII+CD11c+ single DCs were gated (Figure 5.3 A) 
and the presence of kaede-red+ cells was investigated (Figure 5.3 B). There were 
no kaede-red+ DCs in the SI immediately after photoconversion (Figure 5.3 C). 
The entire SI was acquired following photoconversion, to ensure that no 
contaminating cells were missed. In fact, there were no photoconverted cells at 
all in the siLP (data not shown). Therefore, it can be concluded that the 
photoconversion of PPs does not result in the detectable photoconversion of DCs 
in the LP. Thus all kaede-red+ cells have originated from the PPs, and are not 
the result of contamination by the photoconversion of DCs in the LP. 
As an additional control, I wanted to ascertain whether the kaede-red+ DCs 
detected in the MLN were migrating from PP, or were contaminating 
photoconverted cells directly from the siMLN and coMLN during the PP-
photoconversion technique. Therefore the siMLN and coMLN were isolated and 
digested immediately after PP-photoconversion. Cells were labelled for flow 
cytometry and DCs were gated as large, CD45+, B220-, live, single, MHCII+CD11c+ 
cells (Figure 5.4 A). The expression of kaede-red in DCs in the siMLN (Figure 5.4 
B) and coMLN (Figure 5.4 C) were compared. There were no kaede-red+ cells in 
either the siMLN or coMLN immediately after PP photoconversion. Therefore, the 
photoconversion of PPs does not result in photoconversion of cells directly in the 
siMLN or coMLN. 
Taken together, these results confirm that following PP photoconversion the 
only kaede-red+ DCs were in the PPs. There was no photoconversion of DCs in the 
siLP, siMLN or coMLN, meaning it is unlikely that the presence of kaede-red+ DCs 
in the siMLN was due to accidental photoconversion of tissues other than the 
PPs. Therefore, approximately 1.4% of DCs in the siMLN are of PP origin. These 
experiments offer the first direct evidence that PP DCs are able to migrate to 
the MLN.  
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Figure 5-3 Lamina Propria DCs Do Not Express Kaede-Red After Peyer’s Patch 
Photoconversion. 
The PPs of photoconvertible kaede mice were exposed to violet light for two minutes each, 
avoiding the surrounding SI. siLP was isolated and digested from animals that did not undergo 
photoconversion and from animals immediately after photoconversion. DCs were gated as live 
CD45+, CD64-, single MHCII+CD11c+ cells (A) and the presence of kaede-red+ DCs was observed and 
analysed for each group (B and C). Each point represents an individual animal and a students t 
test was performed. 
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Figure 5-4 Small Intestinal Draining MLN and Colonic Draining MLN DCs Do Not Express Kaede-
Red Immediately After Peyer’s Patch Photoconversion. 
The PPs of photoconvertible kaede mice were exposed to violet light for two minutes each, 
avoiding the surrounding SI. siMLN and coMLN were isolated and digested from animals that did 
not undergo photoconversion and from animals immediately after photoconversion. DCs were 
gated gated as live CD45+, B220-, single MHCII+CD11c+ cells (A) and the presence of kaede-red+ 
DCs was observed and analysed for siMLN and coMLN (B and C). Each point represents an 
individual animal and a students t test was performed. 
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5.1.2  Dendritic Cells Migrating From Peyer’s Patches to the 
Mesenteric Lymph Nodes Expand In Response to Flt3 Ligand 
Next I addressed the ontogeny of these DCs migrating from the PP, by 
determining if they would expand in response to the DC specific growth factor 
Flt3L. Kaede mice were treated with recombinant Flt3L for 10 days; this is 
known to result in the specific expansion of DCs (Cerovic et al., 2012; Schulz et 
al., 2009). After the treatment of kaede mice with Flt3L for 9 days, I performed 
photoconversion of the PPs and gave the final administration of Flt3L.  
I confirmed that PP DCs expanded in response to 9 days treatment with Flt3L. 
PPs were carefully excised from the SI and digested to form a single cell 
suspension. Cells were then labelled and analysed for flow cytometry. DCs were 
gated as large, B220-, F4/80-, single, CD11c+MHCII+ cells (Figure 5.5 A). The 
administration of Flt3L resulted in a significant increase in the number and 
percentage of DCs in the PP (Figure 5.5 B). This confirms, in line with previous 
reports, that Flt3L expands the DC populations in the PP.  
Mice were allowed to recover overnight, and the siMLN and coMLN were 
removed. These were digested separately and labelled and analysed by flow 
cytometry, DCs were gated as large, B220-, F4/80-, single, MHCII+CD11c+ cells 
(Figure 5.6 A).  Cells that had not undergone photoconversion were used to 
define the gates for kaede-red+ cells (Figure 5.6 B). In mice that had undergone 
photoconversion there was a significant increase in kaede-red+ DCs in the siMLN. 
These kaede-red+ DCs were not present in the coMLN (Figure 5.6 C). In mice that 
had been treated with Flt3L there was a significant increase in the percentage 
and number of kaede-red+ DCs (Figure 5.6 D). As we have previously shown that 
these kaede-red+ DCs were derived from the PPs after PP photoconversion, we 
can conclude that these kaede-red+ cells in the siMLN are PP derived. 
Therefore, taken together our data demonstrate that the PP DCs that migrate to 
the siMLN expand in response to Flt3L. As Flt3L is a DC specific growth factor 
this confirms that the migrating kaede-red+ PP-derived population we observe 
are bona-fide DCs. 
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Figure 5-5 Peyer’s Patch Dendritic Cells Expand In Response to Flt3 Ligand. 
Photoconvertable kaede mice were injected for 10 days with Flt3L i.p and Peyer’s patches were 
removed and digested. DCs were gated as large, CD11c+, F4/80-, B220- MHCII+ cells (A) and the 
percentage of DCs among total cells was observed and analysed (B). Results are representative 
of two separate experiments with similar results and each point represents an individual animal. 
A students t test was performed, **p<0.01. 
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Figure 5-6 Migratory Peyer’s Patch Dendritic Cells in the MLN Expand In Response to Flt3 
Ligand. 
Photoconvertable kaede mice were injected for 10 days with Flt3L i.p, after 9 days the PPs of 
photoconvertible kaede mice were exposed to violet light for two minutes each, avoiding the 
surrounding SI. 24 hours later the siMLN and coMLN were removed, digested and stained for flow 
cytometry. DCs were gated as B220-, CD64-, MHCII+CD11c+ single cells (A) and the presence of 
kaede-red+ DCs in the siMLN and coMLN of non-photoconverted mice (B), and the siMLN and 
coMLN of photoconverted mice with and without Flt3L was assessed(C). The percentage of 
kaede-red+ DCs of total cells was analysed (D). Results are representative of two separate 
experiments with similar results and each point represents an individual animal. A students t test 
was performed. * p<0.05, **p<0.01. 
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5.1.3  Dendritic Cells From Peyer’s Patches Migrate in Pseudo-
Afferent Lymph 
I next wanted to confirm that these migratory PP DCs were able to migrate in 
pseudo-afferent lymph, a defining feature of DCs. Kaede mice underwent MLNx 
and 5-6 weeks later TDC was performed. Following cannulation, PP 
photoconversion was performed. Animals were then allowed to recover and 
pseudo-afferent lymph was collected overnight. The lymph was processed and 
stained with antibodies for analysis by flow cytometry. Large, MHCII+, CD19-, 
CD11c+ single DCs were gated (Figure 5.7 A) and the presence of kaede-red+ DCs 
was assessed (Figure 5.7 B). There were significantly more kaede-red+ DCs in the 
lymph of mice that had undergone PP photoconversion compared to animals that 
had not undergone PP photoconversion (Figure 5.7 C). Interestingly following PP 
photoconversion, approximately 8% of DCs migrating in lymph were kaede-red+ 
indicating they were of PP origin. 
5.1.4  Subsets of DCs Migrating From the Peyer’s Patches to the 
Mesenteric Lymph Node 
As described in previous chapters, we have identified four distinct subsets of DCs 
that are able to migrate from the SI to the MLN. Therefore, I investigated 
whether DCs that migrate from the PP were of any specific DC subset. Following 
the cannulation of kaede mice that had undergone PP photoconversion, cells 
were analysed by flow cytometry. DCs were gated as large, CD19-, MHCII+, 
CD11c+, single cells (Figure 5.8 A). These DCs were then split into four subsets 
based on their expression of CD11b and CD103, as were PP DCs (Figure 5.8 B). 
The percentage of each DC subset was compared between PP DCs, 
photoconverted kaede-red+ DCs from lymph and non-photoconverted kaede-
green+ DCs from lymph. There was no significant difference in the percentage of 
CD103+CD11b- DCs, CD103-CD11b+ DCs, or CD103-CD11b- DCs between PP DCs, 
kaede-red+ lymph DCs and kaede-green+ lymph DCs (Figure 5.8 C). In 
comparison, there were significantly more CD103+CD11b+ DCs among the kaede-
green+ siLP derived DCs, than there were CD103+CD11b+ DCs among the PP and 
kaede-red+ DCs migrating in lymph (Figure 5.8 C). There were no significant 
differences in the percentage of any DC subset between PP DCs and kaede-red+ 
DCs migrating in lymph following in PP photoconversion. Thus, the subset 
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composition of kaede-red+ DCs reflects that seen in the PPs, providing additional 
evidence that these DCs are PP derived. 
  
 207 
 
Figure 5-7 Migratory Peyer’s Patch Dendritic Cells Migrate in Lymph. 
Photoconvertible kaede mice underwent MLNx, 5-6 weeks later thoracic duct cannulation was 
performed. PPs were then exposed to violet light for two minutes each, avoiding the surrounding 
SI. Pseudo-afferent lymph was collected overnight then processed and stained for flow 
cytometry. DCs were gated as CD19-, MHCII+, CD11c+ single cells (A), and the presence of kaede-
red+ DCs in the lymph of non-photoconverted animals and photoconverted animals was compared 
(B). The percentage of kaede-red+ DCs among total DCs was analysed (C). Each point represents 
an individual animal. A students t test was performed. *p<0.05. 
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Figure 5-8 Subsets of Migratory Peyer’s Patch Dendritic Cells In Psuedo-Afferent Lymph. 
Photoconvertible kaede mice underwent MLNx, 5-6 weeks later thoracic duct cannulation was 
performed. PPs of photoconvertible kaede mice were then exposed to violet light for two 
minutes each, avoiding the surrounding SI. Pseudo-afferent lymph was collected overnight then 
processed and stained for flow cytometry. DCs were gated as large, live, B220-, MHCII+CD11c+ 
single cells (A), and four distinct subsets of DCs based upon their CD103 and CD11b expression 
were identified in kaede-red- DCs, kaede-red+ DCs and PP DCs (B). The percentage of each subset 
of total DCs was assessed and analysed (C). Results are presented as mean of 10 individual 
animals, error bars represent S.E.M. A one-way ANOVA was performed *p<0.05, **p<0.01.  
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5.1.5  Dendritic Cells from the Peyer’s Patches Migrate to the 
Mesenteric Lymph Nodes Following FITC Injection 
In order to confirm a proportion of PP DCs migrate to the siMLN, and to 
investigate the molecular mechanisms that control this migration, we performed 
FITC injections into the PPs. FITC injections into the PP were pioneered by the 
Pabst group, and involve the injection of a precise small volume of liquid under 
high pressure using a micro-injector. This allows the labelling of cells within the 
PPs, without labelling the surrounding LP. 
We performed the FITC injection technique into all accessible PPs. 24 hours 
later the siMLN and coMLN were removed and digested separately. Cells were 
labelled for flow cytometry and large, B220-, MHCII+CD11c+ single cells were 
selected as DCs (Figure 5.9 A). The presence of FITC+ cells amongst DCs in the 
siMLN and coMLN were compared to mice that had received a PP injection of PBS 
(Figure 5.9 B). There were significantly more FITC+ DCs in the siMLN of animals 
that had undergone PP FITC+ injection than in the coMLN, and no FITC+ DCs were 
detectable in the siMLN or coMLN of animals that had received PP injections of 
PBS (Figure 5.9 C). This indicates, in line with our kaede experiments that PP 
DCs are able to migrate to the siMLN. Consistent with our previous data these 
migratory PP DCs were found specifically in the siMLN, not the coMLN.  
In order to confirm that the FITC we were injecting did not contaminate the 
surrounding siLP, leading to a false positive result, the siLP was isolated, 
digested and the presence of FITC+ cells was assessed after the injection of PBS 
or FITC into PPs and after subserosal injection of FITC into the tissue surrounding 
the PPs. The SI was then isolated, digested and stained for flow cytometry. DCs 
were gated as large, CD45+ live, B220-, CD11c+ MHCII+ cells (Figure 5.10 A). The 
presence of FITC+ DCs following the injection of PBS into PPs, the injection of 
FITC into PPs, and the subserosal injection of FITC into the SI tissue surrounding 
the PPs was investigated (Figure 5.10 B). There were no FITC+ DCs in the SI 
following the injection of PBS into PPs, nor were there any following FITC 
injection of PPS. In comparison there was a significant population of FITC+ DCs 
following the subserosal injection of FITC into the SI (Figure 5.10 C). Therefore, 
following FITC injection into the PPs there is no FITC leakage into the 
surrounding SI.   
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Figure 5-9 Peyer’s Patch Dendritic Cells Migrate to the Small Intestinal Draining MLN 
Following FITC Injection. 
All accessible PPs were microinjected with FITC. 24 hours later the siMLN and coMLN were 
isolated, digested separately and stained for flow cytometry. DCs were gated as large, B220-, 
MHCII+CD11c+ single cells (A), and the presence of FITC+ DCs in the siMLN and coMLN of FITC 
injected and non-injected mice was assessed (B). The percentage of FITC+ DCs of total cells was 
assessed (C). Results show one individual experiment, but are representative of at least 6 
separate experiments with similar results. Each point represents an individual animal. A two way 
ANOVA was performed *p<0.05. 
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Figure 5-10 FITC+ DCs Are Not Present in the Small Intestinal Lamina Propria Following 
Peyer’s Patch Injection. 
All accessible PPs were microinjected with FITC, or the surrounding SI was subserosally injected 
with FITC. Immediately after the SI was removed, digested and stained for flow cytometry. DCs 
were gated as large, live, CD45+, B220-, CD11c+, CD64-, MHCII+ single cells (A) and the presence 
of FITC+ DCs was assessed (B). The percentage of FITC+ DCs of total DCs was assessed (C). Each 
point represents an individual animal. A one way ANOVA was performed with post test. *p<0.05. 
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5.1.6  Dendritic Cells Migrating From Peyer’s Patches to the 
Mesenteric Lymph Nodes Do Not Expand In Response to R848 or 
Cholera Toxin 
Cholera toxin (CT) is a powerful mucosal adjuvant, and has previously been 
shown to increase the numbers of mature DCs in the MLN (Anjuere et al., 2004). 
Additionally, it has been shown to mobilise DCs within the PPs, with a rapid 
influx of DCs into the FAE followed by DC migration from the SED to T cell areas 
of the PP after 24 hours (Anosova et al., 2008). The TLR7/8 ligand, R848, has 
also been shown to have a powerful effect upon mucosal DCs. Following oral 
administration of R848 there is a complete loss of LP DCs with a responding 
increase in the MLN, as well as a dramatically altered distribution of PP DCs 
(Yrlid et al., 2006c). Therefore, we decided to investigate the effects of CT and 
R848 upon the migration of PP DCs to the siMLN. 
FITC injections were performed and 10µg of CT or 10µg R848 or PBS was 
administered orally once the animal was fully recovered. 24 hours later the 
siMLN was isolated, enzymatically digested, stained for flow cytometry and 
analysed. DCs were gated as large, B220-, single; MHCII+CD11c+ cells (Figure 5. 
11 A). FITC+ DCs were gated, and compared between animals that had received 
oral PBS, CT or R848 (Figure 5.11 B and C). There was no significant increase in 
the percentage of FITC+ DCs of total cells in the siMLN after any of the 
treatments. 
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Figure 5-11 Neither Cholera Toxin or R848 Increase Peyer’s Patch Dendritic Cells Migration 
to the Small Intestinal Draining MLN. 
All accessible PPs were microinjected with FITC. Immediately after mice had recovered they 
were fed with either PBS, cholera toxin or R848. 24 hours later the siMLN were digested 
separately and stained for flow cytometry. The presence of FITC+ DCs in the siMLN of mice fed 
PBS, CT or R848 was assessed (B). The percentage of FITC+ DCs of total cells was assessed (C). 
Each point represents an individual animal. A one-way ANOVA was performed. 
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5.1.7  Dendritic Cells Migrating From Peyer’s Patches to the 
Mesenteric Lymph Nodes Are Dependent Upon CCR7 and S1PR 
A defining feature of migratory DCs is their expression of CCR7, which enables 
their constitutive migration to LNs (Jang et al., 2006). Consequently genetic 
deficiency in CCR7 results in a loss of all migratory DCs in the MLN, and 
therefore a lack of recognition of fed antigen by T cells in the MLN (Worbs et al., 
2006). Therefore, FITC injections were performed in CCR7-/- mice to confirm 
that DCs migrating from the PP to the MLN were bona-fide DCs. Following FITC 
injection into WT and CCR7-/- mice the siMLN was isolated digested and stained 
for flow cytometry. Large, B220-, MHCII+CD11c+ single cells were gated as DCs 
(Figure 5.12 A), and the percentage of FITC+ DCs of total DCs was assessed in WT 
and CCR7-/- animals (Figure 5.12 B and C). Injection of FITC into PPs of CCR7-/- 
mice revealed that significantly fewer FITC+ DCs were detected in CCR7-/- mice, 
again confirming that these are likely to be bona-fide migratory DCs.  
The immunosuppressant FTY720 induces the sequestration of circulating mature 
lymphocytes in lymphoid tissues, including PPs by acting upon one of the five 
S1P receptors (Yanagawa and Onoe, 2003). There have also been reports 
suggesting that it may also affect DC migration; Lan et al. reported that animals 
treated with an analogue of FTY720 showed reduced transendothelial migration 
towards CCL19 (Lan et al., 2005). However, in vivo reports suggested that 
blocking of S1P receptors did not have an effect upon the number of DCs 
migrating from the intestine in pseudo-afferent lymph of rats (S. Milling, 
personal communication). Therefore, we decided to investigate the effect of 
FTY720 upon the migration of DCs from the PPs to the siMLN. Immediately prior 
to FITC injections, 20µg FTY720 was administered and siMLN were isolated 24 
hours later. The siMLN was digested and stained for flow cytometry. DCs were 
gated as large, B220- MHCII+CD11c+ single cells (Figure 5.13 A). The number and 
percentage of FITC+ DCs was assessed (Figure 5.13 B and C). There were 
significantly fewer PP migratory DCs detected in the MLN of mice following 
treatment with FTY720. These experiments were performed alongside the FITC 
injection of CCR7-/- mice therefore they share controls. 
The fact that FTY720 inhibits migration of DCs from the PP to the MLN indicates 
that this process is dependent upon one of the sphingosine-1-phosphate 
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receptors (S1PRs); FTY720 acts upon five separate S1PRs to block S1PR-
dependent cell migration. We therefore sought to determine which of these G 
protein coupled receptors is expressed upon PP migratory DCs, and controls the 
migration of PP migratory DCs. Therefore we repeated the PP FITC injections in 
mice that lack S1PR3, EDG3-/-. 24 hours after FITC injection, the siMLN was 
digested and stained for flow cytometry. DCs were gated as large, B220- 
MHCII+CD11c+ single cells (Figure 5.14 A). The number and percentage of FITC+ 
DCs was assessed (Figure 5.14 B and C). In the EDG3-/- mice no defects were 
observed in the migration of DCs from the PP, indicating that S1PR3 does not 
control the migration of PP DCs to the MLN.  
  
 216 
 
Figure 5-12 Peyer’s Patch Dendritic Cells That Migrate to the Small Intestinal Draining MLN 
Following FITC Injection Are Missing from CCR7-/- Mice. 
All accessible PPs were microinjected in WT and CCR7-/- mice. 24 hours later the small intestinal 
draining MLN were isolated, digested and stained for flow cytometry. DCs were gated as large, 
B220-, CD11c+MHCII+ single cells (A), and the presence of FITC+ DCs in the MLN of WT and CCR7-/- 
mice was assessed (B). The percentage of FITC+ DCs of total cells was analysed (C). Results are 
representative of 2 separate experiments with similar results. Data are means and S.E.M. A 
students t test was performed. *p<0.05, n=3 per group.  
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Figure 5-13 Peyer’s Patch Dendritic Cells That Migrate to the Small Intestinal Draining MLN 
Following FITC Injection are Missing In FTY720 Treated Animals. 
Before performing FITC injections into each accessible Peyer’s patch animals were fed with 
FTY720 and mice fed with PBS. 24 hours later the small intestinal draining MLN were isolated, 
digested and stained for flow cytometry. DCs were gated as large, B220-, CD11c+MHCII+ single 
cells (A), and the presence of FITC+ DCs in the MLN of untreated and FTY720 treated mice was 
assessed (B). The percentage of FITC+ DCs of total cells was assessed (C). Results are 
representative of at lease 2 separate experiments with similar results. Data are means and 
S.E.M. A students t test was performed. *p<0.05, n=6.  
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Figure 5-14 Peyer’s Patch Dendritic Cells That Migrate to the Small Intestinal Draining MLN 
Following FITC Injection Are Present In EDG3-/- Mice. 
All accessible PPs were microinjected in WT and EDG3-/- mice. 24 hours later the small intestinal 
draining MLN were isolated, digested and stained for flow cytometry. DCs were gated as large, 
B220-, CD11c+MHCII+ single cells (A), and the presence of FITC+ DCs in the siMLN of WT and EDG3-
/- mice was assessed (B). The percentage of FITC+ DCs of total cells was analysed (C). Results are 
representative of at least 2 separate experiments with similar results and each point represents 
an individual animal. A students t test was performed.  
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5.1.8  Subsets of DCs Migrating From the Peyer’s Patches to the 
Mesenteric Lymph Node 
Next, the phenotype of DCs migrating from the PPs to the siMLN following FITC 
injection was investigated. As described previously, PP migratory DCs isolated 
following kaede experiments were more similar to PP DCs. This was 
demonstrated by a reduction in CD103+CD11b+ kaede-red+ DCs in the MLN 
compared to kaede-green+ DCs. Making the kaede-red+ DCs in the MLN more 
similar to PP DCs. Therefore, 24 hours after FITC injections into the PPs the 
siMLN was removed, digested and stained for flow cytometry. DCs were gated as 
large B220-, MHCII+CD11c+ single cells and FITC+ and FITC- DCs were gated (Figure 
5.15A), the four DC subsets were identified based upon the expression of CD103 
and CD11b (Figure 5.15 B). There were no significant differences in the 
percentage of any DC subset between the FITC+ or FITC- DC populations (Figure 
5.15 C). This was in contrast with results from kaede experiments, in which the 
percentage of CD103+CD11b+ DC was significantly lower in PP migratory DCs 
compared to LP migratory DCs.  Next, the same FITC+ DC subsets from the siMLN 
were compared to PP DCs (Figure 5.15 D). There was no significant difference 
between the proportions of DCs in each subset, when compared between FITC+ 
DCs in the siMLN and PP DCs (Figure 5.15 E).   
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Figure 5-15 Subsets of Migratory Peyer’s Patch Dendritic Cells in the Small Intestinal Draining 
MLN Following FITC Injection. 
All accessible PPs were microinjected in mice. 24 hours later the small intestinal draining MLN 
were isolated, digested and stained for flow cytometry. DCs were gated as large, B220-, 
CD11c+MHCII+ single cells (A), and four distinct subsets of MLN DCs based upon CD103 and CD11b 
expression were gated in FITC+ DCs, FITC- DCs, and in the total DCs of PBS injected mice in the 
MLN were gated (B). The percentage of each subset of total DCs was assessed and analysed (C). 
FITC+ DC subsets were also compared to total PP DC subsets (D) and and the percentage of each 
subset of total DCs was assessed and analysed (E). A one-way ANOVA was used to compare 
different conditions (C) and a two way ANOVA was performed to compare subsets from the PP 
and MLN (E). Data are means and S.E.M. N=6 for MLN, n=3 for PP DC subsets. 
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5.2 Discussion 
Conclusively determining whether PP DCs are able to migrate to the MLN is 
essential. DCs migrating from PPs to the MLN represent an important pathway by 
which antigen, which has been acquired in an immunologically distinct 
environment can reach the MLN. Here we present, using two different 
experimental approaches, definitive evidence that DCs can migrate from the PP 
to the MLN. 
 
PPs consist of large B cell follicles with intervening T cell areas; they are 
separated from the intestinal lumen by a single layer of cells known as the 
follicle-associated epithelium. One of the most significant features of the 
follicle-associated epithelium is the presence of fully differentiated functional M 
cells (Kraehenbuhl and Neutra, 2000). M cells are capable of promiscuously 
binding to a wide variety of antigens expressed upon the surface of bacteria and 
viruses to transport these antigenic materials across the intestinal barrier. This 
process is particularly suited to the uptake of large particulate antigen, such as 
bacteria (Schulz and Pabst, 2013). Immediately under the follicle-associated 
epithelium is the DC rich subepithelial dome. DCs in this region are ideally 
located to capture antigen transported into the PP by M cells. Following antigen 
uptake, DCs are able to migrate to the T cell rich areas known as the 
interfollicular region (Iwasaki and Kelsall, 2000). 
 
There is evidence to show that organised lymphoid structures in the SI are 
necessary for the recognition of particulate antigens (Macpherson et al., 2008). 
The role of PP DCs in the induction of oral tolerance is less clear; it has been 
reported that targeting antigen to M cells can facilitate the induction of 
tolerance (Suzuki et al., 2008), however others have shown that there is normal 
oral tolerance in PP-null mice (Spahn et al., 2001; Spahn et al., 2002). In 
comparison, mice lacking both PP and MLN have decreased oral tolerance and 
this defect can be rescued by restoring the development of the MLN (Spahn et 
al., 2002). Furthermore the removal of MLN, or the inability of DCs to migrate to 
the MLN results in a complete lack of oral tolerance (Worbs et al., 2006). 
Therefore, while the MLN is essential for the generation of oral tolerance, DCs 
isolated directly from PPs may behave in a different manner. For instance, 
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delayed-type hypersensitivity to orally primed antigen was reduced upon 
adoptive transfer of DCs from the MLN, but not PPs (Chirdo et al., 2005).  
Instead, DCs in the PP are likely to play a key role in the immune response to 
commensal and pathogenic bacteria by driving the production of IgA. The 
production of IL-10, TGF-β and IL-6 by PP DCs results in the secretion of IL-4 and 
IL-10 from responding CD4+ T cells, and all of these cytokines play a role in class 
switching to IgA (Sato et al., 2003) (Iwasaki and Kelsall, 1999) (Brandtzaeg and 
Johansen, 2005). Additionally, DCs are able to directly present antigen to B, 
cells inducing them to undergo class switching to IgA via the production of IL-5, 
Il-6 and retinoic acid (Mora et al., 2006). IgA class switching is not confined to 
PP DCs, as PP-deficient mice induced IgA production in the MLN, and IgA class 
switching has been demonstrated in GALT (Yamamoto et al., 2000). Therefore, 
in order to manipulate the intestinal immune system with specificity it is 
essential to understand where antigens and acquired, and in which tissues they 
are presented. 
5.2.1  Dendritic Cells from the Peyer’s Patches Migrate to the 
Mesenteric Lymph Nodes 
Previous work has provided indirect evidence that DCs are able to migrate from 
PPs to the MLN (Macpherson and Uhr, 2004; Pron et al., 2001). Macpherson and 
Uhr first showed that DCs carrying the commensal bacteria Enterobacter colacae 
were present in the MLN. Since these bacteria were likely to be primarily taken 
up in the PPs, and were observed in the MLN, the authors postulated that 
bacteria were transported to the MLN by PP-derived DCs. However, macrophages 
in the MLN were also found to contain bacteria.  As it is well documented that 
macrophages do not migrate from the intestine to the MLN (Schulz et al., 2009), 
this suggests that the movement of bacteria from PP to the MLN may not be 
entirely cell dependent; bacteria free in lymph may thus migrate to the MLN. 
Alternatively, there may be some transfer of bacteria between cells. This work, 
therefore, does not conclusively show that DCs migrate from the PP to the MLN.  
Similarly Pron et al. showed that L. monocytogenes specifically gained entry into 
PPs, and were found in the MLN (Pron et al., 2001). However, similar to 
Macpherson and Uhr, there remained the possibility that bacteria could either 
migrate in a non-cell dependent manner or be transferred between cells. 
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Therefore, this was not conclusive evidence that DCs can migrate from the PPs 
to the MLN.  
In contrast, there have been others that have argued that DCs do not migrate 
from the PPs. For example, due to the abundance of chemokines essential for DC 
trafficking within the PPs, it was suggested that DCs would be contained to the 
PP (Kelsall, 2008). In addition, Bogunovic et al. suggested that there was no 
migration from PPs to the MLN because in Id2-/- mice, which lack PPs and ILFs, 
there was a specific lack of CD103+CD11b- DCs (Bogunovic et al., 2009). This led 
the authors to postulate that these cells were specifically from lymphoid tissues 
in the intestine, and were therefore not a migratory population. The suggestion 
that DCs do not migrate from the PP to the MLN under steady-state conditions 
has been further perpetuated by a study in minipigs, in which the authors 
compared the phenotypes of DCs in the PPs, MLNs and pseudo-afferent lymph 
and concluded that DCs were unable to migrate from PP to the MLN (Bimczok et 
al., 2005). However this study was incomplete as they did not deplete PPs or 
label PPs to investigate this further. 
Together these conflicting studies do not fully address the question whether DCs 
migrate from PP to the MLN. Using several novel approaches we are now able to 
definitively show that DCs are able to migrate from the PPs to the MLN.  
Firstly, photoconvertible kaede mice were used to address the question of 
whether DCs migrate from PP to the MLN. We were able to specifically 
photoconvert DCs in PPs, without affecting DCs in the surrounding LP or the 
MLN. Immediately following photoconversion of PPs, we showed that 
approximately 70% PPs DCs were photoconverted (Figure 5.2). This decreased to 
around 50% after 24 hours, and correspondingly we were able to detect 
photoconverted DCs in the MLN (Figure 5.1). As we know that we label only 
around 70% of PP DCs, we are able to calculate that approximately 1.4% of all 
DCs in the MLN were of PP origin. Specifically, the PP DCs migrated to the siMLN, 
not the coMLN. This was expected, as we showed in Chapter 3 that there is 
anatomical segregation of drainage to the MLN, and PPs are located only in the 
SI. These PP DC migration data further validate our conclusion regarding the 
anatomical segregation of lymphatic drainage in the intestine. As antigen 
acquired in the PPs is specifically carried only to the siMLN, this may contribute 
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to the functional differences between the siMLN and coMLN. We were also able 
to identify these photoconverted PP DCs migrating in pseudo-afferent lymph 
following TDC. This confirms that these cells are a population of bona-fide 
migratory DCs (Figure 5.7). In accordance with the results in kaede mice, we 
were also able to detect DCs migrating from PPs to the siMLN following FITC 
injections into the PP (Figure 5.9). This technique also only labels cells in the 
PP, without labelling cells in the surrounding LP (Figure 5.10). Therefore, using 
two separate techniques DCs were observed migrating from PPs to the MLN. 
 
The results from the kaede mice and FITC injections both indicate that DCs are 
able, under specific circumstances, to migrate from one secondary lymphoid 
tissue (PP) to another (the MLN). This migration of DCs in efferent lymphatic 
vessels is highly unusual and has not been observed in other tissues or species in 
the steady-state (Cerovic et al., 2012; Schwartz-Cornil et al., 2006) (Howard et 
al., 1995). There have been reports in sheep that topical administration of the 
chemical carcinogen 7,12-dimethylbenz(a)antharcene (DMBA) or Beryllium may 
cause the migration of Langerhan cells or DCs in efferent lymphatics, traversing 
the LN (Dandie et al., 1994; Hall and Smith, 1971). However, these conditions do 
not represent the physiological steady-state, nor the normal response to a 
pathogen, and the observed DC migration may have been cause by major 
disturbances due to the toxicity of the adjuvants administered. Although our 
studies require laparotomy, and may therefore not fully represent the steady-
state, we have not previously observed the migration of detectable numbers of 
DCs in efferent lymphatics (Cerovic et al., 2012). Further experiments using 
particulate fluorescent particles, or antigen that has been targeted to M cells, 
both of which should be taken up specifically by the PPs, could be used to 
investigate this process under steady-state conditions.  
 
5.2.2  Dendritic Cells Migrating From Peyer’s Patches to the 
Mesenteric Lymph Nodes Expand In Response to Flt3 Ligand 
Flt3L and its receptor Flt3 represent the major interaction that drive the 
generation of steady-state DC subsets from BM progenitors in vivo (Naik et al., 
2005). Additionally in vitro Flt3L generated DCs have a close phenotypical 
correspondence to splenic resident DC subsets, in comparison to the cells 
generated in CFS-2 cultures that resemble inflammatory DCs (Inaba et al., 1992). 
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In the intestine we found that LP DCs expressed levels of Flt3 mRNA 100 times 
higher than macrophages (Cerovic et al., 2012). Furthermore, we showed that 
administration of recombinant Flt3L induced a significant expansion of DCs in 
the LP and intestinal lymph without affecting the number of macrophages 
(Cerovic et al., 2012). 
 
Therefore, we hypothesised that the administration of Flt3L would increase the 
number and percentage of DCs migrating from the PPs to the MLN. In line with 
previous reports (Castellaneta et al., 2004), we found a significant increase in 
the number and percentage of PP DCs following the administration of Flt3L 
(Figure 5.5). Following the photoconversion of PPs in Flt3L treated kaede mice, 
compared to kaede mice that did not receive Flt3L; there was a significant 
increase in the number of PP DCs migrating to the MLN. As Flt3L is a DC specific 
growth factor, this strongly indicates that PP-migratory cells that we have 
described are bona-fide DCs.  
 
5.2.3  Proportions of Dendritic Cells Migrating From Peyer’s 
Patches to the Mesenteric Lymph Nodes Do Not Increase in 
Response to R848 or Cholera Toxin 
As we had shown that PP DCs migrating to the MLN expand in response to Flt3L, 
we sought to determine if conditions of inflammation could result in an increase 
of this population. We first investigated the DCs’ response to the TLR7/8 agonist 
R848. Previous work has demonstrated that orally-administered R848 induced a 
20 to 30-fold increase in DC output from the intestine (Yrlid et al., 2006c). This 
increase in DC migration was likely due to total release of DCs from the LP. 
Although no decrease in the total numbers of DCs in the PP was observed, there 
was an altered distribution of PP DCs. In response to R848, DCs from the 
subepithelial dome moved into the interfollicular T cell areas (Yrlid et al., 
2006c). Thus, although R848 does not empty the PPs of DCs, it can induce DC 
migration within the MLN. Therefore, we investigated the effect of R848 
administration on DC migration from the PPs to the MLN. Following 
administration of R848 there was no increase in DCs migrating from the PP to the 
MLN (Figure 5.11). Therefore, the response to R848 represents a difference 
between LP DCs and PP DCs. R848 induces migration of DCs from the LP, and this 
process is TNFα and IFNα dependent (Yrlid et al., 2006c). PP responsiveness to 
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these cytokines could be investigated, and this may reveal an important 
functional difference between PP and LP derived DCs. In order to investigate this 
further, DC egress in response to TNFα or IFNα may be studied. This would allow 
us to determine if there is one particular cytokine which PP DCs respond 
differently to compared to LP DCs. Alternatively DC migration from the PP to the 
MLN can be investigated under conditions of inflammation caused by a bacterial 
agent, rather than an adjuvant, in the PP could be compared to R848. 
 
Next, we investigated the effect of CT on DCs migrating from PPs to the MLN. 
Unlike R848, CT is a large complex molecule with a mass of around 85 kDa. 
Additionally it has previously been shown to rapidly gain access to the PPs via M 
cells, where it is delivered to the subepithelal dome region (Frey et al., 1996; 
Shreedhar et al., 2003). Like R848, it has been shown to induce the migration of 
DCs within the PP without affecting the overall number of PP DCs (Anjuere et 
al., 2004). CT was able to induce the migration of subepithelial DCs to 
interfollicular T cell areas (Anosova et al., 2008). Therefore, we hypothesised 
that the number of PP DCs migrating to the MLN would be increased following 
the administration of CT. However, there was no significant increase in the 
migration of PP DCs to the MLN following the administration of CT (Figure 5.11). 
Initially this was surprising, as previous work has shown that administration of CT 
results in DC maturation and upregulation of CCR7 (Bagley et al., 2002). In 
contrast, it was also shown that administration of CT results in the migration of 
DCs towards the follicle associated epithelium (Anosova et al., 2008), rather 
than towards T cell zones as an upregualtion of CCR7 would suggest. Instead CT 
may result in the increased expression of CCL20 in the follicle associated 
epithelium, as has been shown in other the villus epithelium (Anjuere et al., 
2004). Therefore upon CT administration there may be upregulation of CCL20 
and CCL19 in the follicle associated epithelium which may provide a stronger 
signal for DCs to migrate towards, compared to T cell zones or draining 
lymphatic vessels. This may explain the apparent lack of increase in DC 
migration from the PPs to the draining MLN. Further time points could be 
investigated to determine if once DCs migrate out of the follicle associated 
epithelium there would be a resultant increase in DC migration to the MLN.  
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These results show that there was no significant increase in DC migration form 
the PP to the MLN following the administration of R848 or CT. In order to further 
investigate these cells other mucosal adjuvants such as heat-liable enterotoxin 
from E. coli could be investigated to determine if these can cause and increase 
of PP migratory DCs. Furthermore the effect of pathogens that specifically 
target PP M cells for their entry, such as L. monocytogenes or S. enterica, upon 
PP DC migration could be investigated. This may give us further insight into the 
mechanism of action, or function of these cells and provide key insights into 
ways to manipulate these PP migratory DCs. 
 
5.2.4  Dendritic Cells Migrating From Peyer’s Patches to the 
Mesenteric Lymph Nodes Are Dependent Upon CCR7 and S1PR 
Under both steady-state and pro-inflammatory conditions migratory DCs must 
express the lymph node homing chemokine receptor CCR7. The inability to do 
so, in CCR7-/- mice, leads to a defect in DC migration to lymph nodes and results 
in less than one tenth the number of DCs in the lymph node (Jang et al., 2006; 
Randolph et al., 2005). In the intestine, CCR7-/- mice have normal numbers of 
PPs as well as normal populations of DCs in the LP (Worbs et al., 2006). 
However, as LP DCs are unable to migrate to the MLN there is a defect in the 
generation of oral tolerance (Worbs et al., 2006). Therefore, we hypothesised 
that the migration of PP DCs to the MLN would be abolished in CCR7-/- mice. To 
test this hypothesis, we performed FITC injections in these animals. The results 
showed that the migration of PP DCs to the MLN was dependent upon CCR7 
(Figure 5.12). This further confirms that these cells are genuine migratory DCs; 
they behave in a similar way to DCs from non-lymphoid tissue. This conclusively 
shows that the movement of antigen from PPs is cell dependent, specifically DC 
dependent, because without CCR7 there were no FITC+ DCs in the MLN. 
Therefore, this is the first time that it has been conclusively shown that the 
transport of material from PPs to the MLN is cell dependent. 
 
Next we investigated the effects of FTY720 upon DCs migrating from PPs to the 
MLN. FTY720 is phosphorylated in vivo to its active metabolite, which can bind 
one of the five S1PRs. In vivo it can act to render lymphocytes unresponsive to 
S1P, thus depriving them of a signal required to egress from lymphoid organs. Its 
effect upon DCs in the lung and skin has also been investigated. It has been 
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shown that FTY720 caused a reduction in DCs migrating from the lung to the 
mediastinal LNs, in both mice that had been challenged with allergen and in 
naïve mice (Idzko et al., 2006). Similarly, following FITC skin paining there was a 
decrease in DCs migrating to the draining LN (Czeloth et al., 2005). The 
mechanism of action of FTY720 upon DCs remains controversial, with some 
attributing its effects to be due to an impaired response to CCR7 (Lan et al., 
2005). Others attribute its effects to a downregulation of S1PR1 (Czeloth et al., 
2005). When a FTY720 analogue was previously administered to rats, a decrease 
in the number of DCs migrating in lymph following TDC of MLNx animals was not 
observed (S Milling, personal communication). Therefore, although FTY720 does 
not appear to affect the majority of intestinal DCs, we investigated the effect of 
FTY720 upon DCs migrating from PPs to the MLN. Following FTY720 
administration, the migration of DCs from the PPs to the MLN was abolished 
(Figure 5.13). This suggests that the molecular mechanism controlling the 
migration of DCs from the PPs is unlike that used by DCs that migrate from the 
conventional villus mucosa. The ability of PP DCs to migrate to the MLN in an S1P 
dependent manner is line with the ability of these cells to migrate from one 
secondary lymphoid organ to another, such as T or B cells.  
 
We next investigated which of the S1PRs might be required for DCs to migrate 
from the PP to the MLN. Previous work has shown that signaling through S1PR1 
and S1PR3 mediated migration, while the action of S1PR2 antagonised it 
(Sanchez and Hla, 2004). Therefore, we made use of EDG3-/- mice, which are 
deficient in S1PR3, to investigate if this was essential for PP DCs migration to 
the MLN. We found that in EDG3-/- mice there was no change in the number or 
percentage of DCs migrating from the PPs to the MLN (Figure 5.14). Previous in 
vitro work has shown that S1PR3 is essential for the mature DC migration and 
their endocytotic capability (Maeda et al., 2007). Therefore, it may be that the 
PP DCs that migrate to the MLN may be similar to LP DCs, which migrate in a 
‘semi-mature’ state (Milling et al., 2010), and hence were unaffected by the 
lack of S1PR3 signalling. Future work could make use of the wide array of 
pharmacological agents and mouse models that can specifically target each of 
the S1PR signalling pathways to determine specifically which of the S1PRs 
FTY720 is acting upon to abolish the migration of PP DCs to the MLN. 
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5.2.5  Subsets of DCs Migrating From the Peyer’s Patches to the 
Mesenteric Lymph Node 
We next examined the subsets of DCs migrating from the PPs to the MLN. Much 
work has investigated DC subsets in the MLN, identified by their expression of 
CD103, CD11b and CD8α. As we have used CD103 and CD11b to define DC 
subsets, we continue to use these markers to investigate the DC subsets from 
the PP in the MLN. Much of the previous work in PPs used CD11b and CD8α to 
investigate DC subsets (Iwasaki and Kelsall, 2001). This showed there were three 
subsets of CD11c+ DC subsets in the PP, present in different locations. CD8α+ DCs 
were observed within the interfollicular regions of the PPs and were shown to 
express CCR7. CD11b+ DCs were observed in the subepithelial dome and were 
able to upregulate CCR7 and migrate to the interfollicular regions. CD11b+ DCs 
express CCR6. Additionally a third, double negative subset was found in both the 
interfollicular region and the subepithelial dome (Iwasaki and Kelsall, 2001). 
More recent work has shown this double negative subset may be comprised of 
two subsets, separated by their expression of CX3CR1 and lysozyme M (Lelouard 
et al., 2012). CD103+ DCs have also been identified in the PPs (Bogunovic et al., 
2009; Jaensson et al., 2008). Although the majority of DCs in the PPs are CD103-, 
currently it is unclear how these relate to the previously defined subsets. 
 
Following photoconversion of PPs, subsets of migratory PP DCs in the MLN were 
investigated. Photoconverted DCs were compared to non-converted DCs in the 
MLN and PP DCs. There was only one significant difference when comparing 
between DC subsets in the PPs, photoconverted DCs in the MLN, and non-
photoconverted DCs in the MLN. We found that there were significantly fewer 
CD103+CD11b+ photoconverted DCs from PPs in the MLN, compared to non-
converted DCs. These non-converted DCs are likely to represent mostly DCs 
derived from the LP, as we have shown that we photoconvert the majority of 
DCs from the PP. There were also significantly fewer CD103+CD11b+ DCs in PPs 
compared to the MLN (Figure 5.8). These data indicate that the photoconverted 
DCs in the MLN have a surface phenotype highly very similar to of PP DCs. As 
CD103+CD11b+ DCs are the most numerous subset in the siLP, this is consistent 
with the fact that photoconverted DCs in the MLN are PP derived. In comparison, 
following FITC injection, although there were fewer FITC+ CD103+CD11b+ DCs in 
the MLN compared to FITC- DCs, this difference was not significant. There were 
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no significant differences between DC subsets amongst FITC+ DCs from PP in the 
MLN and FITC- DCs in the MLN. There were also no significant differences 
between FITC+ DCs in the MLN and PP DCs (Figure 5.15). The reason for the 
difference is subset composition between kaede-red+ DCs and FITC+ DCs in the 
MLN may be due to a number of factors. Firstly, investigations of subsets of DCs 
following photoconversion have been completed on a larger sample size. 
Therefore, in further repeats of FITC injections the difference in CD103+CD11b+ 
cells between FITC+ and FITC- DCs may become significant. Another reason for 
the observed difference in subset composition of DCs migrating to the MLN 
following photoconversion or FITC injection may be due to the labelling 
technique used. FITC is a soluble molecule, while photoconversion induces a 
conformational change in proteins present within cells. It is be possible that FITC 
is transferred to DCs within the MLN in a different manner than photoconverted 
kaede. These data show that migration from the PP to the MLN is not a property 
of only one specific subset of DCs. Further work is required to define the 
properties of the DCs that migrate from the PP to the MLN, and the molecular 
mechanisms that control this migration. 
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5.3 Conclusions 
We show here that migrating DC populations that reach the MLN can be 
separated, both by their specific tissue of origin, and by the molecular 
mechanisms that control their migration. These findings demonstrate a new way 
by which the intestinal immune system communicates. Furthermore, they open 
new avenues for controlling the functions of intestinal DCs, and therefore 
manipulating the intestinal immune response, with exquisite precision. 
 
DC migration from PPs to the MLN is likely to be the main route by which 
particulate antigen gains access to the MLN in the steady-state, although this 
should be further verified. Therefore, these DCs represent an opportunity to 
discover novel functions of the intestinal immune system, and to manipulate 
them. For example, this PP to MLN route is likely to be the way in which 
commensal bacteria and pathogenic bacteria gain access to the MLN. Therefore 
a possible treatment strategy could be to target these DCs via M cells in the 
context of bacterial infections to prevent their dissemination. Alternatively, 
increasing migration of PP DCs to the MLN may prove to be beneficial under 
some conditions, for example when inducing vaccine responses using particulate 
antigen. However, to maximize these opportunities we first must fully 
understand the function of these cells. 
 
 
The function of the DCs that migrate to the MLN from the PPs remain unclear; it 
may be that in order to generate an effective T cell response, a proportion of PP 
DCs must first migrate to the MLN. Previous work has shown that PP DCs were 
less efficient in inducing antigen-specific T cell activation in vivo (Chirdo et al., 
2005). Indeed, some work has suggested that they may in fact suppress T cell 
responses in vitro (Jump and Levine, 2002). The cooperation between PP and 
MLN to promote a functional T cell response has already been demonstrated 
(Kwa et al., 2006). Kwa et al. showed that the immune response to Eimeria 
vermiformis, which requires a rapid Th1 response, was delayed in PP-null mice. 
They attributed this to an observed delay in the increase of CD11b+ DCs in the 
MLN, presumably originating from PPs.  
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Further work should be carried out to investigate the functions of these cells. 
Primarily a full phenotypic analysis should be performed, using available 
antibodies and mRNA expression analysis, as the presence of up or down 
regulated molecules may generate insights into the functions of these cells. 
Second, these cells should be purified and used to stimulate naïve T cells in 
vitro and in vivo. This would begin to give and idea of the type of immune 
response these DCs are specailised to perform.  
 
Additionally, it would be interesting to study these DCs under conditions of 
bacterial infection to determine their role. This may also provide insight into 
mechanisms by which the systemic immune response remains ignorant of 
intestinal microbiota, and how this ignorance breached in some conditions. 
Furthermore, investigating the migration of these DCs that may carry commensal 
microorganisms following treatment with antibiotics to disturb the normal 
microbiota may also provide interesting insights into how these cells react under 
conditions of dysbiosis. 
 
Finally, these cells may provide a novel way to generate oral vaccines with 
exquisite specificity, as they appear to be distinct from LP DCs. Determining the 
functional differences between these PP migratory DCs and LP DCs therefore is 
of paramount importance.  
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Chapter 6:  Final Discussion 
In the preceding chapters I have provided a comprehensive, detailed and up to 
date examination of the migration of DC subsets in the intestine. In addition, I 
have discussed the relevance of my results to published data regarding the 
functions of these subsets. In this final chapter I will provide an overview of the 
novel insights into DC migration I have described, and give an account of how 
these may allow us to manipulate the intestinal immune system.  
 
I have shown that the SI and colon drain to distinct LNs, which can be analysed 
separately. I have also shown that different subsets of DCs in the intestine 
originate in different anatomical locations, with all but one DC subset being 
present in the siLP. Surprisingly, CD103+CD8α+ DCs are not restricted to 
intestinal lymphoid tissues and are present in the siLP, while CD103-CD11b- DCs 
are derived only from ILFs in the SI. Furthermore, I have conclusively 
demonstrated, for the first time, that DCs are able to migrate from PPs to the 
siMLN. These data are depicted in figure 6.1. 
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Figure 6-1 Dendritic Cell Subsets in the Small Intestine and Colon and Draining Mesenteric 
Lymph Nodes. 
The lymphatics of the small intestine (SI) and colon drain to distinct parts of the MLN: the siMLN 
and coMLN respectively. Afferent lymphatic vessels are depicted in purple. CD103+CD11b+ (red), 
CD103+CD11b-CD8α+ (blue), and CD103-CD11b+ (green) dendritic cells (DCs) are located in the SI 
lamina propria, Peyer’s patches (PPs) and colon. The draining lymph nodes for each of these 
distinct anatomical locations are depicted. CD103-CD11b- (orange) DCs are present only in SI 
isolated lymphoid tissues (ILFs), and migrate to the siMLN. 
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I have described the anatomical segregation between lymphatic drainage of DCs 
in the SI and colon. Future work examining immune responses in the SI and colon 
should isolate these LNs separately: independent analyses of the siMLN and 
coMLN will enable a more refined understanding of intestinal immune responses. 
This may reveal much about differences in DC biology between the SI and colon, 
both in the steady-state and under conditions of inflammation. Additionally, 
small changes in cell populations that may have been missed entirely may now 
become apparent upon careful examination of specific draining LNs. Differences 
in lymphatic drainage to distinct parts of the MLN may, in part, explain the 
mechanism by which different immune responses are achived in the SI and 
colon. For example, food proteins in the SI induce both local and systemic 
tolerance, while in the colon there is no systemic response to bacteria, meaning 
the immune system is acting differently. This allows the immune system to 
respond differently to food and bacteria depending upon their location in the 
intestinal tract. Because these different responses are initiated in the 
anatomically-distinct siMLN and coMLN, it is likely that DCs in the siMLN and 
coMLN are functionally distinct. These differences could be exploited to target 
the type of immune response required by specific oral vaccines. For example to 
generate a systemic immune response to a pathogen that may enter via the 
intestine or other routes, it would be preferable to target DCs in the SI.  
Another key difference between the SI and colon is in disease models. For 
example UC causes a massive influx of cells in the cLP accompanied by 
inflammation, yet there is little change in the siLP. One theory to explain the 
difference in effect in the SI and colon is that T cells primed in the siMLN by DCs 
from the SI selectively home to the siLP, while colonic DCs prime T cells in the 
coMLN which home to the colon. Differential homing, induced in the siMLN or 
coMLN would require SI- or colon-specific T cell homing receptors, the blocking 
of which may ameliorate inflammatory symptoms of disease. If indeed such T 
cell specific homing molecules exist, there are many applications by which their 
upregulation, or down-regulation may enhance tolerance or alleviate diseases. 
An intriguing difference between the SI and colon was apparent in their DC 
subset compositions. The SI had the largest population of CD103+CD11b+ DCs, 
while in the colon the CD103+CD8α+ DCs were the largest subset. These CD103+ 
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subsets share considerable functional overlap in terms of the generation of oral 
tolerance (Welty et al., 2013) but the functional relevance of this change in 
subset composition needs further investigation. The differences in DC subset 
composition are likely to reflect differences in the cytokine microenvironments 
between the SI and colon. Recent work in the Mowat laboratory has shown that 
there may be a developmental continuum between CD103-CD11b+ DCs and 
CD103+CD11b+ DCs in the LP (C. Scott, personal communication). As CD103- DCs 
display a more immunogenic phenotype, the reduced number of the 
CD103+CD11b+ DCs in the colon compared to the SI may be due to a more 
immunogenic environment in the colon compared to the SI, which prevents the 
differentiation of these cells into CD103+CD11b+ DCs. CD103+CD11b+ DCs have 
been shown to be essential for the generation of a Th17 response, which, in the 
SI, this is essential in order to mount a response to Citrobacter rodentium 
(Ivanov et al., 2009). Therefore, the differences between CD103+CD11b+ DCs in 
the SI and colon may have evolved to counter the different microbial species 
present in the tissues. Furthermore, an exacerbated Th17 response is associated 
with CD (Ogino et al., 2013), so it may be beneficial for the colon to have an 
expanded population of CD103+CD8α+ DCs, instead of CD103+CD11b+ DCs. These 
CD103+CD8α+ DCs that are able to mediate many of the same tolerogenic 
responses as CD103+CD11b+ DCs, while being less likely to induce pathogenic 
Th17 responses. The consequences of these newly-identified differences 
between DC migration in the SI and colon are far reaching. They should be 
considered in the context of immune responses in the SI and colon. 
I have shown that different subsets of DCs in the intestine originate from 
different anatomical locations. This provides an interesting insight into the 
organisation of the intestinal immune response, as well as providing potential 
avenues by which to target specific DC subsets with defined functions. First, I 
showed that CD103+CD11b+, CD103+CD11b-CD8α+ and CD103-CD11b+ DCs were all 
present in the siLP and cLP. Of these subsets, the presence of CD8α+ DCs was 
most notable. It had been suggested that CD8α+ DCs were only present in 
organised lymphoid tissues. However, we and others, have now conclusively 
shown that CD8α+ DCs are present in other tissues, including the LP and lung 
(Cerovic et al., 2012; Desch et al., 2011; Fujimoto et al., 2011). CD8α+ DCs are 
the only DC subset capable of cross-presenting exogenously derived antigen and 
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inducing a strong CTL response. The observation that CD8α+ DCs are present in 
the LP provides a mechanism by which DCs are able to instigate a primary 
immune response to virally infected cells in the intestine. This information can 
also be used to manipulate the immune system. As such, targeting CD8α+ DCs 
will result in a strong CTL response which would be beneficial for anti-viral and 
anti-tumour immunity. These cells can now be specifically targeted in both the 
SI and colon to provide new treatment avenues. 
 
My data show that three functionally distinct subsets of DCs are able to migrate 
from the siLP and cLP, while one subset of CD103-CD11b- DCs is likely to migrate 
from SI ILFs. This ILF-resident population of DCs warrants much further study, 
and is likely to represent an excellent opportunity to specifically target the 
generation of a SI immune response. The CD103-CD11b- DCs induce the 
production IL-17 from developing T cells, even without exogenous stimulation. 
Therefore, the ability to target this population of DCs would be useful in 
generating a Th17 type response. Compared to DCs from the LP, CD103-CD11b- 
DCs would perhaps present an easier target. They are only present in the SI, 
specifically within ILFs. Therefore, by targeting ILFs, one can specifically target 
CD103-CD11b- DCs which may allow for a more controlled activation of the 
immune response. 
 
I have also presented data that show that DCs are able to migrate from PPs to 
the siMLN. This is a long-standing area of controversy in the field. Previous 
reports have suggested that there may be some migration of DCs from the PP to 
the MLN, however this has never been directly assessed (Macpherson and Uhr, 
2004). It is important to understand whether or not PP DCs are able to migrate 
to the MLN because PP and LP DCs are likely to transport different types of 
antigen, acquired via different routes (Knoop et al., 2009; McDole et al., 2012), 
in different microenvironments (Ermund et al., 2013; Hirota et al., 2013; Schulz 
et al., 2009), and are therefore likely to play different physiological roles. 
 
DCs from the PPs can acquire antigen via M cells, which are specialised for the 
uptake of large particulate antigen. Therefore, data presented in this thesis 
shows how particulate antigen is able to gain access to the MLN, from DCs in the 
PP that migrate to the MLN. Targeting this PP-migratory DC subset via M cell 
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specific agents, such as anti-GP-2, represents a truly unique way to manipulate 
the immune system (Hase et al., 2009a). However, many questions remain 
unanswered regarding these DCs. Their physiological functions, for instance, 
remain unclear. I postulate that the migration of DCs to the MLN from the PP 
may be necessary to initiate T cell responses in the MLN against PP derived 
antigen. Although there are naive T cells in PPs they are present at lower levels 
compared to other lymphatic tissues, therefore DCs may have to migrate to the 
MLN to achieve an effective T cell response. Furthermore, it is unclear what 
type of an immune response is preferentially induced in by PP migratory DCs. PP 
DCs have been associated with an antigen dependent Th2 type response; 
therefore this novel population of migratory DCs may also be expected to induce 
a Th2 type response (Yoshida et al., 2002b). 
 
Further questions remain regarding the mechanisms controlling the migration of 
PP DCs to the MLN. Migratory PP DCs were missing from the MLN of CCR7-/- mice; 
therefore they are likely to migrate in response to CCL19 and CCL21. However 
PPs contain CCL19 and CCL21 expressing cells, so it remains to be determined 
how PP DCs appear selectively able to migrate towards IFRs of the PP, while 
others migrate towards CCL19 and CCL21 from the MLN. It would be interesting 
to determine if there are areas, close to the PP-draining lymphatic vessels, 
where expression of CCL19 and CCL21 is weaker thus giving the PP DC the 
opportunity to migrate to the MLN. Furthermore, the molecular mechanisms 
controlling migration of PP DCs are unlike those used by DCs that migrate from 
the conventional villus mucosa. The migration of PP DCs is controlled by S1P, 
while LP DC migration is unaffected by blocking S1P signalling. This suggests that 
there are fundamental differences between PP and LP migratory DCs, making PP 
migratory DCs an attractive population for further investigation. 
 
I show here that migrating DC populations that reach the MLN can be separated, 
both by their specific tissue of origin, and by the molecular mechanisms that 
control their migration. These findings demonstrate a new way by which the 
intestinal immune system communicates. Furthermore, they open new avenues 
for controlling the functions of intestinal DCs, and therefore manipulating the 
intestinal immune response, with exquisite precision. Finally, these cells may 
provide a novel tool to generate oral vaccines with enhanced specificity, as they 
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appear to be distinct from LP DCs. Determining the functional differences 
between these PP migratory DCs and LP DCs is therefore of paramount 
importance.  
 
6.1 Conclusions 
Experiments presented in this thesis have added to existing knowledge by 
providing a detailed analysis of DC subsets and their migration from specific 
areas in the intestine. I have demonstrated the anatomical segregation of 
lymphatic drainage between the SI and colon and I have identified a novel 
pathway by which PP DC can access the MLN. Future work will should now 
investigate the roles played by these DCs in the prevention of disease, and 
should aim to target these cells to exploit their full immunogenic potential.  
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